Background  ||| S:24 E:43 ||| NNP
Sequence  ||| S:43 E:52 ||| NNP
homology  ||| S:52 E:61 ||| NN
between  ||| S:61 E:69 ||| IN
the  ||| S:69 E:73 ||| DT
serotonin  ||| S:73 E:83 ||| JJ
type  ||| S:83 E:88 ||| NN
3  ||| S:88 E:90 ||| CD
receptor  ||| S:90 E:107 ||| NN
( ||| S:107 E:108 ||| -LRB-
5-HT  ||| S:108 E:122 ||| CD
3  ||| S:122 E:124 ||| CD
R ||| S:124 E:125 ||| NN
) ||| S:125 E:126 ||| -RRB-
,  ||| S:126 E:128 ||| ,
the  ||| S:128 E:132 ||| DT
nicotinic  ||| S:132 E:142 ||| JJ
acetylcholine  ||| S:142 E:164 ||| JJ
receptor  ||| S:164 E:173 ||| NN
( ||| S:173 E:174 ||| -LRB-
nAChR ||| S:174 E:179 ||| NNP
) ||| S:179 E:180 ||| -RRB-
,  ||| S:180 E:182 ||| ,
the  ||| S:182 E:186 ||| DT
GABA  ||| S:186 E:200 ||| NNP
A  ||| S:200 E:202 ||| DT
receptor  ||| S:202 E:211 ||| NN
and  ||| S:211 E:215 ||| CC
the  ||| S:215 E:219 ||| DT
glycine  ||| S:219 E:227 ||| JJ
receptor  ||| S:227 E:244 ||| NN
suggests  ||| S:244 E:253 ||| VBZ
a  ||| S:253 E:255 ||| DT
large  ||| S:255 E:261 ||| JJ
amount  ||| S:261 E:268 ||| NN
of  ||| S:268 E:271 ||| IN
structural  ||| S:271 E:282 ||| JJ
similarity  ||| S:282 E:293 ||| NN
within  ||| S:293 E:308 ||| IN
this  ||| S:308 E:313 ||| DT
superfamily  ||| S:313 E:325 ||| NN
of  ||| S:325 E:328 ||| IN
ligand  ||| S:328 E:335 ||| FW
gated  ||| S:335 E:341 ||| FW
ion  ||| S:341 E:345 ||| FW
channels  ||| S:345 E:354 ||| FW
[  ||| S:354 E:356 ||| -LRB-
1  ||| S:356 E:358 ||| CD
2  ||| S:358 E:360 ||| CD
3  ||| S:360 E:362 ||| CD
]  ||| S:362 E:364 ||| -RRB-
.  ||| S:364 E:374 ||| .
This  ||| S:374 E:379 ||| DT
presumed  ||| S:379 E:388 ||| JJ
structural  ||| S:388 E:399 ||| JJ
homology  ||| S:399 E:408 ||| NN
can  ||| S:408 E:412 ||| MD
be  ||| S:412 E:415 ||| VB
used  ||| S:415 E:420 ||| VBN
to  ||| S:420 E:423 ||| TO
guide  ||| S:423 E:429 ||| VB
site  ||| S:429 E:442 ||| NN
directed  ||| S:442 E:451 ||| VBD
mutagenesis  ||| S:451 E:463 ||| JJ
studies  ||| S:463 E:471 ||| NNS
of  ||| S:471 E:474 ||| IN
particular  ||| S:474 E:485 ||| JJ
receptor  ||| S:485 E:502 ||| NN
subtypes ||| S:502 E:510 ||| NN
.  ||| S:510 E:512 ||| .
On  ||| S:512 E:515 ||| IN
a  ||| S:515 E:517 ||| DT
gross  ||| S:517 E:523 ||| JJ
level ||| S:523 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
all  ||| S:530 E:534 ||| DT
members  ||| S:534 E:542 ||| NNS
of  ||| S:542 E:545 ||| IN
this  ||| S:545 E:550 ||| DT
superfamily  ||| S:550 E:570 ||| JJ
assemble  ||| S:570 E:579 ||| NN
as  ||| S:579 E:582 ||| IN
pentameric  ||| S:582 E:593 ||| JJ
receptors  ||| S:593 E:603 ||| NNS
[  ||| S:603 E:605 ||| -LRB-
4  ||| S:605 E:607 ||| LS
]  ||| S:607 E:609 ||| -RRB-
.  ||| S:609 E:611 ||| .
In  ||| S:611 E:614 ||| IN
some  ||| S:614 E:619 ||| DT
cases ||| S:619 E:624 ||| NNS
,  ||| S:624 E:634 ||| ,
receptors  ||| S:634 E:644 ||| NNS
can  ||| S:644 E:648 ||| MD
be  ||| S:648 E:651 ||| VB
assembled  ||| S:651 E:661 ||| VBN
from  ||| S:661 E:666 ||| IN
a  ||| S:666 E:668 ||| DT
single  ||| S:668 E:675 ||| JJ
subunit  ||| S:675 E:683 ||| NNS
( ||| S:683 E:684 ||| -LRB-
5-HT  ||| S:684 E:698 ||| NNP
3A  ||| S:698 E:701 ||| NNP
R  ||| S:701 E:703 ||| NNP
and  ||| S:703 E:707 ||| CC
nicotinic  ||| S:707 E:717 ||| CD
α7  ||| S:717 E:720 ||| CD
receptors ||| S:720 E:729 ||| CD
)  ||| S:729 E:731 ||| -RRB-
[  ||| S:731 E:733 ||| -LRB-
1  ||| S:733 E:735 ||| CD
5  ||| S:735 E:737 ||| CD
6  ||| S:737 E:747 ||| CD
7  ||| S:747 E:749 ||| CD
8  ||| S:749 E:751 ||| CD
]  ||| S:751 E:753 ||| -RRB-
.  ||| S:753 E:755 ||| .
In  ||| S:755 E:758 ||| IN
other  ||| S:758 E:764 ||| JJ
cases ||| S:764 E:769 ||| NNS
,  ||| S:769 E:771 ||| ,
at  ||| S:771 E:774 ||| IN
least  ||| S:774 E:780 ||| JJS
two  ||| S:780 E:784 ||| CD
different  ||| S:784 E:794 ||| JJ
subunits  ||| S:794 E:803 ||| NNS
are  ||| S:803 E:815 ||| VBP
required  ||| S:815 E:824 ||| VBN
[  ||| S:824 E:826 ||| -LRB-
2  ||| S:826 E:828 ||| CD
4  ||| S:828 E:830 ||| CD
9  ||| S:830 E:832 ||| CD
]  ||| S:832 E:834 ||| -RRB-
.  ||| S:834 E:836 ||| .
The  ||| S:836 E:840 ||| DT
ligand  ||| S:840 E:847 ||| JJ
binding  ||| S:847 E:855 ||| JJ
site  ||| S:855 E:860 ||| NN
is  ||| S:860 E:863 ||| VBZ
thought  ||| S:863 E:871 ||| VBN
to  ||| S:871 E:882 ||| TO
be  ||| S:882 E:885 ||| VB
formed  ||| S:885 E:892 ||| VBN
at  ||| S:892 E:895 ||| IN
the  ||| S:895 E:899 ||| DT
junction  ||| S:899 E:908 ||| NN
between  ||| S:908 E:916 ||| IN
two  ||| S:916 E:920 ||| CD
subunits  ||| S:920 E:929 ||| NNS
[  ||| S:929 E:931 ||| -LRB-
2  ||| S:931 E:933 ||| CD
4  ||| S:933 E:935 ||| CD
]  ||| S:935 E:945 ||| -RRB-
.  ||| S:945 E:955 ||| .
Based  ||| S:955 E:961 ||| VBN
on  ||| S:961 E:964 ||| IN
data  ||| S:964 E:969 ||| NNS
obtained  ||| S:969 E:978 ||| VBN
from  ||| S:978 E:983 ||| IN
affinity  ||| S:983 E:992 ||| JJ
labeling  ||| S:992 E:1001 ||| NN
and  ||| S:1001 E:1005 ||| CC
site  ||| S:1005 E:1018 ||| NN
directed  ||| S:1018 E:1027 ||| VBD
mutagenesis  ||| S:1027 E:1039 ||| JJ
studies ||| S:1039 E:1046 ||| NNS
,  ||| S:1046 E:1048 ||| ,
several  ||| S:1048 E:1056 ||| JJ
regions  ||| S:1056 E:1064 ||| NNS
of  ||| S:1064 E:1067 ||| IN
the  ||| S:1067 E:1079 ||| DT
nicotinic  ||| S:1079 E:1089 ||| JJ
acetylcholine  ||| S:1089 E:1103 ||| JJ
receptor  ||| S:1103 E:1112 ||| NNS
have  ||| S:1112 E:1117 ||| VBP
been  ||| S:1117 E:1122 ||| VBN
implicated  ||| S:1122 E:1133 ||| VBN
in  ||| S:1133 E:1144 ||| IN
ligand  ||| S:1144 E:1151 ||| JJ
binding  ||| S:1151 E:1159 ||| NNS
[  ||| S:1159 E:1161 ||| -LRB-
10  ||| S:1161 E:1164 ||| CD
]  ||| S:1164 E:1166 ||| -RRB-
.  ||| S:1166 E:1168 ||| .
Six  ||| S:1168 E:1172 ||| CD
essential  ||| S:1172 E:1182 ||| JJ
loops  ||| S:1182 E:1188 ||| NNS
appear  ||| S:1188 E:1195 ||| VBP
to  ||| S:1195 E:1206 ||| TO
contribute  ||| S:1206 E:1217 ||| VB
to  ||| S:1217 E:1220 ||| TO
the  ||| S:1220 E:1224 ||| DT
binding  ||| S:1224 E:1232 ||| JJ
site  ||| S:1232 E:1237 ||| NN
with  ||| S:1237 E:1242 ||| IN
the  ||| S:1242 E:1246 ||| DT
position  ||| S:1246 E:1255 ||| NN
of  ||| S:1255 E:1258 ||| IN
each  ||| S:1258 E:1271 ||| DT
loop  ||| S:1271 E:1276 ||| NN
differing  ||| S:1276 E:1286 ||| VBG
slightly  ||| S:1286 E:1295 ||| RB
depending  ||| S:1295 E:1305 ||| VBG
on  ||| S:1305 E:1308 ||| RP
whether  ||| S:1308 E:1316 ||| IN
the  ||| S:1316 E:1320 ||| DT
receptor  ||| S:1320 E:1337 ||| NN
is  ||| S:1337 E:1340 ||| VBZ
heteromeric  ||| S:1340 E:1352 ||| VBN
or  ||| S:1352 E:1355 ||| CC
homomeric  ||| S:1355 E:1365 ||| NNS
[  ||| S:1365 E:1367 ||| -LRB-
4  ||| S:1367 E:1369 ||| LS
]  ||| S:1369 E:1371 ||| -RRB-
.  ||| S:1371 E:1373 ||| .
For  ||| S:1373 E:1377 ||| IN
homomeric  ||| S:1377 E:1387 ||| JJ
receptors  ||| S:1387 E:1405 ||| JJ
such  ||| S:1405 E:1410 ||| JJ
as  ||| S:1410 E:1413 ||| IN
the  ||| S:1413 E:1417 ||| DT
α7  ||| S:1417 E:1420 ||| NNP
nAChR ||| S:1420 E:1425 ||| NNP
,  ||| S:1425 E:1427 ||| ,
the  ||| S:1427 E:1431 ||| DT
loops  ||| S:1431 E:1437 ||| NNS
are  ||| S:1437 E:1441 ||| VBP
identified  ||| S:1441 E:1452 ||| VBN
as  ||| S:1452 E:1455 ||| IN
A ||| S:1455 E:1456 ||| NNP
,  ||| S:1456 E:1458 ||| ,
B ||| S:1458 E:1459 ||| NNP
,  ||| S:1459 E:1461 ||| ,
C ||| S:1461 E:1462 ||| NNP
,  ||| S:1462 E:1472 ||| ,
D ||| S:1472 E:1473 ||| NNP
,  ||| S:1473 E:1475 ||| ,
E  ||| S:1475 E:1477 ||| NNP
and  ||| S:1477 E:1481 ||| CC
F  ||| S:1481 E:1483 ||| NNP
[  ||| S:1483 E:1485 ||| -LRB-
4  ||| S:1485 E:1487 ||| CD
11  ||| S:1487 E:1490 ||| CD
]  ||| S:1490 E:1492 ||| -RRB-
.  ||| S:1492 E:1494 ||| .
The  ||| S:1494 E:1498 ||| DT
amino  ||| S:1498 E:1504 ||| JJ
acids  ||| S:1504 E:1510 ||| NNS
that  ||| S:1510 E:1515 ||| IN
interact  ||| S:1515 E:1524 ||| NN
with  ||| S:1524 E:1537 ||| IN
ligands  ||| S:1537 E:1545 ||| VBG
presumably  ||| S:1545 E:1556 ||| RB
extend  ||| S:1556 E:1563 ||| VB
into  ||| S:1563 E:1568 ||| IN
the  ||| S:1568 E:1572 ||| DT
binding  ||| S:1572 E:1580 ||| JJ
site  ||| S:1580 E:1585 ||| NN
from  ||| S:1585 E:1590 ||| IN
these  ||| S:1590 E:1604 ||| DT
loops ||| S:1604 E:1609 ||| NNS
.  ||| S:1609 E:1611 ||| .
Subunits  ||| S:1611 E:1620 ||| NNS
are  ||| S:1620 E:1624 ||| VBP
composed  ||| S:1624 E:1633 ||| VBN
of  ||| S:1633 E:1636 ||| IN
2  ||| S:1636 E:1638 ||| CD
faces  ||| S:1638 E:1644 ||| NNS
( ||| S:1644 E:1645 ||| -LRB-
+  ||| S:1645 E:1647 ||| NNP
and  ||| S:1647 E:1651 ||| CC
- ||| S:1651 E:1652 ||| NNP
)  ||| S:1652 E:1654 ||| -RRB-
with  ||| S:1654 E:1659 ||| IN
the  ||| S:1659 E:1671 ||| DT
+  ||| S:1671 E:1673 ||| JJ
face  ||| S:1673 E:1678 ||| NN
of  ||| S:1678 E:1681 ||| IN
one  ||| S:1681 E:1685 ||| CD
subunit  ||| S:1685 E:1693 ||| CD
forming  ||| S:1693 E:1701 ||| CD
one  ||| S:1701 E:1705 ||| CD
side  ||| S:1705 E:1710 ||| NN
of  ||| S:1710 E:1713 ||| IN
the  ||| S:1713 E:1717 ||| DT
binding  ||| S:1717 E:1725 ||| JJ
site  ||| S:1725 E:1738 ||| NN
and  ||| S:1738 E:1742 ||| CC
the  ||| S:1742 E:1746 ||| DT
-  ||| S:1746 E:1748 ||| :
face  ||| S:1748 E:1753 ||| NN
of  ||| S:1753 E:1756 ||| IN
another  ||| S:1756 E:1764 ||| DT
subunit  ||| S:1764 E:1772 ||| NN
forming  ||| S:1772 E:1780 ||| VBG
the  ||| S:1780 E:1784 ||| DT
complimentary  ||| S:1784 E:1806 ||| JJ
side ||| S:1806 E:1810 ||| NN
.  ||| S:1810 E:1812 ||| .
Some  ||| S:1812 E:1817 ||| DT
binding  ||| S:1817 E:1825 ||| JJ
loops  ||| S:1825 E:1831 ||| NNS
( ||| S:1831 E:1832 ||| -LRB-
A ||| S:1832 E:1833 ||| NNP
,  ||| S:1833 E:1835 ||| ,
B  ||| S:1835 E:1837 ||| NNP
and  ||| S:1837 E:1841 ||| CC
C ||| S:1841 E:1842 ||| NNP
)  ||| S:1842 E:1844 ||| -RRB-
are  ||| S:1844 E:1848 ||| VBP
present  ||| S:1848 E:1856 ||| JJ
on  ||| S:1856 E:1859 ||| IN
the  ||| S:1859 E:1863 ||| DT
-  ||| S:1863 E:1873 ||| :
face  ||| S:1873 E:1878 ||| NN
while  ||| S:1878 E:1884 ||| IN
the  ||| S:1884 E:1888 ||| DT
remaining  ||| S:1888 E:1898 ||| JJ
loops  ||| S:1898 E:1904 ||| NNS
( ||| S:1904 E:1905 ||| -LRB-
D  ||| S:1905 E:1907 ||| NNP
and  ||| S:1907 E:1911 ||| CC
E ||| S:1911 E:1912 ||| NNP
)  ||| S:1912 E:1914 ||| -RRB-
are  ||| S:1914 E:1918 ||| VBP
present  ||| S:1918 E:1926 ||| JJ
on  ||| S:1926 E:1929 ||| IN
the  ||| S:1929 E:1941 ||| DT
+  ||| S:1941 E:1943 ||| NNP
face.  ||| S:1943 E:1949 ||| NNP
[  ||| S:1949 E:1951 ||| -LRB-
4  ||| S:1951 E:1953 ||| LS
]  ||| S:1953 E:1955 ||| -RRB-
.  ||| S:1955 E:1957 ||| .
The  ||| S:1957 E:1961 ||| DT
individual  ||| S:1961 E:1972 ||| JJ
amino  ||| S:1972 E:1978 ||| JJ
acids  ||| S:1978 E:1984 ||| NNS
that  ||| S:1984 E:1989 ||| WDT
form  ||| S:1989 E:2002 ||| VBP
binding  ||| S:2002 E:2010 ||| JJ
interactions  ||| S:2010 E:2023 ||| NNS
with  ||| S:2023 E:2028 ||| IN
the  ||| S:2028 E:2032 ||| DT
functional  ||| S:2032 E:2043 ||| JJ
groups  ||| S:2043 E:2050 ||| NNS
present  ||| S:2050 E:2058 ||| JJ
on  ||| S:2058 E:2069 ||| IN
a  ||| S:2069 E:2071 ||| DT
ligand  ||| S:2071 E:2078 ||| NNS
are  ||| S:2078 E:2082 ||| VBP
likely  ||| S:2082 E:2089 ||| JJ
to  ||| S:2089 E:2092 ||| TO
differ  ||| S:2092 E:2099 ||| VB
for  ||| S:2099 E:2103 ||| IN
each  ||| S:2103 E:2108 ||| DT
receptor  ||| S:2108 E:2117 ||| NN
subtype ||| S:2117 E:2124 ||| NN
,  ||| S:2124 E:2134 ||| ,
reflecting  ||| S:2134 E:2145 ||| VBG
the  ||| S:2145 E:2149 ||| DT
specificity  ||| S:2149 E:2161 ||| NN
of  ||| S:2161 E:2164 ||| IN
a  ||| S:2164 E:2166 ||| DT
particular  ||| S:2166 E:2177 ||| JJ
binding  ||| S:2177 E:2185 ||| JJ
site ||| S:2185 E:2189 ||| NN
,  ||| S:2189 E:2199 ||| ,
however ||| S:2199 E:2206 ||| RB
,  ||| S:2206 E:2208 ||| ,
the  ||| S:2208 E:2212 ||| DT
overall  ||| S:2212 E:2220 ||| JJ
structure  ||| S:2220 E:2230 ||| NN
of  ||| S:2230 E:2233 ||| IN
the  ||| S:2233 E:2237 ||| DT
binding  ||| S:2237 E:2245 ||| JJ
domain  ||| S:2245 E:2252 ||| NN
may  ||| S:2252 E:2256 ||| MD
be  ||| S:2256 E:2267 ||| VB
similar  ||| S:2267 E:2275 ||| JJ
even  ||| S:2275 E:2280 ||| RB
for  ||| S:2280 E:2284 ||| IN
binding  ||| S:2284 E:2292 ||| JJ
sites  ||| S:2292 E:2298 ||| NNS
with  ||| S:2298 E:2303 ||| IN
different  ||| S:2303 E:2313 ||| JJ
ligand  ||| S:2313 E:2328 ||| JJ
specificities ||| S:2328 E:2341 ||| NN
.  ||| S:2341 E:2343 ||| .
Identification  ||| S:2343 E:2358 ||| NN
of  ||| S:2358 E:2361 ||| IN
ligand  ||| S:2361 E:2368 ||| JJ
specificity  ||| S:2368 E:2388 ||| NN
requires  ||| S:2388 E:2397 ||| VBZ
identification  ||| S:2397 E:2412 ||| VBN
of  ||| S:2412 E:2415 ||| IN
both  ||| S:2415 E:2420 ||| PDT
the  ||| S:2420 E:2424 ||| DT
location  ||| S:2424 E:2433 ||| NN
or  ||| S:2433 E:2436 ||| CC
structure  ||| S:2436 E:2454 ||| NN
of  ||| S:2454 E:2457 ||| IN
individual  ||| S:2457 E:2468 ||| JJ
binding  ||| S:2468 E:2476 ||| JJ
site  ||| S:2476 E:2481 ||| NN
loops  ||| S:2481 E:2487 ||| NNS
and  ||| S:2487 E:2491 ||| CC
the  ||| S:2491 E:2495 ||| DT
amino  ||| S:2495 E:2501 ||| JJ
acids  ||| S:2501 E:2515 ||| JJ
present  ||| S:2515 E:2523 ||| NN
in  ||| S:2523 E:2526 ||| IN
a  ||| S:2526 E:2528 ||| DT
particular  ||| S:2528 E:2539 ||| JJ
receptor  ||| S:2539 E:2548 ||| NN
subtype ||| S:2548 E:2555 ||| NN
.  ||| S:2555 E:2565 ||| .
The  ||| S:2565 E:2569 ||| DT
purpose  ||| S:2569 E:2577 ||| NN
of  ||| S:2577 E:2580 ||| IN
this  ||| S:2580 E:2585 ||| DT
study  ||| S:2585 E:2591 ||| NN
is  ||| S:2591 E:2594 ||| VBZ
to  ||| S:2594 E:2597 ||| TO
extend  ||| S:2597 E:2604 ||| VB
the  ||| S:2604 E:2608 ||| DT
information  ||| S:2608 E:2628 ||| NN
available  ||| S:2628 E:2638 ||| JJ
from  ||| S:2638 E:2643 ||| IN
other  ||| S:2643 E:2649 ||| JJ
members  ||| S:2649 E:2657 ||| NNS
of  ||| S:2657 E:2660 ||| IN
this  ||| S:2660 E:2665 ||| DT
receptor  ||| S:2665 E:2674 ||| NN
family  ||| S:2674 E:2681 ||| NN
to  ||| S:2681 E:2684 ||| TO
the  ||| S:2684 E:2696 ||| DT
5-HT  ||| S:2696 E:2710 ||| CD
3  ||| S:2710 E:2712 ||| CD
R.  ||| S:2712 E:2715 ||| NNP
Sequence  ||| S:2715 E:2724 ||| NNP
homology  ||| S:2724 E:2733 ||| NN
and  ||| S:2733 E:2737 ||| CC
a  ||| S:2737 E:2739 ||| DT
presumed  ||| S:2739 E:2756 ||| JJ
structural  ||| S:2756 E:2767 ||| JJ
similarity  ||| S:2767 E:2778 ||| NN
to  ||| S:2778 E:2781 ||| TO
other  ||| S:2781 E:2787 ||| JJ
ligand  ||| S:2787 E:2794 ||| FW
gated  ||| S:2794 E:2800 ||| FW
ion  ||| S:2800 E:2804 ||| FW
channels  ||| S:2804 E:2821 ||| FW
suggests  ||| S:2821 E:2830 ||| VBZ
that  ||| S:2830 E:2835 ||| IN
the  ||| S:2835 E:2839 ||| DT
E  ||| S:2839 E:2841 ||| NN
loop  ||| S:2841 E:2846 ||| NN
region  ||| S:2846 E:2853 ||| NN
of  ||| S:2853 E:2856 ||| IN
the  ||| S:2856 E:2860 ||| DT
5-HT  ||| S:2860 E:2874 ||| CD
3A  ||| S:2874 E:2877 ||| CD
R  ||| S:2877 E:2879 ||| NN
forms  ||| S:2879 E:2885 ||| NNS
part  ||| S:2885 E:2890 ||| NN
of  ||| S:2890 E:2893 ||| IN
the  ||| S:2893 E:2897 ||| DT
ligand  ||| S:2897 E:2904 ||| JJ
binding  ||| S:2904 E:2920 ||| JJ
domain  ||| S:2920 E:2927 ||| NN
for  ||| S:2927 E:2931 ||| IN
5-HT  ||| S:2931 E:2945 ||| CD
3  ||| S:2945 E:2947 ||| CD
R  ||| S:2947 E:2949 ||| NN
ligands ||| S:2949 E:2956 ||| NN
.  ||| S:2956 E:2958 ||| .
This  ||| S:2958 E:2963 ||| DT
region  ||| S:2963 E:2970 ||| NN
extends  ||| S:2970 E:2978 ||| VBZ
from  ||| S:2978 E:2991 ||| IN
Y140  ||| S:2991 E:2996 ||| CD
to  ||| S:2996 E:2999 ||| TO
K153  ||| S:2999 E:3004 ||| CD
and  ||| S:3004 E:3008 ||| CC
is  ||| S:3008 E:3011 ||| VBZ
shown  ||| S:3011 E:3017 ||| VBN
in  ||| S:3017 E:3020 ||| IN
Table  ||| S:3020 E:3026 ||| NNP
1 ||| S:3026 E:3027 ||| CD
.  ||| S:3027 E:3029 ||| .
The  ||| S:3029 E:3033 ||| DT
homologous  ||| S:3033 E:3052 ||| JJ
sequences  ||| S:3052 E:3062 ||| NN
of  ||| S:3062 E:3065 ||| IN
other  ||| S:3065 E:3071 ||| JJ
representative  ||| S:3071 E:3086 ||| NN
members  ||| S:3086 E:3094 ||| NNS
of  ||| S:3094 E:3097 ||| IN
this  ||| S:3097 E:3102 ||| DT
family  ||| S:3102 E:3117 ||| NN
are  ||| S:3117 E:3121 ||| VBP
also  ||| S:3121 E:3126 ||| RB
shown ||| S:3126 E:3131 ||| VBN
.  ||| S:3131 E:3133 ||| .
In  ||| S:3133 E:3136 ||| IN
the  ||| S:3136 E:3140 ||| DT
center  ||| S:3140 E:3147 ||| NN
of  ||| S:3147 E:3150 ||| IN
this  ||| S:3150 E:3155 ||| DT
region  ||| S:3155 E:3162 ||| NN
is  ||| S:3162 E:3165 ||| VBZ
a  ||| S:3165 E:3167 ||| DT
critical  ||| S:3167 E:3184 ||| JJ
glycine  ||| S:3184 E:3192 ||| JJ
residue  ||| S:3192 E:3200 ||| NN
that  ||| S:3200 E:3205 ||| WDT
is  ||| S:3205 E:3208 ||| VBZ
thought  ||| S:3208 E:3216 ||| VBN
to  ||| S:3216 E:3219 ||| TO
play  ||| S:3219 E:3224 ||| VB
a  ||| S:3224 E:3226 ||| DT
role  ||| S:3226 E:3231 ||| NN
in  ||| S:3231 E:3242 ||| IN
establishing  ||| S:3242 E:3255 ||| VBG
a  ||| S:3255 E:3257 ||| DT
hairpin  ||| S:3257 E:3265 ||| JJ
loop  ||| S:3265 E:3270 ||| NNS
[  ||| S:3270 E:3272 ||| -LRB-
12  ||| S:3272 E:3275 ||| CD
]  ||| S:3275 E:3277 ||| -RRB-
.  ||| S:3277 E:3279 ||| .
Recent  ||| S:3279 E:3286 ||| JJ
x-ray  ||| S:3286 E:3300 ||| JJ
crystallographic  ||| S:3300 E:3317 ||| JJ
data  ||| S:3317 E:3322 ||| NNS
obtained  ||| S:3322 E:3331 ||| VBN
from  ||| S:3331 E:3336 ||| IN
an  ||| S:3336 E:3339 ||| DT
ACh  ||| S:3339 E:3343 ||| JJ
binding  ||| S:3343 E:3351 ||| JJ
protein  ||| S:3351 E:3367 ||| NN
( ||| S:3367 E:3368 ||| -LRB-
AChBP ||| S:3368 E:3373 ||| NNP
)  ||| S:3373 E:3375 ||| -RRB-
shows  ||| S:3375 E:3381 ||| VBZ
a  ||| S:3381 E:3383 ||| DT
loop  ||| S:3383 E:3388 ||| JJ
structure  ||| S:3388 E:3398 ||| NN
in  ||| S:3398 E:3401 ||| IN
this  ||| S:3401 E:3406 ||| DT
region  ||| S:3406 E:3413 ||| NN
resulting  ||| S:3413 E:3431 ||| VBG
from  ||| S:3431 E:3436 ||| IN
a  ||| S:3436 E:3438 ||| DT
3  ||| S:3438 E:3440 ||| CD
residue  ||| S:3440 E:3448 ||| NNS
turn  ||| S:3448 E:3453 ||| VBP
containing  ||| S:3453 E:3464 ||| VBG
a  ||| S:3464 E:3466 ||| DT
glycine  ||| S:3466 E:3474 ||| JJ
homologous  ||| S:3474 E:3485 ||| NN
to  ||| S:3485 E:3496 ||| TO
G147  ||| S:3496 E:3501 ||| CD
of  ||| S:3501 E:3504 ||| IN
the  ||| S:3504 E:3508 ||| DT
5-HT  ||| S:3508 E:3522 ||| CD
3  ||| S:3522 E:3524 ||| CD
R.  ||| S:3524 E:3527 ||| NNP
On  ||| S:3527 E:3530 ||| IN
either  ||| S:3530 E:3537 ||| DT
side  ||| S:3537 E:3542 ||| NN
of  ||| S:3542 E:3545 ||| IN
this  ||| S:3545 E:3550 ||| DT
putative  ||| S:3550 E:3567 ||| JJ
turn  ||| S:3567 E:3572 ||| NN
region  ||| S:3572 E:3579 ||| NN
are  ||| S:3579 E:3583 ||| VBP
residues  ||| S:3583 E:3592 ||| NNS
that  ||| S:3592 E:3597 ||| WDT
have  ||| S:3597 E:3602 ||| VBP
been  ||| S:3602 E:3607 ||| VBN
identified  ||| S:3607 E:3618 ||| VBN
as  ||| S:3618 E:3629 ||| IN
important  ||| S:3629 E:3639 ||| JJ
to  ||| S:3639 E:3642 ||| TO
receptor  ||| S:3642 E:3651 ||| VB
binding  ||| S:3651 E:3659 ||| JJ
[  ||| S:3659 E:3661 ||| -LRB-
12  ||| S:3661 E:3664 ||| CD
13  ||| S:3664 E:3667 ||| CD
14  ||| S:3667 E:3670 ||| CD
15  ||| S:3670 E:3673 ||| CD
16  ||| S:3673 E:3676 ||| CD
17  ||| S:3676 E:3679 ||| CD
18  ||| S:3679 E:3682 ||| CD
]  ||| S:3682 E:3684 ||| -RRB-
.  ||| S:3684 E:3694 ||| .
The  ||| S:3694 E:3698 ||| DT
formation  ||| S:3698 E:3708 ||| NN
of  ||| S:3708 E:3711 ||| IN
this  ||| S:3711 E:3716 ||| DT
loop  ||| S:3716 E:3721 ||| JJ
structure  ||| S:3721 E:3731 ||| NN
brings  ||| S:3731 E:3738 ||| VBZ
amino  ||| S:3738 E:3744 ||| JJ
acids  ||| S:3744 E:3750 ||| NNS
on  ||| S:3750 E:3761 ||| IN
either  ||| S:3761 E:3768 ||| DT
side  ||| S:3768 E:3773 ||| NN
of  ||| S:3773 E:3776 ||| IN
glycine  ||| S:3776 E:3784 ||| NN
into  ||| S:3784 E:3789 ||| IN
close  ||| S:3789 E:3795 ||| JJ
proximity  ||| S:3795 E:3805 ||| NN
and  ||| S:3805 E:3809 ||| CC
may  ||| S:3809 E:3813 ||| MD
form  ||| S:3813 E:3818 ||| VB
a  ||| S:3818 E:3828 ||| DT
binding  ||| S:3828 E:3836 ||| JJ
pocket  ||| S:3836 E:3843 ||| NN
that  ||| S:3843 E:3848 ||| WDT
will  ||| S:3848 E:3853 ||| MD
accommodate  ||| S:3853 E:3865 ||| VB
one  ||| S:3865 E:3869 ||| CD
or  ||| S:3869 E:3872 ||| CC
more  ||| S:3872 E:3877 ||| RBR
functional  ||| S:3877 E:3896 ||| JJ
groups ||| S:3896 E:3902 ||| NNS
.  ||| S:3902 E:3904 ||| .
In  ||| S:3904 E:3907 ||| IN
order  ||| S:3907 E:3913 ||| NN
to  ||| S:3913 E:3916 ||| TO
identify  ||| S:3916 E:3925 ||| VB
the  ||| S:3925 E:3929 ||| DT
interaction  ||| S:3929 E:3941 ||| NN
of  ||| S:3941 E:3944 ||| IN
amino  ||| S:3944 E:3950 ||| JJ
acids  ||| S:3950 E:3964 ||| NNS
in  ||| S:3964 E:3967 ||| IN
this  ||| S:3967 E:3972 ||| DT
binding  ||| S:3972 E:3980 ||| JJ
loop  ||| S:3980 E:3985 ||| NN
with  ||| S:3985 E:3990 ||| IN
5-HT  ||| S:3990 E:4004 ||| CD
3  ||| S:4004 E:4006 ||| CD
R  ||| S:4006 E:4008 ||| NN
ligands ||| S:4008 E:4015 ||| NN
,  ||| S:4015 E:4017 ||| ,
we  ||| S:4017 E:4020 ||| PRP
have  ||| S:4020 E:4025 ||| VBP
constructed  ||| S:4025 E:4037 ||| VBN
alanine  ||| S:4037 E:4053 ||| JJ
mutations  ||| S:4053 E:4063 ||| NNS
of  ||| S:4063 E:4066 ||| IN
residues  ||| S:4066 E:4075 ||| NNS
throughout  ||| S:4075 E:4086 ||| IN
this  ||| S:4086 E:4091 ||| DT
region  ||| S:4091 E:4098 ||| NN
and  ||| S:4098 E:4102 ||| CC
evaluated  ||| S:4102 E:4120 ||| VBD
the  ||| S:4120 E:4124 ||| DT
alteration  ||| S:4124 E:4135 ||| NN
in  ||| S:4135 E:4138 ||| IN
binding  ||| S:4138 E:4146 ||| JJ
affinity  ||| S:4146 E:4155 ||| NN
of  ||| S:4155 E:4158 ||| IN
5  ||| S:4158 E:4160 ||| CD
different  ||| S:4160 E:4170 ||| JJ
classes  ||| S:4170 E:4186 ||| NNS
of  ||| S:4186 E:4189 ||| IN
5-HT  ||| S:4189 E:4203 ||| CD
3  ||| S:4203 E:4205 ||| CD
R  ||| S:4205 E:4207 ||| NN
ligands  ||| S:4207 E:4215 ||| NNS
( ||| S:4215 E:4216 ||| -LRB-
Figure  ||| S:4216 E:4223 ||| NNP
1 ||| S:4223 E:4224 ||| CD
) ||| S:4224 E:4225 ||| -RRB-
.  ||| S:4225 E:4227 ||| .
Our  ||| S:4227 E:4231 ||| PRP$
data  ||| S:4231 E:4244 ||| NN
identifies  ||| S:4244 E:4255 ||| VBZ
3  ||| S:4255 E:4257 ||| CD
tyrosine  ||| S:4257 E:4266 ||| CD
residues  ||| S:4266 E:4275 ||| NNS
that  ||| S:4275 E:4280 ||| WDT
appear  ||| S:4280 E:4287 ||| VBP
to  ||| S:4287 E:4290 ||| TO
interact  ||| S:4290 E:4307 ||| VB
selectively  ||| S:4307 E:4319 ||| RB
with  ||| S:4319 E:4324 ||| IN
each  ||| S:4324 E:4329 ||| DT
structural  ||| S:4329 E:4340 ||| JJ
class  ||| S:4340 E:4346 ||| NN
and  ||| S:4346 E:4350 ||| CC
supports  ||| S:4350 E:4359 ||| VBZ
the  ||| S:4359 E:4371 ||| DT
existence  ||| S:4371 E:4381 ||| NN
of  ||| S:4381 E:4384 ||| IN
a  ||| S:4384 E:4386 ||| DT
loop  ||| S:4386 E:4391 ||| JJ
structure  ||| S:4391 E:4401 ||| NN
in  ||| S:4401 E:4404 ||| IN
this  ||| S:4404 E:4409 ||| DT
region  ||| S:4409 E:4416 ||| NN
of  ||| S:4416 E:4419 ||| IN
the  ||| S:4419 E:4431 ||| DT
receptor ||| S:4431 E:4439 ||| NN
.  ||| S:4439 E:4463 ||| .
Results  ||| S:4463 E:4479 ||| NNS
All  ||| S:4479 E:4483 ||| DT
mutant  ||| S:4483 E:4490 ||| JJ
receptors  ||| S:4490 E:4500 ||| NNS
were  ||| S:4500 E:4505 ||| VBD
tested  ||| S:4505 E:4512 ||| VBN
for  ||| S:4512 E:4516 ||| IN
their  ||| S:4516 E:4522 ||| PRP$
ability  ||| S:4522 E:4530 ||| NN
to  ||| S:4530 E:4541 ||| TO
bind  ||| S:4541 E:4546 ||| VB
the  ||| S:4546 E:4550 ||| DT
5-HT  ||| S:4550 E:4564 ||| CD
3  ||| S:4564 E:4566 ||| CD
R  ||| S:4566 E:4568 ||| NN
antagonist  ||| S:4568 E:4579 ||| NNS
[  ||| S:4579 E:4581 ||| -LRB-
3H ||| S:4581 E:4583 ||| NNP
] ||| S:4583 E:4584 ||| -RRB-
granisetron ||| S:4584 E:4595 ||| NN
.  ||| S:4595 E:4597 ||| .
Table  ||| S:4597 E:4611 ||| NN
2shows  ||| S:4611 E:4618 ||| VBZ
the  ||| S:4618 E:4622 ||| DT
K  ||| S:4622 E:4633 ||| NNP
d  ||| S:4633 E:4635 ||| NN
values  ||| S:4635 E:4642 ||| NNS
for  ||| S:4642 E:4646 ||| IN
wildtype  ||| S:4646 E:4655 ||| JJ
mouse  ||| S:4655 E:4661 ||| NN
5-HT  ||| S:4661 E:4675 ||| NNP
3AS  ||| S:4675 E:4679 ||| NNP
Rs  ||| S:4679 E:4682 ||| NNP
and  ||| S:4682 E:4686 ||| CC
the  ||| S:4686 E:4690 ||| DT
13  ||| S:4690 E:4693 ||| CD
alanine  ||| S:4693 E:4701 ||| NNS
mutations  ||| S:4701 E:4711 ||| VBP
we  ||| S:4711 E:4722 ||| PRP
evaluated.  ||| S:4722 E:4733 ||| VBP
[  ||| S:4733 E:4735 ||| -LRB-
3H ||| S:4735 E:4737 ||| NNP
] ||| S:4737 E:4738 ||| -RRB-
granisetron  ||| S:4738 E:4750 ||| NN
is  ||| S:4750 E:4753 ||| VBZ
a  ||| S:4753 E:4755 ||| DT
potent  ||| S:4755 E:4762 ||| JJ
antagonist  ||| S:4762 E:4773 ||| NN
of  ||| S:4773 E:4776 ||| IN
the  ||| S:4776 E:4788 ||| DT
wt  ||| S:4788 E:4791 ||| JJ
5-HT  ||| S:4791 E:4805 ||| CD
3  ||| S:4805 E:4807 ||| CD
R  ||| S:4807 E:4809 ||| NN
( ||| S:4809 E:4810 ||| -LRB-
K  ||| S:4810 E:4821 ||| NNP
d  ||| S:4821 E:4823 ||| SYM
=  ||| S:4823 E:4825 ||| SYM
0.98  ||| S:4825 E:4830 ||| FW
±  ||| S:4830 E:4832 ||| FW
0.12  ||| S:4832 E:4837 ||| FW
nM ||| S:4837 E:4839 ||| FW
) ||| S:4839 E:4840 ||| -RRB-
.  ||| S:4840 E:4842 ||| .
This  ||| S:4842 E:4847 ||| DT
value  ||| S:4847 E:4853 ||| NN
agrees  ||| S:4853 E:4868 ||| VBZ
with  ||| S:4868 E:4873 ||| IN
published  ||| S:4873 E:4883 ||| JJ
data  ||| S:4883 E:4888 ||| NNS
for  ||| S:4888 E:4892 ||| IN
this  ||| S:4892 E:4897 ||| DT
compound  ||| S:4897 E:4906 ||| NN
[  ||| S:4906 E:4908 ||| -LRB-
19  ||| S:4908 E:4911 ||| CD
20  ||| S:4911 E:4914 ||| CD
]  ||| S:4914 E:4916 ||| -RRB-
.  ||| S:4916 E:4918 ||| .
B  ||| S:4918 E:4929 ||| SYM
max  ||| S:4929 E:4933 ||| JJ
values  ||| S:4933 E:4940 ||| NNS
range  ||| S:4940 E:4946 ||| VBP
from  ||| S:4946 E:4951 ||| IN
the  ||| S:4951 E:4955 ||| DT
5.5  ||| S:4955 E:4959 ||| CD
pmoles ||| S:4959 E:4965 ||| CD
/ ||| S:4965 E:4966 ||| CD
mg  ||| S:4966 E:4977 ||| JJ
protein  ||| S:4977 E:4985 ||| NN
observed  ||| S:4985 E:4994 ||| VBD
for  ||| S:4994 E:4998 ||| IN
E148A  ||| S:4998 E:5004 ||| CD
to  ||| S:5004 E:5007 ||| TO
0.30  ||| S:5007 E:5012 ||| CD
pmoles ||| S:5012 E:5018 ||| CD
/ ||| S:5018 E:5019 ||| CD
mg  ||| S:5019 E:5022 ||| JJ
protein  ||| S:5022 E:5030 ||| NN
for  ||| S:5030 E:5042 ||| IN
the  ||| S:5042 E:5046 ||| DT
K153A  ||| S:5046 E:5052 ||| JJ
mutation ||| S:5052 E:5060 ||| NN
,  ||| S:5060 E:5062 ||| ,
indicating  ||| S:5062 E:5073 ||| VBG
some  ||| S:5073 E:5078 ||| DT
variability  ||| S:5078 E:5090 ||| NN
in  ||| S:5090 E:5101 ||| IN
expression  ||| S:5101 E:5112 ||| NN
of  ||| S:5112 E:5115 ||| IN
the  ||| S:5115 E:5119 ||| DT
different  ||| S:5119 E:5129 ||| JJ
receptors ||| S:5129 E:5138 ||| NNS
.  ||| S:5138 E:5140 ||| .
In  ||| S:5140 E:5143 ||| IN
general ||| S:5143 E:5150 ||| JJ
,  ||| S:5150 E:5152 ||| ,
however ||| S:5152 E:5159 ||| RB
,  ||| S:5159 E:5169 ||| ,
receptor  ||| S:5169 E:5178 ||| JJ
expression  ||| S:5178 E:5189 ||| NN
was  ||| S:5189 E:5193 ||| VBD
similar  ||| S:5193 E:5201 ||| JJ
to  ||| S:5201 E:5204 ||| TO
that  ||| S:5204 E:5209 ||| WDT
reported  ||| S:5209 E:5218 ||| VBD
by  ||| S:5218 E:5221 ||| IN
other  ||| S:5221 E:5235 ||| JJ
laboratories  ||| S:5235 E:5248 ||| NNS
[  ||| S:5248 E:5250 ||| -LRB-
1  ||| S:5250 E:5252 ||| CD
20  ||| S:5252 E:5255 ||| CD
21  ||| S:5255 E:5258 ||| CD
22  ||| S:5258 E:5261 ||| CD
]  ||| S:5261 E:5263 ||| -RRB-
.  ||| S:5263 E:5265 ||| .
No  ||| S:5265 E:5268 ||| DT
detectable  ||| S:5268 E:5279 ||| JJ
binding  ||| S:5279 E:5287 ||| NN
was  ||| S:5287 E:5299 ||| VBD
observed  ||| S:5299 E:5308 ||| VBN
for  ||| S:5308 E:5312 ||| IN
G147A  ||| S:5312 E:5318 ||| NNP
and  ||| S:5318 E:5322 ||| CC
V149A  ||| S:5322 E:5328 ||| CD
mutant  ||| S:5328 E:5335 ||| CD
receptors ||| S:5335 E:5344 ||| NNS
.  ||| S:5344 E:5346 ||| .
For  ||| S:5346 E:5350 ||| IN
all  ||| S:5350 E:5362 ||| DT
other  ||| S:5362 E:5368 ||| JJ
mutants ||| S:5368 E:5375 ||| NN
,  ||| S:5375 E:5377 ||| ,
decreases  ||| S:5377 E:5387 ||| NNS
in  ||| S:5387 E:5390 ||| IN
binding  ||| S:5390 E:5398 ||| JJ
affinity  ||| S:5398 E:5407 ||| NNS
( ||| S:5407 E:5408 ||| -LRB-
increased  ||| S:5408 E:5418 ||| VBN
K  ||| S:5418 E:5429 ||| NN
d  ||| S:5429 E:5431 ||| LS
)  ||| S:5431 E:5433 ||| -RRB-
were  ||| S:5433 E:5438 ||| VBD
observed  ||| S:5438 E:5447 ||| VBN
although  ||| S:5447 E:5456 ||| IN
the  ||| S:5456 E:5460 ||| DT
magnitude  ||| S:5460 E:5478 ||| NN
of  ||| S:5478 E:5481 ||| IN
the  ||| S:5481 E:5485 ||| DT
change  ||| S:5485 E:5492 ||| NN
was  ||| S:5492 E:5496 ||| VBD
less  ||| S:5496 E:5501 ||| JJR
than  ||| S:5501 E:5506 ||| IN
10  ||| S:5506 E:5509 ||| CD
fold  ||| S:5509 E:5514 ||| NN
in  ||| S:5514 E:5517 ||| IN
all  ||| S:5517 E:5521 ||| DT
cases ||| S:5521 E:5526 ||| NNS
.  ||| S:5526 E:5528 ||| .
A  ||| S:5528 E:5530 ||| DT
bar  ||| S:5530 E:5542 ||| NN
graph  ||| S:5542 E:5548 ||| NN
showing  ||| S:5548 E:5556 ||| VBG
the  ||| S:5556 E:5560 ||| DT
change  ||| S:5560 E:5567 ||| NN
in  ||| S:5567 E:5570 ||| IN
K  ||| S:5570 E:5581 ||| NNP
d  ||| S:5581 E:5583 ||| JJ
value  ||| S:5583 E:5589 ||| NN
resulting  ||| S:5589 E:5599 ||| VBG
from  ||| S:5599 E:5604 ||| IN
each  ||| S:5604 E:5609 ||| DT
alanine  ||| S:5609 E:5625 ||| JJ
mutation  ||| S:5625 E:5634 ||| NN
is  ||| S:5634 E:5637 ||| VBZ
shown  ||| S:5637 E:5643 ||| VBN
in  ||| S:5643 E:5646 ||| IN
Figure  ||| S:5646 E:5653 ||| NNP
2A ||| S:5653 E:5655 ||| NNP
.  ||| S:5655 E:5657 ||| .
The  ||| S:5657 E:5661 ||| DT
largest  ||| S:5661 E:5669 ||| JJS
decreases  ||| S:5669 E:5679 ||| NNS
in  ||| S:5679 E:5690 ||| IN
binding  ||| S:5690 E:5698 ||| JJ
affinity  ||| S:5698 E:5707 ||| NN
were  ||| S:5707 E:5712 ||| VBD
observed  ||| S:5712 E:5721 ||| VBN
for  ||| S:5721 E:5725 ||| IN
Y142A  ||| S:5725 E:5731 ||| NNP
( ||| S:5731 E:5732 ||| -LRB-
4.6  ||| S:5732 E:5736 ||| CD
fold ||| S:5736 E:5740 ||| NN
,  ||| S:5740 E:5742 ||| ,
Figure  ||| S:5742 E:5757 ||| NNP
3 ||| S:5757 E:5758 ||| CD
) ||| S:5758 E:5759 ||| -RRB-
,  ||| S:5759 E:5761 ||| ,
E148A  ||| S:5761 E:5767 ||| NNP
( ||| S:5767 E:5768 ||| -LRB-
5.3  ||| S:5768 E:5772 ||| CD
fold ||| S:5772 E:5776 ||| CD
)  ||| S:5776 E:5778 ||| -RRB-
and  ||| S:5778 E:5782 ||| CC
Q150A  ||| S:5782 E:5788 ||| NNP
-  ||| S:5788 E:5790 ||| :
K153A  ||| S:5790 E:5796 ||| CD
( ||| S:5796 E:5797 ||| -LRB-
6  ||| S:5797 E:5799 ||| CD
-  ||| S:5799 E:5801 ||| :
8  ||| S:5801 E:5803 ||| CD
fold ||| S:5803 E:5807 ||| CD
) ||| S:5807 E:5808 ||| -RRB-
.  ||| S:5808 E:5818 ||| .
Inhibition  ||| S:5818 E:5829 ||| JJ
binding  ||| S:5829 E:5837 ||| JJ
assays  ||| S:5837 E:5844 ||| NN
were  ||| S:5844 E:5849 ||| VBD
also  ||| S:5849 E:5854 ||| RB
conducted ||| S:5854 E:5863 ||| VBN
.  ||| S:5863 E:5865 ||| .
Four  ||| S:5865 E:5870 ||| CD
test  ||| S:5870 E:5883 ||| NN
compounds  ||| S:5883 E:5893 ||| NN
with  ||| S:5893 E:5898 ||| IN
structures  ||| S:5898 E:5909 ||| JJ
representative  ||| S:5909 E:5924 ||| NN
of  ||| S:5924 E:5927 ||| IN
the  ||| S:5927 E:5931 ||| DT
major  ||| S:5931 E:5945 ||| JJ
classes  ||| S:5945 E:5953 ||| NNS
of  ||| S:5953 E:5956 ||| IN
5-HT  ||| S:5956 E:5970 ||| CD
3  ||| S:5970 E:5972 ||| CD
R  ||| S:5972 E:5974 ||| NN
ligands  ||| S:5974 E:5982 ||| NNS
were  ||| S:5982 E:5987 ||| VBD
chosen ||| S:5987 E:5993 ||| VBN
:  ||| S:5993 E:5995 ||| :
serotonin  ||| S:5995 E:6013 ||| CD
( ||| S:6013 E:6014 ||| -LRB-
5-HT ||| S:6014 E:6018 ||| NNP
,  ||| S:6018 E:6020 ||| ,
the  ||| S:6020 E:6024 ||| DT
endogenous  ||| S:6024 E:6035 ||| JJ
agonist ||| S:6035 E:6042 ||| NN
) ||| S:6042 E:6043 ||| -RRB-
,  ||| S:6043 E:6054 ||| ,
m  ||| S:6054 E:6056 ||| JJ
-chlorophenylbiguanide  ||| S:6056 E:6079 ||| NN
(  ||| S:6079 E:6090 ||| -LRB-
m  ||| S:6090 E:6092 ||| UH
CPBG ||| S:6092 E:6096 ||| UH
,  ||| S:6096 E:6098 ||| ,
agonist ||| S:6098 E:6105 ||| CD
) ||| S:6105 E:6106 ||| -RRB-
,  ||| S:6106 E:6117 ||| ,
d  ||| S:6117 E:6119 ||| JJ
-tubocurarine  ||| S:6119 E:6133 ||| NN
(  ||| S:6133 E:6144 ||| -LRB-
d  ||| S:6144 E:6146 ||| LS
-tc ||| S:6146 E:6149 ||| JJ
,  ||| S:6149 E:6151 ||| ,
antagonist ||| S:6151 E:6161 ||| CD
)  ||| S:6161 E:6163 ||| -RRB-
and  ||| S:6163 E:6167 ||| CC
lerisetron  ||| S:6167 E:6186 ||| NNS
( ||| S:6186 E:6187 ||| -LRB-
antagonist ||| S:6187 E:6197 ||| LS
) ||| S:6197 E:6198 ||| -RRB-
.  ||| S:6198 E:6200 ||| .
The  ||| S:6200 E:6204 ||| DT
K  ||| S:6204 E:6215 ||| NNP
i  ||| S:6215 E:6217 ||| FW
values  ||| S:6217 E:6224 ||| NNS
for  ||| S:6224 E:6228 ||| IN
inhibition  ||| S:6228 E:6239 ||| NN
of  ||| S:6239 E:6242 ||| IN
[  ||| S:6242 E:6252 ||| -LRB-
3H ||| S:6252 E:6254 ||| NNP
] ||| S:6254 E:6255 ||| -RRB-
granisetron  ||| S:6255 E:6267 ||| JJ
binding  ||| S:6267 E:6275 ||| NN
by  ||| S:6275 E:6278 ||| IN
all  ||| S:6278 E:6282 ||| DT
four  ||| S:6282 E:6287 ||| CD
compounds  ||| S:6287 E:6297 ||| NNS
are  ||| S:6297 E:6301 ||| VBP
shown  ||| S:6301 E:6307 ||| VBN
in  ||| S:6307 E:6318 ||| IN
Table  ||| S:6318 E:6324 ||| NNP
3 ||| S:6324 E:6325 ||| CD
.  ||| S:6325 E:6327 ||| .
Little  ||| S:6327 E:6334 ||| JJ
change  ||| S:6334 E:6341 ||| NN
in  ||| S:6341 E:6344 ||| IN
K  ||| S:6344 E:6355 ||| NNP
i  ||| S:6355 E:6357 ||| FW
value  ||| S:6357 E:6363 ||| NN
was  ||| S:6363 E:6367 ||| VBD
observed  ||| S:6367 E:6376 ||| VBN
for  ||| S:6376 E:6380 ||| IN
the  ||| S:6380 E:6384 ||| DT
majority  ||| S:6384 E:6393 ||| NN
of  ||| S:6393 E:6404 ||| IN
mutations ||| S:6404 E:6413 ||| NNS
.  ||| S:6413 E:6415 ||| .
The  ||| S:6415 E:6419 ||| DT
values  ||| S:6419 E:6426 ||| NNS
highlighted  ||| S:6426 E:6438 ||| VBD
in  ||| S:6438 E:6441 ||| IN
bold  ||| S:6441 E:6446 ||| JJ
in  ||| S:6446 E:6449 ||| IN
Table  ||| S:6449 E:6463 ||| NNP
3represent  ||| S:6463 E:6474 ||| CD
the  ||| S:6474 E:6478 ||| DT
K  ||| S:6478 E:6489 ||| NNP
i  ||| S:6489 E:6491 ||| FW
values  ||| S:6491 E:6498 ||| NNS
for  ||| S:6498 E:6502 ||| IN
inhibition  ||| S:6502 E:6513 ||| NN
of  ||| S:6513 E:6516 ||| IN
[  ||| S:6516 E:6526 ||| -LRB-
3H ||| S:6526 E:6528 ||| NNP
] ||| S:6528 E:6529 ||| -RRB-
granisetron  ||| S:6529 E:6541 ||| JJ
binding  ||| S:6541 E:6549 ||| NN
on  ||| S:6549 E:6552 ||| IN
mutant  ||| S:6552 E:6559 ||| JJ
receptors  ||| S:6559 E:6569 ||| NNS
that  ||| S:6569 E:6574 ||| WDT
increased  ||| S:6574 E:6592 ||| VBD
over  ||| S:6592 E:6597 ||| IN
10  ||| S:6597 E:6600 ||| CD
fold  ||| S:6600 E:6605 ||| NNS
compared  ||| S:6605 E:6614 ||| VBN
to  ||| S:6614 E:6617 ||| TO
the  ||| S:6617 E:6621 ||| DT
K  ||| S:6621 E:6632 ||| NNP
i  ||| S:6632 E:6634 ||| VBD
obtained  ||| S:6634 E:6643 ||| VBN
for  ||| S:6643 E:6647 ||| IN
wildtype  ||| S:6647 E:6656 ||| JJ
receptors ||| S:6656 E:6665 ||| NNS
.  ||| S:6665 E:6667 ||| .
The  ||| S:6667 E:6679 ||| DT
bar  ||| S:6679 E:6683 ||| NN
chart  ||| S:6683 E:6689 ||| NN
in  ||| S:6689 E:6692 ||| IN
Figure  ||| S:6692 E:6699 ||| NNP
2Billustrates  ||| S:6699 E:6713 ||| CD
the  ||| S:6713 E:6717 ||| DT
changes  ||| S:6717 E:6725 ||| NNS
in  ||| S:6725 E:6728 ||| IN
K  ||| S:6728 E:6739 ||| NNP
i  ||| S:6739 E:6741 ||| VBZ
resulting  ||| S:6741 E:6751 ||| VBG
from  ||| S:6751 E:6756 ||| IN
each  ||| S:6756 E:6761 ||| DT
mutation  ||| S:6761 E:6770 ||| NN
on  ||| S:6770 E:6773 ||| IN
the  ||| S:6773 E:6785 ||| DT
test  ||| S:6785 E:6790 ||| NN
compounds ||| S:6790 E:6799 ||| NN
.  ||| S:6799 E:6801 ||| .
Ratios  ||| S:6801 E:6808 ||| NNS
of  ||| S:6808 E:6811 ||| IN
K  ||| S:6811 E:6822 ||| NNP
i  ||| S:6822 E:6824 ||| NNS
are  ||| S:6824 E:6828 ||| VBP
shown  ||| S:6828 E:6834 ||| VBN
as  ||| S:6834 E:6837 ||| IN
positive  ||| S:6837 E:6846 ||| JJ
for  ||| S:6846 E:6850 ||| IN
increases  ||| S:6850 E:6860 ||| NNS
in  ||| S:6860 E:6871 ||| IN
K  ||| S:6871 E:6882 ||| NNP
i  ||| S:6882 E:6884 ||| FW
on  ||| S:6884 E:6887 ||| FW
mutant  ||| S:6887 E:6894 ||| FW
receptors  ||| S:6894 E:6904 ||| FW
versus  ||| S:6904 E:6911 ||| FW
wildtype  ||| S:6911 E:6928 ||| FW
and  ||| S:6928 E:6932 ||| CC
negative  ||| S:6932 E:6941 ||| JJ
for  ||| S:6941 E:6945 ||| IN
decreases ||| S:6945 E:6954 ||| NNS
.  ||| S:6954 E:6956 ||| .
A  ||| S:6956 E:6958 ||| DT
positive  ||| S:6958 E:6967 ||| JJ
change  ||| S:6967 E:6974 ||| NN
thus  ||| S:6974 E:6987 ||| RB
corresponds  ||| S:6987 E:6999 ||| VBN
to  ||| S:6999 E:7002 ||| TO
a  ||| S:7002 E:7004 ||| DT
decrease  ||| S:7004 E:7013 ||| NN
in  ||| S:7013 E:7016 ||| IN
binding  ||| S:7016 E:7024 ||| JJ
affinity  ||| S:7024 E:7033 ||| NN
for  ||| S:7033 E:7037 ||| IN
the  ||| S:7037 E:7049 ||| DT
compound  ||| S:7049 E:7058 ||| NN
as  ||| S:7058 E:7061 ||| IN
a  ||| S:7061 E:7063 ||| DT
result  ||| S:7063 E:7070 ||| NN
of  ||| S:7070 E:7073 ||| IN
the  ||| S:7073 E:7077 ||| DT
mutation ||| S:7077 E:7085 ||| NN
.  ||| S:7085 E:7087 ||| .
Large  ||| S:7087 E:7093 ||| JJ
decreases  ||| S:7093 E:7103 ||| NNS
in  ||| S:7103 E:7114 ||| IN
binding  ||| S:7114 E:7122 ||| JJ
affinity  ||| S:7122 E:7131 ||| NN
were  ||| S:7131 E:7136 ||| VBD
observed  ||| S:7136 E:7145 ||| VBN
for  ||| S:7145 E:7149 ||| IN
select  ||| S:7149 E:7156 ||| JJ
compounds  ||| S:7156 E:7166 ||| NNS
only  ||| S:7166 E:7171 ||| RB
on  ||| S:7171 E:7182 ||| IN
the  ||| S:7182 E:7186 ||| DT
Y140A ||| S:7186 E:7191 ||| NNP
,  ||| S:7191 E:7193 ||| ,
Y142A  ||| S:7193 E:7199 ||| NNP
and  ||| S:7199 E:7203 ||| CC
Y152A  ||| S:7203 E:7209 ||| CD
mutations ||| S:7209 E:7218 ||| NNS
.  ||| S:7218 E:7228 ||| .
A  ||| S:7228 E:7230 ||| DT
more  ||| S:7230 E:7235 ||| RBR
detailed  ||| S:7235 E:7244 ||| JJ
analysis  ||| S:7244 E:7253 ||| NN
of  ||| S:7253 E:7256 ||| IN
the  ||| S:7256 E:7260 ||| DT
competition  ||| S:7260 E:7272 ||| NN
binding  ||| S:7272 E:7280 ||| JJ
data  ||| S:7280 E:7293 ||| NNS
obtained  ||| S:7293 E:7302 ||| VBN
for  ||| S:7302 E:7306 ||| IN
the  ||| S:7306 E:7310 ||| DT
Y140A ||| S:7310 E:7315 ||| NNP
,  ||| S:7315 E:7317 ||| ,
Y142A  ||| S:7317 E:7323 ||| NNP
and  ||| S:7323 E:7327 ||| CC
Y152A  ||| S:7327 E:7333 ||| CD
mutations  ||| S:7333 E:7343 ||| NN
is  ||| S:7343 E:7346 ||| VBZ
shown  ||| S:7346 E:7360 ||| VBN
in  ||| S:7360 E:7363 ||| IN
Figure  ||| S:7363 E:7370 ||| NNP
4 ||| S:7370 E:7371 ||| CD
.  ||| S:7371 E:7373 ||| .
For  ||| S:7373 E:7377 ||| IN
5-HT ||| S:7377 E:7381 ||| NNP
,  ||| S:7381 E:7383 ||| ,
the  ||| S:7383 E:7387 ||| DT
Y142A  ||| S:7387 E:7393 ||| JJ
mutation  ||| S:7393 E:7402 ||| NN
produced  ||| S:7402 E:7411 ||| VBD
a  ||| S:7411 E:7413 ||| DT
110  ||| S:7413 E:7425 ||| CD
fold  ||| S:7425 E:7430 ||| JJ
increase  ||| S:7430 E:7439 ||| NN
in  ||| S:7439 E:7442 ||| IN
K  ||| S:7442 E:7453 ||| NNP
i  ||| S:7453 E:7455 ||| FW
and  ||| S:7455 E:7459 ||| CC
Y152A  ||| S:7459 E:7465 ||| NNP
produced  ||| S:7465 E:7474 ||| VBD
a  ||| S:7474 E:7476 ||| DT
24  ||| S:7476 E:7479 ||| CD
fold  ||| S:7479 E:7484 ||| JJ
increase ||| S:7484 E:7492 ||| NN
.  ||| S:7492 E:7502 ||| .
No  ||| S:7502 E:7505 ||| DT
change  ||| S:7505 E:7512 ||| NN
in  ||| S:7512 E:7515 ||| IN
K  ||| S:7515 E:7526 ||| NNP
i  ||| S:7526 E:7528 ||| NN
was  ||| S:7528 E:7532 ||| VBD
observed  ||| S:7532 E:7541 ||| VBN
for  ||| S:7541 E:7545 ||| IN
the  ||| S:7545 E:7549 ||| DT
Y140A  ||| S:7549 E:7555 ||| JJ
mutation  ||| S:7555 E:7572 ||| NN
( ||| S:7572 E:7573 ||| -LRB-
Figure  ||| S:7573 E:7580 ||| NNP
4A ||| S:7580 E:7582 ||| NNP
) ||| S:7582 E:7583 ||| -RRB-
.  ||| S:7583 E:7585 ||| .
The  ||| S:7585 E:7589 ||| DT
5-HT  ||| S:7589 E:7603 ||| CD
3  ||| S:7603 E:7605 ||| CD
R  ||| S:7605 E:7607 ||| NN
agonist  ||| S:7607 E:7624 ||| NNS
m  ||| S:7624 E:7626 ||| VBD
CPBG  ||| S:7626 E:7631 ||| NNP
showed  ||| S:7631 E:7638 ||| VBD
a  ||| S:7638 E:7640 ||| DT
similar  ||| S:7640 E:7648 ||| JJ
profile  ||| S:7648 E:7656 ||| NN
for  ||| S:7656 E:7668 ||| IN
the  ||| S:7668 E:7672 ||| DT
changes  ||| S:7672 E:7680 ||| NNS
in  ||| S:7680 E:7683 ||| IN
K  ||| S:7683 E:7694 ||| NNP
i  ||| S:7694 E:7696 ||| FW
values  ||| S:7696 E:7703 ||| VBZ
resulting  ||| S:7703 E:7713 ||| VBG
from  ||| S:7713 E:7718 ||| IN
mutations  ||| S:7718 E:7728 ||| NNS
of  ||| S:7728 E:7731 ||| IN
the  ||| S:7731 E:7743 ||| DT
three  ||| S:7743 E:7749 ||| CD
tyrosines  ||| S:7749 E:7759 ||| NNS
( ||| S:7759 E:7760 ||| -LRB-
Figure  ||| S:7760 E:7767 ||| NNP
4B ||| S:7767 E:7769 ||| NNP
) ||| S:7769 E:7770 ||| -RRB-
.  ||| S:7770 E:7772 ||| .
As  ||| S:7772 E:7775 ||| RB
was  ||| S:7775 E:7779 ||| VBD
observed  ||| S:7779 E:7788 ||| VBN
for  ||| S:7788 E:7792 ||| IN
5-HT ||| S:7792 E:7796 ||| NNP
,  ||| S:7796 E:7798 ||| ,
the  ||| S:7798 E:7810 ||| DT
Y142A  ||| S:7810 E:7816 ||| JJ
mutation  ||| S:7816 E:7825 ||| NN
produced  ||| S:7825 E:7834 ||| VBD
a  ||| S:7834 E:7836 ||| DT
large  ||| S:7836 E:7842 ||| JJ
increase  ||| S:7842 E:7851 ||| NN
in  ||| S:7851 E:7854 ||| IN
K  ||| S:7854 E:7865 ||| NNP
i  ||| S:7865 E:7867 ||| FW
( ||| S:7867 E:7868 ||| -LRB-
160  ||| S:7868 E:7872 ||| CD
fold ||| S:7872 E:7876 ||| CD
)  ||| S:7876 E:7878 ||| -RRB-
while  ||| S:7878 E:7884 ||| IN
the  ||| S:7884 E:7888 ||| DT
Y14  ||| S:7888 E:7892 ||| NNP
0A  ||| S:7892 E:7895 ||| NNP
and  ||| S:7895 E:7899 ||| CC
Y152A  ||| S:7899 E:7913 ||| CD
mutations  ||| S:7913 E:7923 ||| NNS
produced  ||| S:7923 E:7932 ||| VBD
only  ||| S:7932 E:7937 ||| RB
7  ||| S:7937 E:7939 ||| CD
and  ||| S:7939 E:7943 ||| CC
24  ||| S:7943 E:7946 ||| CD
fold  ||| S:7946 E:7951 ||| CD
changes  ||| S:7951 E:7967 ||| NNS
respectively ||| S:7967 E:7979 ||| RB
.  ||| S:7979 E:7989 ||| .
The  ||| S:7989 E:7993 ||| DT
K  ||| S:7993 E:8004 ||| NNP
i  ||| S:8004 E:8006 ||| FW
value  ||| S:8006 E:8012 ||| NN
for  ||| S:8012 E:8025 ||| IN
d  ||| S:8025 E:8027 ||| JJ
-tc  ||| S:8027 E:8031 ||| JJ
inhibition  ||| S:8031 E:8042 ||| NN
of  ||| S:8042 E:8045 ||| IN
[  ||| S:8045 E:8047 ||| -LRB-
3H ||| S:8047 E:8049 ||| NNP
] ||| S:8049 E:8050 ||| -RRB-
granisetron  ||| S:8050 E:8070 ||| JJ
binding  ||| S:8070 E:8078 ||| NN
was  ||| S:8078 E:8082 ||| VBD
altered  ||| S:8082 E:8090 ||| VBN
only  ||| S:8090 E:8095 ||| RB
slightly  ||| S:8095 E:8104 ||| RB
by  ||| S:8104 E:8107 ||| IN
the  ||| S:8107 E:8111 ||| DT
Y142A  ||| S:8111 E:8117 ||| NNP
or  ||| S:8117 E:8120 ||| CC
Y152A  ||| S:8120 E:8134 ||| CD
mutations  ||| S:8134 E:8144 ||| NNS
( ||| S:8144 E:8145 ||| -LRB-
6.5  ||| S:8145 E:8149 ||| CD
fold  ||| S:8149 E:8154 ||| NNS
and  ||| S:8154 E:8158 ||| CC
10  ||| S:8158 E:8161 ||| CD
fold  ||| S:8161 E:8166 ||| CD
changes  ||| S:8166 E:8174 ||| NNS
respectively ||| S:8174 E:8186 ||| RB
) ||| S:8186 E:8187 ||| -RRB-
.  ||| S:8187 E:8189 ||| .
The  ||| S:8189 E:8201 ||| DT
Y140A  ||| S:8201 E:8207 ||| JJ
mutation ||| S:8207 E:8215 ||| NN
,  ||| S:8215 E:8217 ||| ,
however ||| S:8217 E:8224 ||| RB
,  ||| S:8224 E:8226 ||| ,
produced  ||| S:8226 E:8235 ||| VBD
a  ||| S:8235 E:8237 ||| DT
50  ||| S:8237 E:8240 ||| CD
fold  ||| S:8240 E:8245 ||| JJ
increase  ||| S:8245 E:8254 ||| NN
in  ||| S:8254 E:8257 ||| IN
the  ||| S:8257 E:8269 ||| DT
K  ||| S:8269 E:8280 ||| NNP
i  ||| S:8280 E:8282 ||| VBD
compared  ||| S:8282 E:8291 ||| VBN
to  ||| S:8291 E:8294 ||| TO
wildtype  ||| S:8294 E:8303 ||| VB
receptors  ||| S:8303 E:8313 ||| NNS
( ||| S:8313 E:8314 ||| -LRB-
Figure  ||| S:8314 E:8329 ||| NNP
4C ||| S:8329 E:8331 ||| NNP
) ||| S:8331 E:8332 ||| -RRB-
.  ||| S:8332 E:8342 ||| .
The  ||| S:8342 E:8346 ||| DT
K  ||| S:8346 E:8357 ||| NNP
i  ||| S:8357 E:8359 ||| FW
value  ||| S:8359 E:8365 ||| NN
for  ||| S:8365 E:8369 ||| IN
lerisetron  ||| S:8369 E:8380 ||| JJ
inhibition  ||| S:8380 E:8391 ||| NN
of  ||| S:8391 E:8394 ||| IN
[  ||| S:8394 E:8404 ||| -LRB-
3H ||| S:8404 E:8406 ||| NNP
] ||| S:8406 E:8407 ||| -RRB-
granisetron  ||| S:8407 E:8419 ||| JJ
binding  ||| S:8419 E:8427 ||| NN
was  ||| S:8427 E:8431 ||| VBD
increased  ||| S:8431 E:8441 ||| VBN
160  ||| S:8441 E:8445 ||| CD
fold  ||| S:8445 E:8450 ||| NN
by  ||| S:8450 E:8453 ||| IN
the  ||| S:8453 E:8457 ||| DT
Y142A  ||| S:8457 E:8471 ||| JJ
mutation  ||| S:8471 E:8480 ||| NN
and  ||| S:8480 E:8484 ||| CC
190  ||| S:8484 E:8488 ||| CD
fold  ||| S:8488 E:8493 ||| NN
by  ||| S:8493 E:8496 ||| IN
the  ||| S:8496 E:8500 ||| DT
Y152A  ||| S:8500 E:8506 ||| JJ
mutation ||| S:8506 E:8514 ||| NN
.  ||| S:8514 E:8516 ||| .
Only  ||| S:8516 E:8521 ||| RB
a  ||| S:8521 E:8523 ||| DT
4.6  ||| S:8523 E:8535 ||| CD
fold  ||| S:8535 E:8540 ||| JJ
change  ||| S:8540 E:8547 ||| NN
in  ||| S:8547 E:8550 ||| IN
K  ||| S:8550 E:8561 ||| NNP
i  ||| S:8561 E:8563 ||| VBD
resulted  ||| S:8563 E:8572 ||| VBN
from  ||| S:8572 E:8577 ||| IN
the  ||| S:8577 E:8581 ||| DT
Y140A  ||| S:8581 E:8587 ||| JJ
mutation ||| S:8587 E:8595 ||| NN
.  ||| S:8595 E:8605 ||| .
Lerisetron  ||| S:8605 E:8616 ||| NNP
was  ||| S:8616 E:8620 ||| VBD
the  ||| S:8620 E:8624 ||| DT
only  ||| S:8624 E:8629 ||| JJ
compound  ||| S:8629 E:8638 ||| NN
for  ||| S:8638 E:8642 ||| IN
which  ||| S:8642 E:8648 ||| WDT
a  ||| S:8648 E:8650 ||| DT
large  ||| S:8650 E:8656 ||| JJ
increase  ||| S:8656 E:8673 ||| NN
in  ||| S:8673 E:8676 ||| IN
the  ||| S:8676 E:8680 ||| DT
K  ||| S:8680 E:8691 ||| NNP
i  ||| S:8691 E:8693 ||| NN
was  ||| S:8693 E:8697 ||| VBD
observed  ||| S:8697 E:8706 ||| VBN
on  ||| S:8706 E:8709 ||| IN
the  ||| S:8709 E:8713 ||| DT
Y152A  ||| S:8713 E:8719 ||| JJ
mutation  ||| S:8719 E:8736 ||| NN
( ||| S:8736 E:8737 ||| -LRB-
Figure  ||| S:8737 E:8744 ||| NNP
4D ||| S:8744 E:8746 ||| NNP
) ||| S:8746 E:8747 ||| -RRB-
.  ||| S:8747 E:8749 ||| .
This  ||| S:8749 E:8754 ||| DT
mutation  ||| S:8754 E:8763 ||| NN
produced  ||| S:8763 E:8772 ||| VBD
smaller  ||| S:8772 E:8780 ||| JJR
changes  ||| S:8780 E:8788 ||| NNS
in  ||| S:8788 E:8791 ||| IN
K  ||| S:8791 E:8802 ||| NNP
i  ||| S:8802 E:8804 ||| NN
for  ||| S:8804 E:8808 ||| IN
5-HT  ||| S:8808 E:8813 ||| NNP
and  ||| S:8813 E:8826 ||| CC
m  ||| S:8826 E:8828 ||| JJ
CPBG  ||| S:8828 E:8833 ||| NNP
( ||| S:8833 E:8834 ||| -LRB-
24  ||| S:8834 E:8837 ||| CD
fold  ||| S:8837 E:8842 ||| NN
for  ||| S:8842 E:8846 ||| IN
both ||| S:8846 E:8850 ||| DT
)  ||| S:8850 E:8852 ||| -RRB-
and  ||| S:8852 E:8856 ||| CC
only  ||| S:8856 E:8861 ||| RB
a  ||| S:8861 E:8871 ||| DT
10  ||| S:8871 E:8874 ||| CD
fold  ||| S:8874 E:8879 ||| JJ
change  ||| S:8879 E:8886 ||| NN
for  ||| S:8886 E:8899 ||| IN
d  ||| S:8899 E:8901 ||| JJ
-tc ||| S:8901 E:8904 ||| NN
.  ||| S:8904 E:8914 ||| .
In  ||| S:8914 E:8917 ||| IN
whole  ||| S:8917 E:8923 ||| JJ
cell  ||| S:8923 E:8928 ||| NN
patch  ||| S:8928 E:8934 ||| NN
clamp  ||| S:8934 E:8940 ||| NN
studies ||| S:8940 E:8947 ||| NNS
,  ||| S:8947 E:8949 ||| ,
5-HT  ||| S:8949 E:8954 ||| CD
perfusion  ||| S:8954 E:8964 ||| NN
of  ||| S:8964 E:8975 ||| IN
cells  ||| S:8975 E:8981 ||| NNS
transfected  ||| S:8981 E:8993 ||| VBN
with  ||| S:8993 E:8998 ||| IN
Y140A  ||| S:8998 E:9004 ||| NNP
and  ||| S:9004 E:9008 ||| CC
Y142A  ||| S:9008 E:9014 ||| NNP
cDNA  ||| S:9014 E:9019 ||| NNP
produced  ||| S:9019 E:9028 ||| VBD
no  ||| S:9028 E:9039 ||| DT
responses  ||| S:9039 E:9049 ||| NNS
at  ||| S:9049 E:9052 ||| IN
5-HT  ||| S:9052 E:9057 ||| CD
concentrations  ||| S:9057 E:9072 ||| NNS
of  ||| S:9072 E:9075 ||| IN
up  ||| S:9075 E:9078 ||| RB
to  ||| S:9078 E:9081 ||| TO
1  ||| S:9081 E:9083 ||| CD
mM  ||| S:9083 E:9086 ||| NN
although  ||| S:9086 E:9103 ||| IN
specific  ||| S:9103 E:9112 ||| JJ
binding  ||| S:9112 E:9120 ||| NN
to  ||| S:9120 E:9123 ||| TO
these  ||| S:9123 E:9129 ||| DT
receptors  ||| S:9129 E:9139 ||| NN
was  ||| S:9139 E:9143 ||| VBD
identified  ||| S:9143 E:9154 ||| VBN
in  ||| S:9154 E:9165 ||| IN
receptor  ||| S:9165 E:9174 ||| JJ
binding  ||| S:9174 E:9182 ||| JJ
studies ||| S:9182 E:9189 ||| NNS
.  ||| S:9189 E:9191 ||| .
Unlike  ||| S:9191 E:9198 ||| IN
Y140A  ||| S:9198 E:9204 ||| NNP
and  ||| S:9204 E:9208 ||| CC
Y142A ||| S:9208 E:9213 ||| NNP
,  ||| S:9213 E:9215 ||| ,
Y152A  ||| S:9215 E:9229 ||| CD
receptors  ||| S:9229 E:9239 ||| NNS
responded  ||| S:9239 E:9249 ||| VBD
to  ||| S:9249 E:9252 ||| TO
application  ||| S:9252 E:9264 ||| NN
of  ||| S:9264 E:9267 ||| IN
5-HT ||| S:9267 E:9271 ||| CD
.  ||| S:9271 E:9273 ||| .
Due  ||| S:9273 E:9277 ||| JJ
to  ||| S:9277 E:9280 ||| TO
the  ||| S:9280 E:9284 ||| DT
low  ||| S:9284 E:9296 ||| JJ
potency  ||| S:9296 E:9304 ||| NN
of  ||| S:9304 E:9307 ||| IN
5-HT  ||| S:9307 E:9312 ||| CD
on  ||| S:9312 E:9315 ||| IN
these  ||| S:9315 E:9321 ||| DT
receptors ||| S:9321 E:9330 ||| NN
,  ||| S:9330 E:9332 ||| ,
only  ||| S:9332 E:9337 ||| RB
a  ||| S:9337 E:9339 ||| DT
portion  ||| S:9339 E:9347 ||| NN
of  ||| S:9347 E:9350 ||| IN
the  ||| S:9350 E:9362 ||| DT
concentration  ||| S:9362 E:9376 ||| NN
response  ||| S:9376 E:9385 ||| NN
curve  ||| S:9385 E:9391 ||| NN
could  ||| S:9391 E:9397 ||| MD
be  ||| S:9397 E:9400 ||| VB
determined  ||| S:9400 E:9411 ||| VBN
( ||| S:9411 E:9412 ||| -LRB-
up  ||| S:9412 E:9415 ||| RB
to  ||| S:9415 E:9418 ||| TO
1  ||| S:9418 E:9428 ||| CD
mM ||| S:9428 E:9430 ||| NN
) ||| S:9430 E:9431 ||| -RRB-
.  ||| S:9431 E:9433 ||| .
The  ||| S:9433 E:9437 ||| DT
EC  ||| S:9437 E:9449 ||| NNP
50  ||| S:9449 E:9452 ||| CD
value  ||| S:9452 E:9458 ||| NN
was  ||| S:9458 E:9462 ||| VBD
estimated  ||| S:9462 E:9472 ||| VBN
as  ||| S:9472 E:9475 ||| IN
greater  ||| S:9475 E:9483 ||| JJR
than  ||| S:9483 E:9496 ||| IN
370  ||| S:9496 E:9500 ||| CD
μM  ||| S:9500 E:9503 ||| NNS
( ||| S:9503 E:9504 ||| -LRB-
Figure  ||| S:9504 E:9511 ||| NNP
5 ||| S:9511 E:9512 ||| CD
) ||| S:9512 E:9513 ||| -RRB-
.  ||| S:9513 E:9515 ||| .
This  ||| S:9515 E:9520 ||| DT
value  ||| S:9520 E:9526 ||| NN
shows  ||| S:9526 E:9532 ||| VBZ
a  ||| S:9532 E:9534 ||| DT
greater  ||| S:9534 E:9542 ||| JJR
than  ||| S:9542 E:9547 ||| IN
140  ||| S:9547 E:9551 ||| CD
fold  ||| S:9551 E:9564 ||| JJ
increase  ||| S:9564 E:9573 ||| NN
in  ||| S:9573 E:9576 ||| IN
EC  ||| S:9576 E:9588 ||| NNP
50  ||| S:9588 E:9591 ||| CD
compared  ||| S:9591 E:9600 ||| VBN
to  ||| S:9600 E:9603 ||| TO
wildtype  ||| S:9603 E:9612 ||| VB
receptors ||| S:9612 E:9621 ||| NNS
;  ||| S:9621 E:9623 ||| :
a  ||| S:9623 E:9633 ||| DT
larger  ||| S:9633 E:9640 ||| JJR
change  ||| S:9640 E:9647 ||| NN
than  ||| S:9647 E:9652 ||| IN
was  ||| S:9652 E:9656 ||| VBD
observed  ||| S:9656 E:9665 ||| VBN
for  ||| S:9665 E:9669 ||| IN
the  ||| S:9669 E:9673 ||| DT
K  ||| S:9673 E:9684 ||| NNP
i  ||| S:9684 E:9686 ||| FW
( ||| S:9686 E:9687 ||| -LRB-
24  ||| S:9687 E:9690 ||| CD
fold ||| S:9690 E:9694 ||| CD
) ||| S:9694 E:9695 ||| -RRB-
.  ||| S:9695 E:9697 ||| .
The  ||| S:9697 E:9701 ||| DT
most  ||| S:9701 E:9706 ||| RBS
dramatic  ||| S:9706 E:9715 ||| JJ
change  ||| S:9715 E:9730 ||| NN
observed  ||| S:9730 E:9739 ||| VBD
for  ||| S:9739 E:9743 ||| IN
whole  ||| S:9743 E:9749 ||| JJ
cell  ||| S:9749 E:9754 ||| NN
currents  ||| S:9754 E:9763 ||| NNS
was  ||| S:9763 E:9767 ||| VBD
an  ||| S:9767 E:9770 ||| DT
alteration  ||| S:9770 E:9781 ||| NN
in  ||| S:9781 E:9784 ||| IN
the  ||| S:9784 E:9796 ||| DT
kinetics  ||| S:9796 E:9805 ||| NN
of  ||| S:9805 E:9808 ||| IN
the  ||| S:9808 E:9812 ||| DT
response  ||| S:9812 E:9821 ||| NN
elicited  ||| S:9821 E:9830 ||| NN
by  ||| S:9830 E:9833 ||| IN
application  ||| S:9833 E:9845 ||| NN
of  ||| S:9845 E:9848 ||| IN
5-HT ||| S:9848 E:9852 ||| CD
.  ||| S:9852 E:9862 ||| .
Y152A  ||| S:9862 E:9868 ||| NNP
mutant  ||| S:9868 E:9875 ||| JJ
receptors  ||| S:9875 E:9885 ||| NNS
displayed  ||| S:9885 E:9895 ||| VBD
much  ||| S:9895 E:9900 ||| RB
slower  ||| S:9900 E:9907 ||| JJR
rise  ||| S:9907 E:9912 ||| NN
times  ||| S:9912 E:9926 ||| NNS
compared  ||| S:9926 E:9935 ||| VBN
to  ||| S:9935 E:9938 ||| TO
wildtype  ||| S:9938 E:9947 ||| VB
receptors  ||| S:9947 E:9957 ||| VBN
at  ||| S:9957 E:9960 ||| IN
all  ||| S:9960 E:9964 ||| DT
concentrations  ||| S:9964 E:9987 ||| NNS
tested ||| S:9987 E:9993 ||| VBD
.  ||| S:9993 E:9995 ||| .
Peak  ||| S:9995 E:10000 ||| JJ
wt  ||| S:10000 E:10003 ||| JJ
responses  ||| S:10003 E:10013 ||| NNS
were  ||| S:10013 E:10018 ||| VBD
typically  ||| S:10018 E:10028 ||| RB
obtained  ||| S:10028 E:10037 ||| VBN
in  ||| S:10037 E:10040 ||| IN
less  ||| S:10040 E:10053 ||| JJR
than  ||| S:10053 E:10058 ||| IN
80  ||| S:10058 E:10061 ||| CD
ms  ||| S:10061 E:10064 ||| NN
while  ||| S:10064 E:10070 ||| IN
Y152A  ||| S:10070 E:10076 ||| CD
responses  ||| S:10076 E:10086 ||| NNS
required  ||| S:10086 E:10095 ||| VBN
several  ||| S:10095 E:10103 ||| JJ
seconds  ||| S:10103 E:10119 ||| NNS
to  ||| S:10119 E:10122 ||| TO
plateau ||| S:10122 E:10129 ||| NN
.  ||| S:10129 E:10131 ||| .
Desensitization  ||| S:10131 E:10147 ||| JJ
kinetics  ||| S:10147 E:10156 ||| NN
were  ||| S:10156 E:10161 ||| VBD
also  ||| S:10161 E:10166 ||| RB
altered ||| S:10166 E:10173 ||| VBN
.  ||| S:10173 E:10183 ||| .
While  ||| S:10183 E:10189 ||| IN
wt  ||| S:10189 E:10192 ||| JJ
receptors  ||| S:10192 E:10202 ||| NNS
desensitized  ||| S:10202 E:10215 ||| VBP
rapidly ||| S:10215 E:10222 ||| RB
,  ||| S:10222 E:10224 ||| ,
mutant  ||| S:10224 E:10231 ||| JJ
receptors  ||| S:10231 E:10249 ||| NNS
showed  ||| S:10249 E:10256 ||| VBD
no  ||| S:10256 E:10259 ||| DT
desensitization  ||| S:10259 E:10275 ||| NN
during  ||| S:10275 E:10282 ||| IN
the  ||| S:10282 E:10286 ||| DT
8  ||| S:10286 E:10288 ||| CD
s  ||| S:10288 E:10290 ||| CD
perfusion  ||| S:10290 E:10308 ||| JJ
time ||| S:10308 E:10312 ||| NN
.  ||| S:10312 E:10336 ||| .
Discussion  ||| S:10336 E:10355 ||| NN
The  ||| S:10355 E:10359 ||| DT
putative  ||| S:10359 E:10368 ||| JJ
E-loop  ||| S:10368 E:10375 ||| JJ
region  ||| S:10375 E:10382 ||| NN
of  ||| S:10382 E:10385 ||| IN
the  ||| S:10385 E:10389 ||| DT
LGIC  ||| S:10389 E:10394 ||| NNP
family  ||| S:10394 E:10401 ||| NN
of  ||| S:10401 E:10412 ||| IN
receptors  ||| S:10412 E:10422 ||| NN
is  ||| S:10422 E:10425 ||| VBZ
homologous  ||| S:10425 E:10436 ||| VBN
to  ||| S:10436 E:10439 ||| TO
residues  ||| S:10439 E:10448 ||| CD
Y140  ||| S:10448 E:10453 ||| CD
through  ||| S:10453 E:10461 ||| IN
K153  ||| S:10461 E:10466 ||| CD
in  ||| S:10466 E:10477 ||| IN
the  ||| S:10477 E:10481 ||| DT
5-HT  ||| S:10481 E:10495 ||| CD
3  ||| S:10495 E:10497 ||| CD
R  ||| S:10497 E:10499 ||| NN
[  ||| S:10499 E:10501 ||| -LRB-
4  ||| S:10501 E:10503 ||| CD
12  ||| S:10503 E:10506 ||| CD
13  ||| S:10506 E:10509 ||| CD
14  ||| S:10509 E:10512 ||| CD
15  ||| S:10512 E:10515 ||| CD
16  ||| S:10515 E:10518 ||| CD
17  ||| S:10518 E:10521 ||| CD
18  ||| S:10521 E:10524 ||| CD
]  ||| S:10524 E:10526 ||| -RRB-
.  ||| S:10526 E:10536 ||| .
Structure-function  ||| S:10536 E:10555 ||| JJ
studies  ||| S:10555 E:10563 ||| NNS
of  ||| S:10563 E:10566 ||| IN
this  ||| S:10566 E:10571 ||| DT
region  ||| S:10571 E:10578 ||| NN
have  ||| S:10578 E:10583 ||| VBP
been  ||| S:10583 E:10596 ||| VBN
conducted  ||| S:10596 E:10606 ||| VBN
in  ||| S:10606 E:10609 ||| IN
several  ||| S:10609 E:10617 ||| JJ
other  ||| S:10617 E:10623 ||| JJ
members  ||| S:10623 E:10631 ||| NNS
of  ||| S:10631 E:10634 ||| IN
this  ||| S:10634 E:10639 ||| DT
family  ||| S:10639 E:10646 ||| NN
of  ||| S:10646 E:10657 ||| IN
receptors  ||| S:10657 E:10667 ||| NNS
including  ||| S:10667 E:10677 ||| VBG
GABA  ||| S:10677 E:10691 ||| NNP
A  ||| S:10691 E:10693 ||| NNP
and  ||| S:10693 E:10697 ||| CC
nAChR  ||| S:10697 E:10703 ||| JJ
subtypes ||| S:10703 E:10711 ||| NN
.  ||| S:10711 E:10713 ||| .
In  ||| S:10713 E:10716 ||| IN
each  ||| S:10716 E:10721 ||| DT
case ||| S:10721 E:10725 ||| NN
,  ||| S:10725 E:10735 ||| ,
residues  ||| S:10735 E:10744 ||| NNS
have  ||| S:10744 E:10749 ||| VBP
been  ||| S:10749 E:10754 ||| VBN
identified  ||| S:10754 E:10765 ||| VBN
that  ||| S:10765 E:10770 ||| IN
alter  ||| S:10770 E:10776 ||| NN
either  ||| S:10776 E:10783 ||| CC
the  ||| S:10783 E:10787 ||| DT
binding  ||| S:10787 E:10803 ||| NN
of  ||| S:10803 E:10806 ||| IN
selective  ||| S:10806 E:10816 ||| JJ
ligands  ||| S:10816 E:10824 ||| NN
or  ||| S:10824 E:10827 ||| CC
receptor  ||| S:10827 E:10836 ||| JJ
function  ||| S:10836 E:10845 ||| NN
[  ||| S:10845 E:10847 ||| -LRB-
4  ||| S:10847 E:10849 ||| CD
11  ||| S:10849 E:10852 ||| CD
12  ||| S:10852 E:10855 ||| CD
13  ||| S:10855 E:10858 ||| CD
14  ||| S:10858 E:10869 ||| CD
15  ||| S:10869 E:10872 ||| CD
16  ||| S:10872 E:10875 ||| CD
17  ||| S:10875 E:10878 ||| CD
18  ||| S:10878 E:10881 ||| CD
]  ||| S:10881 E:10883 ||| -RRB-
.  ||| S:10883 E:10885 ||| .
In  ||| S:10885 E:10888 ||| IN
order  ||| S:10888 E:10894 ||| NN
to  ||| S:10894 E:10897 ||| TO
determine  ||| S:10897 E:10907 ||| VB
if  ||| S:10907 E:10910 ||| IN
this  ||| S:10910 E:10915 ||| DT
loop  ||| S:10915 E:10920 ||| NN
also  ||| S:10920 E:10933 ||| RB
contains  ||| S:10933 E:10942 ||| VBZ
residues  ||| S:10942 E:10951 ||| JJ
critical  ||| S:10951 E:10960 ||| JJ
to  ||| S:10960 E:10963 ||| TO
the  ||| S:10963 E:10967 ||| DT
structure  ||| S:10967 E:10977 ||| NN
or  ||| S:10977 E:10980 ||| CC
function  ||| S:10980 E:10989 ||| NN
of  ||| S:10989 E:11000 ||| IN
the  ||| S:11000 E:11004 ||| DT
5-HT  ||| S:11004 E:11018 ||| CD
3  ||| S:11018 E:11020 ||| CD
R ||| S:11020 E:11021 ||| NN
,  ||| S:11021 E:11023 ||| ,
we  ||| S:11023 E:11026 ||| PRP
have  ||| S:11026 E:11031 ||| VBP
constructed  ||| S:11031 E:11043 ||| VBN
alanine  ||| S:11043 E:11059 ||| JJ
mutations  ||| S:11059 E:11069 ||| NNS
of  ||| S:11069 E:11072 ||| IN
amino  ||| S:11072 E:11078 ||| JJ
acids  ||| S:11078 E:11084 ||| NNS
throughout  ||| S:11084 E:11095 ||| IN
the  ||| S:11095 E:11099 ||| DT
homologous  ||| S:11099 E:11110 ||| JJ
region  ||| S:11110 E:11125 ||| NN
of  ||| S:11125 E:11128 ||| IN
the  ||| S:11128 E:11132 ||| DT
mouse  ||| S:11132 E:11138 ||| NN
5-HT  ||| S:11138 E:11152 ||| CD
3AS  ||| S:11152 E:11156 ||| CD
R  ||| S:11156 E:11158 ||| NN
and  ||| S:11158 E:11162 ||| CC
investigated  ||| S:11162 E:11175 ||| VBD
the  ||| S:11175 E:11179 ||| DT
affects  ||| S:11179 E:11187 ||| NN
on  ||| S:11187 E:11198 ||| IN
binding  ||| S:11198 E:11206 ||| VBG
of  ||| S:11206 E:11209 ||| IN
5  ||| S:11209 E:11211 ||| CD
different  ||| S:11211 E:11221 ||| JJ
structural  ||| S:11221 E:11232 ||| JJ
classes  ||| S:11232 E:11240 ||| NNS
of  ||| S:11240 E:11243 ||| IN
5-HT  ||| S:11243 E:11257 ||| CD
3  ||| S:11257 E:11259 ||| CD
R  ||| S:11259 E:11261 ||| NN
ligands ||| S:11261 E:11268 ||| NN
.  ||| S:11268 E:11270 ||| .
We  ||| S:11270 E:11273 ||| PRP
have  ||| S:11273 E:11278 ||| VBP
identified  ||| S:11278 E:11289 ||| VBN
three  ||| S:11289 E:11303 ||| CD
tyrosine  ||| S:11303 E:11312 ||| CD
residues  ||| S:11312 E:11321 ||| NNS
that  ||| S:11321 E:11326 ||| WDT
appear  ||| S:11326 E:11333 ||| VBP
to  ||| S:11333 E:11336 ||| TO
play  ||| S:11336 E:11341 ||| VB
a  ||| S:11341 E:11343 ||| DT
role  ||| S:11343 E:11348 ||| NN
in  ||| S:11348 E:11351 ||| IN
binding  ||| S:11351 E:11359 ||| VBG
of  ||| S:11359 E:11370 ||| IN
selective  ||| S:11370 E:11380 ||| JJ
ligands  ||| S:11380 E:11388 ||| NN
to  ||| S:11388 E:11391 ||| TO
this  ||| S:11391 E:11396 ||| DT
receptor ||| S:11396 E:11404 ||| NN
.  ||| S:11404 E:11406 ||| .
In  ||| S:11406 E:11409 ||| IN
addition ||| S:11409 E:11417 ||| NN
,  ||| S:11417 E:11419 ||| ,
our  ||| S:11419 E:11423 ||| PRP$
data  ||| S:11423 E:11436 ||| NNS
support  ||| S:11436 E:11444 ||| VBP
the  ||| S:11444 E:11448 ||| DT
existence  ||| S:11448 E:11458 ||| NN
of  ||| S:11458 E:11461 ||| IN
a  ||| S:11461 E:11463 ||| DT
loop  ||| S:11463 E:11468 ||| JJ
structure  ||| S:11468 E:11478 ||| NN
in  ||| S:11478 E:11481 ||| IN
this  ||| S:11481 E:11486 ||| DT
region  ||| S:11486 E:11493 ||| NN
as  ||| S:11493 E:11504 ||| RB
has  ||| S:11504 E:11508 ||| VBZ
been  ||| S:11508 E:11513 ||| VBN
hypothesized  ||| S:11513 E:11526 ||| VBN
for  ||| S:11526 E:11530 ||| IN
the  ||| S:11530 E:11534 ||| DT
nAChR  ||| S:11534 E:11540 ||| JJ
and  ||| S:11540 E:11544 ||| CC
identified  ||| S:11544 E:11555 ||| VBN
in  ||| S:11555 E:11558 ||| IN
a  ||| S:11558 E:11568 ||| DT
homologous  ||| S:11568 E:11579 ||| JJ
AChBP  ||| S:11579 E:11585 ||| NN
[  ||| S:11585 E:11587 ||| -LRB-
12  ||| S:11587 E:11590 ||| CD
23  ||| S:11590 E:11593 ||| CD
24  ||| S:11593 E:11596 ||| CD
]  ||| S:11596 E:11598 ||| -RRB-
.  ||| S:11598 E:11608 ||| .
Representative  ||| S:11608 E:11623 ||| JJ
members  ||| S:11623 E:11631 ||| NNS
of  ||| S:11631 E:11634 ||| IN
5  ||| S:11634 E:11636 ||| CD
major  ||| S:11636 E:11642 ||| JJ
structural  ||| S:11642 E:11653 ||| JJ
classes  ||| S:11653 E:11661 ||| NNS
of  ||| S:11661 E:11672 ||| IN
5-HT  ||| S:11672 E:11686 ||| CD
3  ||| S:11686 E:11688 ||| CD
R  ||| S:11688 E:11690 ||| NN
ligands  ||| S:11690 E:11698 ||| NNS
were  ||| S:11698 E:11703 ||| VBD
tested  ||| S:11703 E:11710 ||| VBN
on  ||| S:11710 E:11713 ||| IN
all  ||| S:11713 E:11717 ||| DT
mutants  ||| S:11717 E:11733 ||| NN
( ||| S:11733 E:11734 ||| -LRB-
Figure  ||| S:11734 E:11741 ||| NNP
1 ||| S:11741 E:11742 ||| CD
) ||| S:11742 E:11743 ||| -RRB-
.  ||| S:11743 E:11745 ||| .
These  ||| S:11745 E:11751 ||| DT
ligands  ||| S:11751 E:11759 ||| NNS
include  ||| S:11759 E:11767 ||| VBP
the  ||| S:11767 E:11771 ||| DT
antagonists  ||| S:11771 E:11783 ||| NNS
[  ||| S:11783 E:11793 ||| -LRB-
3H ||| S:11793 E:11795 ||| NNP
] ||| S:11795 E:11796 ||| -RRB-
granisetron ||| S:11796 E:11807 ||| NN
,  ||| S:11807 E:11818 ||| ,
d  ||| S:11818 E:11820 ||| JJ
-tc  ||| S:11820 E:11824 ||| JJ
and  ||| S:11824 E:11828 ||| CC
lerisetron ||| S:11828 E:11838 ||| NN
,  ||| S:11838 E:11840 ||| ,
and  ||| S:11840 E:11844 ||| CC
the  ||| S:11844 E:11856 ||| DT
agonists  ||| S:11856 E:11865 ||| JJ
5-HT  ||| S:11865 E:11870 ||| NN
and  ||| S:11870 E:11883 ||| CC
m  ||| S:11883 E:11885 ||| JJ
CPBG ||| S:11885 E:11889 ||| NNP
.  ||| S:11889 E:11891 ||| .
Most  ||| S:11891 E:11896 ||| JJS
of  ||| S:11896 E:11899 ||| IN
the  ||| S:11899 E:11903 ||| DT
mutations  ||| S:11903 E:11913 ||| NN
tested  ||| S:11913 E:11928 ||| VBD
produced  ||| S:11928 E:11937 ||| VBN
only  ||| S:11937 E:11942 ||| RB
minor  ||| S:11942 E:11948 ||| JJ
changes  ||| S:11948 E:11956 ||| NNS
in  ||| S:11956 E:11959 ||| IN
binding  ||| S:11959 E:11967 ||| JJ
affinity  ||| S:11967 E:11976 ||| NN
for  ||| S:11976 E:11980 ||| IN
these  ||| S:11980 E:11994 ||| DT
ligands ||| S:11994 E:12001 ||| NN
.  ||| S:12001 E:12003 ||| .
Large  ||| S:12003 E:12009 ||| JJ
changes  ||| S:12009 E:12017 ||| NNS
in  ||| S:12017 E:12020 ||| IN
binding  ||| S:12020 E:12028 ||| NNS
are  ||| S:12028 E:12032 ||| VBP
only  ||| S:12032 E:12037 ||| RB
apparent  ||| S:12037 E:12046 ||| JJ
on  ||| S:12046 E:12057 ||| IN
Y140A ||| S:12057 E:12062 ||| NNP
,  ||| S:12062 E:12064 ||| ,
Y142A  ||| S:12064 E:12070 ||| NNP
and  ||| S:12070 E:12074 ||| CC
Y152A  ||| S:12074 E:12080 ||| CD
receptors  ||| S:12080 E:12090 ||| NNS
for  ||| S:12090 E:12094 ||| IN
select  ||| S:12094 E:12101 ||| JJ
ligands ||| S:12101 E:12108 ||| NN
.  ||| S:12108 E:12110 ||| .
The  ||| S:12110 E:12122 ||| DT
resulting  ||| S:12122 E:12132 ||| VBG
effects  ||| S:12132 E:12140 ||| NNS
of  ||| S:12140 E:12143 ||| IN
individual  ||| S:12143 E:12154 ||| JJ
mutations  ||| S:12154 E:12164 ||| NNS
are  ||| S:12164 E:12168 ||| VBP
specific  ||| S:12168 E:12177 ||| JJ
to  ||| S:12177 E:12188 ||| TO
particular  ||| S:12188 E:12199 ||| JJ
structural  ||| S:12199 E:12210 ||| JJ
classes  ||| S:12210 E:12218 ||| NNS
of  ||| S:12218 E:12221 ||| IN
ligands ||| S:12221 E:12228 ||| NN
.  ||| S:12228 E:12230 ||| .
The  ||| S:12230 E:12234 ||| DT
Y140A  ||| S:12234 E:12248 ||| JJ
mutation  ||| S:12248 E:12257 ||| NN
altered  ||| S:12257 E:12265 ||| VBD
the  ||| S:12265 E:12269 ||| DT
K  ||| S:12269 E:12280 ||| NNP
i  ||| S:12280 E:12282 ||| NN
for  ||| S:12282 E:12295 ||| IN
d  ||| S:12295 E:12297 ||| JJ
-tc  ||| S:12297 E:12301 ||| JJ
inhibition ||| S:12301 E:12311 ||| NN
,  ||| S:12311 E:12313 ||| ,
but  ||| S:12313 E:12317 ||| CC
did  ||| S:12317 E:12321 ||| VBD
not  ||| S:12321 E:12325 ||| RB
alter  ||| S:12325 E:12339 ||| VB
the  ||| S:12339 E:12343 ||| DT
K  ||| S:12343 E:12354 ||| NNP
i  ||| S:12354 E:12356 ||| VBD
obtained  ||| S:12356 E:12365 ||| VBN
for  ||| S:12365 E:12369 ||| IN
any  ||| S:12369 E:12373 ||| DT
other  ||| S:12373 E:12379 ||| JJ
compound  ||| S:12379 E:12396 ||| NN
tested ||| S:12396 E:12402 ||| VBD
,  ||| S:12402 E:12404 ||| ,
while  ||| S:12404 E:12410 ||| IN
Y142A  ||| S:12410 E:12416 ||| NNP
altered  ||| S:12416 E:12424 ||| VBD
the  ||| S:12424 E:12428 ||| DT
K  ||| S:12428 E:12439 ||| NNP
i  ||| S:12439 E:12441 ||| NN
for  ||| S:12441 E:12454 ||| IN
m  ||| S:12454 E:12456 ||| JJ
CPBG ||| S:12456 E:12460 ||| NNP
,  ||| S:12460 E:12462 ||| ,
5-HT  ||| S:12462 E:12467 ||| NNP
and  ||| S:12467 E:12471 ||| CC
lerisetron  ||| S:12471 E:12482 ||| NNS
but  ||| S:12482 E:12486 ||| CC
had  ||| S:12486 E:12498 ||| VBD
little  ||| S:12498 E:12505 ||| RB
if  ||| S:12505 E:12508 ||| IN
any  ||| S:12508 E:12512 ||| DT
effect  ||| S:12512 E:12519 ||| NN
on  ||| S:12519 E:12522 ||| IN
inhibition  ||| S:12522 E:12533 ||| NN
by  ||| S:12533 E:12545 ||| IN
d  ||| S:12545 E:12547 ||| JJ
-tc ||| S:12547 E:12550 ||| NN
.  ||| S:12550 E:12552 ||| .
These  ||| S:12552 E:12558 ||| DT
data  ||| S:12558 E:12563 ||| NNS
indicate  ||| S:12563 E:12572 ||| VBP
the  ||| S:12572 E:12576 ||| DT
highly  ||| S:12576 E:12591 ||| RB
specific  ||| S:12591 E:12600 ||| JJ
nature  ||| S:12600 E:12607 ||| NN
of  ||| S:12607 E:12610 ||| IN
the  ||| S:12610 E:12614 ||| DT
effects  ||| S:12614 E:12622 ||| NNS
introduced  ||| S:12622 E:12633 ||| VBN
by  ||| S:12633 E:12636 ||| IN
the  ||| S:12636 E:12640 ||| DT
alanine  ||| S:12640 E:12656 ||| JJ
mutations  ||| S:12656 E:12666 ||| NNS
and  ||| S:12666 E:12670 ||| CC
appear  ||| S:12670 E:12677 ||| VB
to  ||| S:12677 E:12680 ||| TO
reflect  ||| S:12680 E:12688 ||| VB
specific  ||| S:12688 E:12697 ||| JJ
changes  ||| S:12697 E:12705 ||| NNS
in  ||| S:12705 E:12716 ||| IN
ligand ||| S:12716 E:12722 ||| FW
/ ||| S:12722 E:12723 ||| FW
receptor  ||| S:12723 E:12732 ||| FW
interaction ||| S:12732 E:12743 ||| FW
.  ||| S:12743 E:12753 ||| .
Binding  ||| S:12753 E:12761 ||| VBG
of  ||| S:12761 E:12764 ||| IN
[  ||| S:12764 E:12766 ||| -LRB-
3H ||| S:12766 E:12768 ||| NNP
] ||| S:12768 E:12769 ||| -RRB-
granisetron  ||| S:12769 E:12781 ||| NN
is  ||| S:12781 E:12784 ||| VBZ
altered  ||| S:12784 E:12792 ||| VBN
only  ||| S:12792 E:12797 ||| RB
slightly  ||| S:12797 E:12806 ||| RB
by  ||| S:12806 E:12817 ||| IN
the  ||| S:12817 E:12821 ||| DT
alanine  ||| S:12821 E:12829 ||| JJ
mutations  ||| S:12829 E:12839 ||| NNS
introduced  ||| S:12839 E:12850 ||| VBN
in  ||| S:12850 E:12853 ||| IN
this  ||| S:12853 E:12858 ||| DT
study  ||| S:12858 E:12864 ||| NN
(  ||| S:12864 E:12865 ||| -LRB-
< ||| S:12865 E:12866 ||| SYM
10  ||| S:12866 E:12877 ||| CD
fold ||| S:12877 E:12881 ||| CD
) ||| S:12881 E:12882 ||| -RRB-
.  ||| S:12882 E:12884 ||| .
This  ||| S:12884 E:12889 ||| DT
result  ||| S:12889 E:12896 ||| NN
indicates  ||| S:12896 E:12906 ||| VBZ
the  ||| S:12906 E:12910 ||| DT
lack  ||| S:12910 E:12915 ||| NN
of  ||| S:12915 E:12918 ||| IN
involvement  ||| S:12918 E:12930 ||| NN
of  ||| S:12930 E:12941 ||| IN
amino  ||| S:12941 E:12947 ||| JJ
acids  ||| S:12947 E:12953 ||| NNS
in  ||| S:12953 E:12956 ||| IN
this  ||| S:12956 E:12961 ||| DT
binding  ||| S:12961 E:12969 ||| JJ
loop  ||| S:12969 E:12974 ||| NN
in  ||| S:12974 E:12977 ||| IN
the  ||| S:12977 E:12981 ||| DT
binding  ||| S:12981 E:12989 ||| NN
of  ||| S:12989 E:12992 ||| IN
[  ||| S:12992 E:13002 ||| -LRB-
3H ||| S:13002 E:13004 ||| NNP
] ||| S:13004 E:13005 ||| -RRB-
granisetron ||| S:13005 E:13016 ||| NN
.  ||| S:13016 E:13018 ||| .
It  ||| S:13018 E:13021 ||| PRP
is  ||| S:13021 E:13024 ||| VBZ
apparent ||| S:13024 E:13032 ||| JJ
,  ||| S:13032 E:13034 ||| ,
however ||| S:13034 E:13041 ||| RB
,  ||| S:13041 E:13043 ||| ,
that  ||| S:13043 E:13048 ||| WDT
[  ||| S:13048 E:13058 ||| -LRB-
3H ||| S:13058 E:13060 ||| NNP
] ||| S:13060 E:13061 ||| -RRB-
granisetron  ||| S:13061 E:13073 ||| NN
does  ||| S:13073 E:13078 ||| VBZ
occupy  ||| S:13078 E:13085 ||| VBG
the  ||| S:13085 E:13089 ||| DT
same  ||| S:13089 E:13094 ||| JJ
binding  ||| S:13094 E:13102 ||| JJ
cleft  ||| S:13102 E:13108 ||| NN
as  ||| S:13108 E:13111 ||| IN
other  ||| S:13111 E:13125 ||| JJ
5-HT  ||| S:13125 E:13139 ||| CD
3  ||| S:13139 E:13141 ||| CD
R  ||| S:13141 E:13143 ||| NN
ligands  ||| S:13143 E:13151 ||| VBZ
as  ||| S:13151 E:13154 ||| RB
evidenced  ||| S:13154 E:13164 ||| VBN
by  ||| S:13164 E:13167 ||| IN
the  ||| S:13167 E:13171 ||| DT
ability  ||| S:13171 E:13187 ||| NN
of  ||| S:13187 E:13190 ||| IN
5-HT ||| S:13190 E:13194 ||| NNP
,  ||| S:13194 E:13205 ||| ,
m  ||| S:13205 E:13207 ||| VBG
CPBG ||| S:13207 E:13211 ||| NNP
,  ||| S:13211 E:13222 ||| ,
d  ||| S:13222 E:13224 ||| JJ
-tc  ||| S:13224 E:13228 ||| JJ
and  ||| S:13228 E:13232 ||| CC
lerisetron  ||| S:13232 E:13243 ||| JJ
to  ||| S:13243 E:13246 ||| TO
displace  ||| S:13246 E:13255 ||| VB
it  ||| S:13255 E:13266 ||| PRP
from  ||| S:13266 E:13271 ||| IN
the  ||| S:13271 E:13275 ||| DT
binding  ||| S:13275 E:13283 ||| JJ
site ||| S:13283 E:13287 ||| NN
.  ||| S:13287 E:13289 ||| .
The  ||| S:13289 E:13293 ||| DT
lack  ||| S:13293 E:13298 ||| NN
of  ||| S:13298 E:13301 ||| IN
any  ||| S:13301 E:13305 ||| DT
large  ||| S:13305 E:13311 ||| JJ
change  ||| S:13311 E:13318 ||| NN
in  ||| S:13318 E:13329 ||| IN
binding  ||| S:13329 E:13337 ||| VBG
of  ||| S:13337 E:13340 ||| IN
granisetron  ||| S:13340 E:13352 ||| NN
supports  ||| S:13352 E:13361 ||| VBZ
our  ||| S:13361 E:13365 ||| PRP$
contention  ||| S:13365 E:13376 ||| NN
that  ||| S:13376 E:13381 ||| IN
there  ||| S:13381 E:13395 ||| EX
is  ||| S:13395 E:13398 ||| VBZ
little  ||| S:13398 E:13405 ||| RB
global  ||| S:13405 E:13412 ||| JJ
structural  ||| S:13412 E:13423 ||| JJ
perturbation  ||| S:13423 E:13436 ||| NN
of  ||| S:13436 E:13439 ||| IN
the  ||| S:13439 E:13443 ||| DT
binding  ||| S:13443 E:13459 ||| JJ
site  ||| S:13459 E:13464 ||| NN
resulting  ||| S:13464 E:13474 ||| VBG
from  ||| S:13474 E:13479 ||| IN
the  ||| S:13479 E:13483 ||| DT
introduction  ||| S:13483 E:13496 ||| NN
of  ||| S:13496 E:13499 ||| IN
each  ||| S:13499 E:13504 ||| DT
individual  ||| S:13504 E:13523 ||| JJ
alanine  ||| S:13523 E:13531 ||| JJ
mutation ||| S:13531 E:13539 ||| NN
.  ||| S:13539 E:13549 ||| .
The  ||| S:13549 E:13553 ||| DT
K  ||| S:13553 E:13564 ||| NNP
i  ||| S:13564 E:13566 ||| NN
for  ||| S:13566 E:13570 ||| IN
inhibition  ||| S:13570 E:13581 ||| NN
of  ||| S:13581 E:13584 ||| IN
[  ||| S:13584 E:13586 ||| -LRB-
3H ||| S:13586 E:13588 ||| NNP
] ||| S:13588 E:13589 ||| -RRB-
granisetron  ||| S:13589 E:13609 ||| JJ
binding  ||| S:13609 E:13617 ||| NN
by  ||| S:13617 E:13620 ||| IN
5-HT  ||| S:13620 E:13625 ||| NNP
was  ||| S:13625 E:13629 ||| VBD
increased  ||| S:13629 E:13639 ||| VBN
110  ||| S:13639 E:13643 ||| CD
fold  ||| S:13643 E:13648 ||| NN
by  ||| S:13648 E:13651 ||| IN
the  ||| S:13651 E:13655 ||| DT
Y142A  ||| S:13655 E:13669 ||| JJ
mutation ||| S:13669 E:13677 ||| NN
.  ||| S:13677 E:13679 ||| .
A  ||| S:13679 E:13681 ||| DT
similar  ||| S:13681 E:13689 ||| JJ
increase  ||| S:13689 E:13698 ||| NN
was  ||| S:13698 E:13702 ||| VBD
also  ||| S:13702 E:13707 ||| RB
observed  ||| S:13707 E:13716 ||| VBN
for  ||| S:13716 E:13729 ||| IN
m  ||| S:13729 E:13731 ||| JJ
CPBG  ||| S:13731 E:13736 ||| NNP
( ||| S:13736 E:13737 ||| -LRB-
160  ||| S:13737 E:13741 ||| CD
fold ||| S:13741 E:13745 ||| CD
) ||| S:13745 E:13746 ||| -RRB-
.  ||| S:13746 E:13748 ||| .
In  ||| S:13748 E:13751 ||| IN
contrast ||| S:13751 E:13759 ||| NN
,  ||| S:13759 E:13761 ||| ,
the  ||| S:13761 E:13773 ||| DT
Y140A  ||| S:13773 E:13779 ||| NNP
and  ||| S:13779 E:13783 ||| CC
Y152A  ||| S:13783 E:13789 ||| CD
mutations  ||| S:13789 E:13799 ||| NNS
produced  ||| S:13799 E:13808 ||| VBD
relatively  ||| S:13808 E:13819 ||| RB
small  ||| S:13819 E:13825 ||| JJ
changes  ||| S:13825 E:13841 ||| NNS
in  ||| S:13841 E:13844 ||| IN
the  ||| S:13844 E:13848 ||| DT
K  ||| S:13848 E:13859 ||| NNP
i  ||| S:13859 E:13861 ||| FW
.  ||| S:13861 E:13863 ||| .
Since  ||| S:13863 E:13869 ||| IN
both  ||| S:13869 E:13874 ||| DT
compounds  ||| S:13874 E:13884 ||| NNS
are  ||| S:13884 E:13888 ||| VBP
5-HT  ||| S:13888 E:13902 ||| CD
3  ||| S:13902 E:13904 ||| CD
R  ||| S:13904 E:13906 ||| NN
agonists ||| S:13906 E:13914 ||| NN
,  ||| S:13914 E:13916 ||| ,
they  ||| S:13916 E:13921 ||| PRP
are  ||| S:13921 E:13925 ||| VBP
likely  ||| S:13925 E:13932 ||| JJ
to  ||| S:13932 E:13935 ||| TO
share  ||| S:13935 E:13949 ||| VB
the  ||| S:13949 E:13953 ||| DT
same  ||| S:13953 E:13958 ||| JJ
binding  ||| S:13958 E:13966 ||| JJ
interactions ||| S:13966 E:13978 ||| NNS
.  ||| S:13978 E:13980 ||| .
One  ||| S:13980 E:13984 ||| CD
of  ||| S:13984 E:13987 ||| IN
these  ||| S:13987 E:13993 ||| DT
interactions  ||| S:13993 E:14014 ||| NN
appears  ||| S:14014 E:14022 ||| VBZ
to  ||| S:14022 E:14025 ||| TO
be  ||| S:14025 E:14028 ||| VB
with  ||| S:14028 E:14033 ||| IN
Y142 ||| S:14033 E:14037 ||| CD
.  ||| S:14037 E:14039 ||| .
Other  ||| S:14039 E:14045 ||| JJ
studies  ||| S:14045 E:14053 ||| NNS
have  ||| S:14053 E:14058 ||| VBP
also  ||| S:14058 E:14063 ||| RB
identified  ||| S:14063 E:14082 ||| VBN
binding  ||| S:14082 E:14090 ||| JJ
site  ||| S:14090 E:14095 ||| NN
interactions  ||| S:14095 E:14108 ||| NNS
for  ||| S:14108 E:14112 ||| IN
agonists ||| S:14112 E:14120 ||| NN
.  ||| S:14120 E:14122 ||| .
R91 ||| S:14122 E:14125 ||| NNP
,  ||| S:14125 E:14127 ||| ,
E106 ||| S:14127 E:14131 ||| NNP
,  ||| S:14131 E:14133 ||| ,
F107 ||| S:14133 E:14137 ||| NNP
,  ||| S:14137 E:14147 ||| ,
W183  ||| S:14147 E:14152 ||| NNP
and  ||| S:14152 E:14156 ||| CC
several  ||| S:14156 E:14164 ||| JJ
residues  ||| S:14164 E:14173 ||| JJ
adjacent  ||| S:14173 E:14182 ||| JJ
to  ||| S:14182 E:14185 ||| TO
the  ||| S:14185 E:14189 ||| DT
M1  ||| S:14189 E:14192 ||| JJ
region  ||| S:14192 E:14199 ||| NN
have  ||| S:14199 E:14212 ||| VBP
all  ||| S:14212 E:14216 ||| RB
been  ||| S:14216 E:14221 ||| VBN
demonstrated  ||| S:14221 E:14234 ||| VBN
to  ||| S:14234 E:14237 ||| TO
alter  ||| S:14237 E:14243 ||| VB
the  ||| S:14243 E:14247 ||| DT
action  ||| S:14247 E:14254 ||| NN
of  ||| S:14254 E:14257 ||| IN
5-HT  ||| S:14257 E:14262 ||| NNP
and ||| S:14262 E:14265 ||| CC
/ ||| S:14265 E:14266 ||| NNP
or  ||| S:14266 E:14278 ||| CC
m  ||| S:14278 E:14280 ||| JJ
CPBG  ||| S:14280 E:14285 ||| NNP
[  ||| S:14285 E:14287 ||| -LRB-
20  ||| S:14287 E:14290 ||| CD
21  ||| S:14290 E:14293 ||| CD
25  ||| S:14293 E:14296 ||| CD
26  ||| S:14296 E:14299 ||| CD
]  ||| S:14299 E:14301 ||| -RRB-
.  ||| S:14301 E:14303 ||| .
Within  ||| S:14303 E:14310 ||| IN
the  ||| S:14310 E:14322 ||| DT
crystal  ||| S:14322 E:14330 ||| NN
structure  ||| S:14330 E:14340 ||| NN
of  ||| S:14340 E:14343 ||| IN
the  ||| S:14343 E:14347 ||| DT
AChBP ||| S:14347 E:14352 ||| JJ
,  ||| S:14352 E:14354 ||| ,
homologous  ||| S:14354 E:14365 ||| JJ
residues  ||| S:14365 E:14374 ||| NNS
are  ||| S:14374 E:14386 ||| VBP
located  ||| S:14386 E:14394 ||| VBN
in  ||| S:14394 E:14397 ||| IN
the  ||| S:14397 E:14401 ||| DT
apparent  ||| S:14401 E:14410 ||| JJ
binding  ||| S:14410 E:14418 ||| JJ
site  ||| S:14418 E:14423 ||| NN
[  ||| S:14423 E:14425 ||| -LRB-
24  ||| S:14425 E:14428 ||| CD
]  ||| S:14428 E:14430 ||| -RRB-
.  ||| S:14430 E:14432 ||| .
The  ||| S:14432 E:14436 ||| DT
effects  ||| S:14436 E:14452 ||| NNS
of  ||| S:14452 E:14455 ||| IN
agonist  ||| S:14455 E:14463 ||| NN
on  ||| S:14463 E:14466 ||| IN
the  ||| S:14466 E:14470 ||| DT
5-HT  ||| S:14470 E:14484 ||| CD
3  ||| S:14484 E:14486 ||| CD
R  ||| S:14486 E:14488 ||| NN
are  ||| S:14488 E:14492 ||| VBP
mediated  ||| S:14492 E:14501 ||| VBN
by  ||| S:14501 E:14504 ||| IN
their  ||| S:14504 E:14510 ||| PRP$
interaction  ||| S:14510 E:14530 ||| NN
with  ||| S:14530 E:14535 ||| IN
these  ||| S:14535 E:14541 ||| DT
binding  ||| S:14541 E:14549 ||| JJ
site  ||| S:14549 E:14554 ||| NN
residues ||| S:14554 E:14562 ||| NNS
,  ||| S:14562 E:14564 ||| ,
resulting  ||| S:14564 E:14574 ||| VBG
in  ||| S:14574 E:14577 ||| IN
stable  ||| S:14577 E:14592 ||| JJ
receptor  ||| S:14592 E:14601 ||| NN
conformations ||| S:14601 E:14614 ||| NN
,  ||| S:14614 E:14616 ||| ,
including  ||| S:14616 E:14626 ||| VBG
the  ||| S:14626 E:14630 ||| DT
channel  ||| S:14630 E:14638 ||| NN
open  ||| S:14638 E:14643 ||| JJ
state ||| S:14643 E:14648 ||| NN
.  ||| S:14648 E:14658 ||| .
Identification  ||| S:14658 E:14673 ||| NN
of  ||| S:14673 E:14676 ||| IN
interacting  ||| S:14676 E:14688 ||| JJ
amino  ||| S:14688 E:14694 ||| JJ
acids  ||| S:14694 E:14700 ||| NNS
and  ||| S:14700 E:14704 ||| CC
their  ||| S:14704 E:14718 ||| PRP$
location  ||| S:14718 E:14727 ||| NN
in  ||| S:14727 E:14730 ||| IN
the  ||| S:14730 E:14734 ||| DT
tertiary  ||| S:14734 E:14743 ||| JJ
structure  ||| S:14743 E:14753 ||| NN
of  ||| S:14753 E:14756 ||| IN
the  ||| S:14756 E:14760 ||| DT
receptor  ||| S:14760 E:14769 ||| NN
may  ||| S:14769 E:14781 ||| MD
provide  ||| S:14781 E:14789 ||| VB
clues  ||| S:14789 E:14795 ||| NNS
to  ||| S:14795 E:14798 ||| TO
the  ||| S:14798 E:14802 ||| DT
mechanism  ||| S:14802 E:14812 ||| NN
of  ||| S:14812 E:14815 ||| IN
channel  ||| S:14815 E:14823 ||| NN
opening ||| S:14823 E:14830 ||| NN
.  ||| S:14830 E:14832 ||| .
For  ||| S:14832 E:14844 ||| IN
example ||| S:14844 E:14851 ||| NN
,  ||| S:14851 E:14853 ||| ,
amino  ||| S:14853 E:14859 ||| JJ
acids  ||| S:14859 E:14865 ||| NNS
homologous  ||| S:14865 E:14876 ||| VBP
to  ||| S:14876 E:14879 ||| TO
Y142  ||| S:14879 E:14884 ||| CD
and  ||| S:14884 E:14888 ||| CC
W183  ||| S:14888 E:14893 ||| NNP
( ||| S:14893 E:14894 ||| -LRB-
R104  ||| S:14894 E:14899 ||| NNP
and  ||| S:14899 E:14911 ||| CC
W143  ||| S:14911 E:14916 ||| CD
respectively ||| S:14916 E:14928 ||| CD
)  ||| S:14928 E:14930 ||| -RRB-
are  ||| S:14930 E:14934 ||| VBP
in  ||| S:14934 E:14937 ||| IN
close  ||| S:14937 E:14943 ||| JJ
proximity  ||| S:14943 E:14953 ||| NN
in  ||| S:14953 E:14956 ||| IN
the  ||| S:14956 E:14960 ||| DT
AChBP ||| S:14960 E:14965 ||| JJ
,  ||| S:14965 E:14975 ||| ,
although  ||| S:14975 E:14984 ||| IN
on  ||| S:14984 E:14987 ||| IN
complementary  ||| S:14987 E:15001 ||| JJ
faces  ||| S:15001 E:15007 ||| NNS
of  ||| S:15007 E:15010 ||| IN
the  ||| S:15010 E:15014 ||| DT
receptor  ||| S:15014 E:15023 ||| NN
subunits  ||| S:15023 E:15032 ||| NNS
[  ||| S:15032 E:15042 ||| -LRB-
24  ||| S:15042 E:15045 ||| CD
]  ||| S:15045 E:15047 ||| -RRB-
.  ||| S:15047 E:15049 ||| .
Spier  ||| S:15049 E:15064 ||| NNP
et.  ||| S:15064 E:15068 ||| NNP
al  ||| S:15068 E:15071 ||| NN
.  ||| S:15071 E:15073 ||| .
have  ||| S:15073 E:15078 ||| VBP
suggested  ||| S:15078 E:15088 ||| VBN
that  ||| S:15088 E:15093 ||| IN
W183  ||| S:15093 E:15098 ||| NNP
may  ||| S:15098 E:15110 ||| MD
be  ||| S:15110 E:15113 ||| VB
involved  ||| S:15113 E:15122 ||| VBN
in  ||| S:15122 E:15125 ||| IN
a  ||| S:15125 E:15127 ||| DT
cation-π  ||| S:15127 E:15136 ||| JJ
interaction  ||| S:15136 E:15148 ||| NN
with  ||| S:15148 E:15153 ||| IN
the  ||| S:15153 E:15157 ||| DT
amino  ||| S:15157 E:15163 ||| JJ
group  ||| S:15163 E:15177 ||| NN
of  ||| S:15177 E:15180 ||| IN
5-HT  ||| S:15180 E:15185 ||| NNP
and  ||| S:15185 E:15198 ||| CC
m  ||| S:15198 E:15200 ||| JJ
CPBG  ||| S:15200 E:15205 ||| NNP
[  ||| S:15205 E:15207 ||| -LRB-
26  ||| S:15207 E:15210 ||| CD
]  ||| S:15210 E:15212 ||| -RRB-
.  ||| S:15212 E:15214 ||| .
If  ||| S:15214 E:15217 ||| IN
W183  ||| S:15217 E:15222 ||| NNP
and  ||| S:15222 E:15226 ||| CC
Y142  ||| S:15226 E:15231 ||| NNP
are  ||| S:15231 E:15243 ||| VBP
located  ||| S:15243 E:15251 ||| VBN
near  ||| S:15251 E:15256 ||| IN
each  ||| S:15256 E:15261 ||| DT
other  ||| S:15261 E:15267 ||| JJ
but  ||| S:15267 E:15271 ||| CC
on  ||| S:15271 E:15274 ||| IN
opposite  ||| S:15274 E:15283 ||| NN
faces  ||| S:15283 E:15289 ||| VBZ
of  ||| S:15289 E:15292 ||| IN
the  ||| S:15292 E:15304 ||| DT
binding  ||| S:15304 E:15312 ||| JJ
site  ||| S:15312 E:15317 ||| NN
in  ||| S:15317 E:15320 ||| IN
the  ||| S:15320 E:15324 ||| DT
5-HT  ||| S:15324 E:15338 ||| CD
3  ||| S:15338 E:15340 ||| CD
R ||| S:15340 E:15341 ||| NN
,  ||| S:15341 E:15343 ||| ,
then  ||| S:15343 E:15348 ||| RB
they  ||| S:15348 E:15353 ||| PRP
could  ||| S:15353 E:15359 ||| MD
potentially  ||| S:15359 E:15371 ||| RB
act  ||| S:15371 E:15375 ||| VB
in  ||| S:15375 E:15386 ||| IN
concert  ||| S:15386 E:15394 ||| NN
to  ||| S:15394 E:15397 ||| TO
help  ||| S:15397 E:15402 ||| VB
stabilize  ||| S:15402 E:15412 ||| VB
a  ||| S:15412 E:15414 ||| DT
conformation  ||| S:15414 E:15427 ||| NN
of  ||| S:15427 E:15430 ||| IN
the  ||| S:15430 E:15434 ||| DT
receptor  ||| S:15434 E:15451 ||| NN
leading  ||| S:15451 E:15459 ||| VBG
to  ||| S:15459 E:15462 ||| TO
channel  ||| S:15462 E:15470 ||| VB
opening.  ||| S:15470 E:15496 ||| CD
d  ||| S:15496 E:15498 ||| SYM
-Tubocurarine  ||| S:15498 E:15512 ||| JJ
inhibition  ||| S:15512 E:15523 ||| NN
was  ||| S:15523 E:15535 ||| VBD
uniquely  ||| S:15535 E:15544 ||| RB
altered  ||| S:15544 E:15552 ||| VBN
by  ||| S:15552 E:15555 ||| IN
the  ||| S:15555 E:15559 ||| DT
Y140A  ||| S:15559 E:15565 ||| JJ
mutation ||| S:15565 E:15573 ||| NN
.  ||| S:15573 E:15575 ||| .
An  ||| S:15575 E:15578 ||| DT
increase  ||| S:15578 E:15587 ||| NN
in  ||| S:15587 E:15590 ||| IN
K  ||| S:15590 E:15601 ||| NNP
i  ||| S:15601 E:15603 ||| NN
of  ||| S:15603 E:15606 ||| IN
50  ||| S:15606 E:15609 ||| CD
fold  ||| S:15609 E:15614 ||| NNS
was  ||| S:15614 E:15618 ||| VBD
observed  ||| S:15618 E:15627 ||| VBN
for  ||| S:15627 E:15640 ||| IN
d  ||| S:15640 E:15642 ||| JJ
-tc  ||| S:15642 E:15646 ||| NN
on  ||| S:15646 E:15649 ||| IN
this  ||| S:15649 E:15654 ||| DT
mutant ||| S:15654 E:15660 ||| NN
.  ||| S:15660 E:15662 ||| .
Little  ||| S:15662 E:15669 ||| RB
if  ||| S:15669 E:15672 ||| IN
any  ||| S:15672 E:15684 ||| DT
change  ||| S:15684 E:15691 ||| NN
resulted  ||| S:15691 E:15700 ||| VBD
for  ||| S:15700 E:15704 ||| IN
any  ||| S:15704 E:15708 ||| DT
other  ||| S:15708 E:15714 ||| JJ
mutation ||| S:15714 E:15722 ||| NN
.  ||| S:15722 E:15724 ||| .
Thus ||| S:15724 E:15728 ||| RB
,  ||| S:15728 E:15730 ||| ,
while  ||| S:15730 E:15745 ||| IN
d  ||| S:15745 E:15747 ||| JJ
-tc  ||| S:15747 E:15751 ||| NN
may  ||| S:15751 E:15755 ||| MD
form  ||| S:15755 E:15760 ||| VB
an  ||| S:15760 E:15763 ||| DT
interaction  ||| S:15763 E:15775 ||| NN
with  ||| S:15775 E:15788 ||| IN
the  ||| S:15788 E:15792 ||| DT
receptor  ||| S:15792 E:15801 ||| NN
at  ||| S:15801 E:15804 ||| IN
this  ||| S:15804 E:15809 ||| DT
binding  ||| S:15809 E:15817 ||| JJ
loop ||| S:15817 E:15821 ||| NN
,  ||| S:15821 E:15823 ||| ,
it  ||| S:15823 E:15826 ||| PRP
appears  ||| S:15826 E:15834 ||| VBZ
to  ||| S:15834 E:15837 ||| TO
interact  ||| S:15837 E:15854 ||| VB
with  ||| S:15854 E:15859 ||| IN
Y140  ||| S:15859 E:15864 ||| NNP
rather  ||| S:15864 E:15871 ||| RB
than  ||| S:15871 E:15876 ||| IN
Y142  ||| S:15876 E:15881 ||| NNP
or  ||| S:15881 E:15884 ||| CC
Y152 ||| S:15884 E:15888 ||| NNP
.  ||| S:15888 E:15890 ||| .
This  ||| S:15890 E:15895 ||| DT
difference  ||| S:15895 E:15906 ||| NN
in  ||| S:15906 E:15917 ||| IN
binding  ||| S:15917 E:15925 ||| JJ
site  ||| S:15925 E:15930 ||| NN
interactions  ||| S:15930 E:15943 ||| NNS
of  ||| S:15943 E:15946 ||| IN
the  ||| S:15946 E:15950 ||| DT
antagonist  ||| S:15950 E:15970 ||| JJ
d  ||| S:15970 E:15972 ||| JJ
-tc  ||| S:15972 E:15976 ||| JJ
and  ||| S:15976 E:15980 ||| CC
the  ||| S:15980 E:15984 ||| DT
agonists  ||| S:15984 E:15993 ||| JJ
5-HT  ||| S:15993 E:15998 ||| NN
and  ||| S:15998 E:16011 ||| CC
m  ||| S:16011 E:16013 ||| JJ
CPBG  ||| S:16013 E:16018 ||| NNP
could  ||| S:16018 E:16024 ||| MD
be  ||| S:16024 E:16027 ||| VB
the  ||| S:16027 E:16031 ||| DT
result  ||| S:16031 E:16038 ||| NN
of  ||| S:16038 E:16041 ||| IN
a  ||| S:16041 E:16051 ||| DT
slightly  ||| S:16051 E:16060 ||| RB
different  ||| S:16060 E:16070 ||| JJ
positioning  ||| S:16070 E:16082 ||| NN
of  ||| S:16082 E:16094 ||| IN
d  ||| S:16094 E:16096 ||| JJ
-tc  ||| S:16096 E:16100 ||| NN
in  ||| S:16100 E:16103 ||| IN
the  ||| S:16103 E:16107 ||| DT
binding  ||| S:16107 E:16115 ||| JJ
site ||| S:16115 E:16119 ||| NN
.  ||| S:16119 E:16121 ||| .
The  ||| S:16121 E:16133 ||| DT
antagonists  ||| S:16133 E:16154 ||| JJ
d  ||| S:16154 E:16156 ||| JJ
-tc  ||| S:16156 E:16160 ||| JJ
and  ||| S:16160 E:16164 ||| CC
[  ||| S:16164 E:16166 ||| -LRB-
3H ||| S:16166 E:16168 ||| NNP
] ||| S:16168 E:16169 ||| -RRB-
granisetron  ||| S:16169 E:16181 ||| VBZ
also  ||| S:16181 E:16194 ||| RB
interact  ||| S:16194 E:16203 ||| VBN
differently  ||| S:16203 E:16215 ||| RB
with  ||| S:16215 E:16220 ||| IN
this  ||| S:16220 E:16225 ||| DT
region  ||| S:16225 E:16232 ||| NN
since  ||| S:16232 E:16238 ||| IN
[  ||| S:16238 E:16248 ||| -LRB-
3H ||| S:16248 E:16250 ||| NNP
] ||| S:16250 E:16251 ||| -RRB-
granisetron  ||| S:16251 E:16263 ||| JJ
binding  ||| S:16263 E:16271 ||| NN
was  ||| S:16271 E:16275 ||| VBD
not  ||| S:16275 E:16279 ||| RB
altered  ||| S:16279 E:16287 ||| VBN
by  ||| S:16287 E:16290 ||| IN
mutations  ||| S:16290 E:16300 ||| NNS
at  ||| S:16300 E:16303 ||| IN
any  ||| S:16303 E:16315 ||| DT
of  ||| S:16315 E:16318 ||| IN
the  ||| S:16318 E:16322 ||| DT
amino  ||| S:16322 E:16328 ||| JJ
acids  ||| S:16328 E:16334 ||| NNS
tested ||| S:16334 E:16340 ||| VBD
.  ||| S:16340 E:16342 ||| .
While  ||| S:16342 E:16348 ||| IN
the  ||| S:16348 E:16352 ||| DT
binding  ||| S:16352 E:16360 ||| NN
of  ||| S:16360 E:16372 ||| IN
d  ||| S:16372 E:16374 ||| JJ
-tc  ||| S:16374 E:16378 ||| NN
appears  ||| S:16378 E:16386 ||| VBZ
to  ||| S:16386 E:16389 ||| TO
involve  ||| S:16389 E:16397 ||| VB
some  ||| S:16397 E:16410 ||| DT
interaction  ||| S:16410 E:16422 ||| NN
with  ||| S:16422 E:16427 ||| IN
this  ||| S:16427 E:16432 ||| DT
binding  ||| S:16432 E:16440 ||| JJ
loop ||| S:16440 E:16444 ||| NN
,  ||| S:16444 E:16446 ||| ,
the  ||| S:16446 E:16450 ||| DT
binding  ||| S:16450 E:16458 ||| NN
of  ||| S:16458 E:16461 ||| IN
[  ||| S:16461 E:16471 ||| -LRB-
3H ||| S:16471 E:16473 ||| NNP
] ||| S:16473 E:16474 ||| -RRB-
granisetron  ||| S:16474 E:16486 ||| NN
does  ||| S:16486 E:16491 ||| VBZ
not ||| S:16491 E:16494 ||| RB
.  ||| S:16494 E:16496 ||| .
Previous  ||| S:16496 E:16505 ||| JJ
studies  ||| S:16505 E:16513 ||| NNS
have  ||| S:16513 E:16518 ||| VBP
indicated  ||| S:16518 E:16528 ||| VBN
a  ||| S:16528 E:16538 ||| DT
point  ||| S:16538 E:16544 ||| NN
of  ||| S:16544 E:16547 ||| IN
overlap  ||| S:16547 E:16555 ||| NN
between  ||| S:16555 E:16563 ||| IN
[  ||| S:16563 E:16565 ||| -LRB-
3H ||| S:16565 E:16567 ||| NNP
] ||| S:16567 E:16568 ||| -RRB-
granisetron  ||| S:16568 E:16580 ||| NN
and  ||| S:16580 E:16593 ||| CC
d  ||| S:16593 E:16595 ||| JJ
-tc  ||| S:16595 E:16599 ||| NN
at  ||| S:16599 E:16602 ||| IN
W89  ||| S:16602 E:16606 ||| CD
of  ||| S:16606 E:16609 ||| IN
the  ||| S:16609 E:16613 ||| DT
5-HT  ||| S:16613 E:16627 ||| NNP
3AS  ||| S:16627 E:16631 ||| NNP
R.  ||| S:16631 E:16634 ||| NNP
[  ||| S:16634 E:16636 ||| -LRB-
20  ||| S:16636 E:16639 ||| CD
]  ||| S:16639 E:16641 ||| -RRB-
.  ||| S:16641 E:16643 ||| .
These  ||| S:16643 E:16649 ||| DT
studies  ||| S:16649 E:16657 ||| NNS
indicate  ||| S:16657 E:16674 ||| VBP
that  ||| S:16674 E:16679 ||| IN
the  ||| S:16679 E:16683 ||| DT
binding  ||| S:16683 E:16691 ||| JJ
regions  ||| S:16691 E:16699 ||| NNS
for  ||| S:16699 E:16703 ||| IN
these  ||| S:16703 E:16709 ||| DT
antagonists  ||| S:16709 E:16721 ||| NNS
are  ||| S:16721 E:16733 ||| VBP
partially  ||| S:16733 E:16743 ||| RB
overlapping  ||| S:16743 E:16755 ||| VBG
at  ||| S:16755 E:16758 ||| IN
W89  ||| S:16758 E:16762 ||| NNP
but  ||| S:16762 E:16766 ||| CC
not  ||| S:16766 E:16770 ||| RB
at  ||| S:16770 E:16773 ||| IN
Y140 ||| S:16773 E:16777 ||| CD
.  ||| S:16777 E:16779 ||| .
In  ||| S:16779 E:16782 ||| IN
addition  ||| S:16782 E:16799 ||| NN
to  ||| S:16799 E:16802 ||| TO
Y140  ||| S:16802 E:16807 ||| CD
and  ||| S:16807 E:16811 ||| CC
W89 ||| S:16811 E:16814 ||| NNP
,  ||| S:16814 E:16825 ||| ,
d  ||| S:16825 E:16827 ||| JJ
-tc  ||| S:16827 E:16831 ||| NN
has  ||| S:16831 E:16835 ||| VBZ
also  ||| S:16835 E:16840 ||| RB
been  ||| S:16840 E:16845 ||| VBN
observed  ||| S:16845 E:16854 ||| VBN
to  ||| S:16854 E:16865 ||| TO
interact  ||| S:16865 E:16874 ||| VB
with  ||| S:16874 E:16879 ||| IN
D206  ||| S:16879 E:16884 ||| NNP
and  ||| S:16884 E:16888 ||| CC
several  ||| S:16888 E:16896 ||| JJ
other  ||| S:16896 E:16902 ||| JJ
residues  ||| S:16902 E:16911 ||| NNS
in  ||| S:16911 E:16914 ||| IN
loop  ||| S:16914 E:16919 ||| JJ
C  ||| S:16919 E:16921 ||| NNP
[  ||| S:16921 E:16931 ||| -LRB-
27  ||| S:16931 E:16934 ||| CD
]  ||| S:16934 E:16936 ||| -RRB-
.  ||| S:16936 E:16938 ||| .
The  ||| S:16938 E:16951 ||| DT
d  ||| S:16951 E:16953 ||| JJ
-tc  ||| S:16953 E:16957 ||| JJ
binding  ||| S:16957 E:16965 ||| JJ
site  ||| S:16965 E:16970 ||| NN
appears  ||| S:16970 E:16978 ||| VBZ
to  ||| S:16978 E:16981 ||| TO
involve  ||| S:16981 E:16997 ||| VB
interaction  ||| S:16997 E:17009 ||| VBN
with  ||| S:17009 E:17014 ||| IN
at  ||| S:17014 E:17017 ||| IN
least  ||| S:17017 E:17023 ||| JJS
three  ||| S:17023 E:17029 ||| CD
different  ||| S:17029 E:17039 ||| JJ
binding  ||| S:17039 E:17047 ||| JJ
loops  ||| S:17047 E:17053 ||| NNS
( ||| S:17053 E:17054 ||| -LRB-
A ||| S:17054 E:17055 ||| NNP
,  ||| S:17055 E:17065 ||| ,
E  ||| S:17065 E:17067 ||| NNP
and  ||| S:17067 E:17071 ||| CC
C ||| S:17071 E:17072 ||| NNP
)  ||| S:17072 E:17074 ||| -RRB-
although  ||| S:17074 E:17083 ||| IN
additional  ||| S:17083 E:17094 ||| JJ
interacting  ||| S:17094 E:17106 ||| JJ
amino  ||| S:17106 E:17112 ||| JJ
acids  ||| S:17112 E:17118 ||| NNS
may  ||| S:17118 E:17122 ||| MD
be  ||| S:17122 E:17133 ||| VB
found ||| S:17133 E:17138 ||| VBN
.  ||| S:17138 E:17140 ||| .
Data  ||| S:17140 E:17145 ||| NNS
obtained  ||| S:17145 E:17154 ||| VBN
for  ||| S:17154 E:17167 ||| IN
d  ||| S:17167 E:17169 ||| JJ
-tc  ||| S:17169 E:17173 ||| NN
is  ||| S:17173 E:17176 ||| VBZ
particularly  ||| S:17176 E:17189 ||| RB
valuable  ||| S:17189 E:17198 ||| JJ
due  ||| S:17198 E:17202 ||| JJ
to  ||| S:17202 E:17213 ||| TO
the  ||| S:17213 E:17217 ||| DT
rigid  ||| S:17217 E:17223 ||| JJ
nature  ||| S:17223 E:17230 ||| NN
of  ||| S:17230 E:17233 ||| IN
this  ||| S:17233 E:17238 ||| DT
molecule ||| S:17238 E:17246 ||| NN
.  ||| S:17246 E:17248 ||| .
Determination  ||| S:17248 E:17262 ||| NN
of  ||| S:17262 E:17273 ||| IN
interacting  ||| S:17273 E:17285 ||| JJ
functional  ||| S:17285 E:17296 ||| JJ
groups  ||| S:17296 E:17303 ||| NNS
and  ||| S:17303 E:17307 ||| CC
their  ||| S:17307 E:17313 ||| PRP$
relationship  ||| S:17313 E:17326 ||| NN
to  ||| S:17326 E:17337 ||| TO
individual  ||| S:17337 E:17348 ||| JJ
amino  ||| S:17348 E:17354 ||| JJ
acids  ||| S:17354 E:17360 ||| NNS
could  ||| S:17360 E:17366 ||| MD
enable  ||| S:17366 E:17382 ||| VB
d  ||| S:17382 E:17384 ||| JJ
-tc  ||| S:17384 E:17388 ||| JJ
to  ||| S:17388 E:17391 ||| TO
be  ||| S:17391 E:17394 ||| VB
used  ||| S:17394 E:17399 ||| VBN
as  ||| S:17399 E:17402 ||| IN
a  ||| S:17402 E:17404 ||| DT
molecular  ||| S:17404 E:17414 ||| JJ
ruler  ||| S:17414 E:17428 ||| NN
to  ||| S:17428 E:17431 ||| TO
determine  ||| S:17431 E:17441 ||| VB
relative  ||| S:17441 E:17450 ||| JJ
positions  ||| S:17450 E:17460 ||| NNS
of  ||| S:17460 E:17463 ||| IN
these  ||| S:17463 E:17469 ||| DT
amino  ||| S:17469 E:17475 ||| JJ
acids ||| S:17475 E:17480 ||| NNS
.  ||| S:17480 E:17490 ||| .
Lerisetron  ||| S:17490 E:17501 ||| JJ
inhibition  ||| S:17501 E:17512 ||| NN
of  ||| S:17512 E:17515 ||| IN
[  ||| S:17515 E:17517 ||| -LRB-
3H ||| S:17517 E:17519 ||| NNP
] ||| S:17519 E:17520 ||| -RRB-
granisetron  ||| S:17520 E:17532 ||| VBP
binding  ||| S:17532 E:17540 ||| VBG
to  ||| S:17540 E:17551 ||| TO
mutant  ||| S:17551 E:17558 ||| VB
receptors  ||| S:17558 E:17568 ||| NNS
was  ||| S:17568 E:17572 ||| VBD
also  ||| S:17572 E:17577 ||| RB
investigated ||| S:17577 E:17589 ||| VBN
.  ||| S:17589 E:17591 ||| .
Lerisetron  ||| S:17591 E:17602 ||| NNP
is  ||| S:17602 E:17605 ||| VBZ
a  ||| S:17605 E:17615 ||| DT
potent  ||| S:17615 E:17622 ||| JJ
5-HT  ||| S:17622 E:17636 ||| CD
3  ||| S:17636 E:17638 ||| CD
R  ||| S:17638 E:17640 ||| NN
antagonist  ||| S:17640 E:17651 ||| VBZ
first  ||| S:17651 E:17657 ||| JJ
synthesized  ||| S:17657 E:17669 ||| NN
by  ||| S:17669 E:17680 ||| IN
Orales  ||| S:17680 E:17696 ||| NNP
et.  ||| S:17696 E:17700 ||| NNP
al.  ||| S:17700 E:17704 ||| NNP
[  ||| S:17704 E:17706 ||| -LRB-
28  ||| S:17706 E:17709 ||| CD
]  ||| S:17709 E:17711 ||| -RRB-
.  ||| S:17711 E:17713 ||| .
As  ||| S:17713 E:17716 ||| RB
was  ||| S:17716 E:17720 ||| VBD
observed  ||| S:17720 E:17729 ||| VBN
for  ||| S:17729 E:17741 ||| IN
5-HT  ||| S:17741 E:17755 ||| CD
3  ||| S:17755 E:17757 ||| CD
R  ||| S:17757 E:17759 ||| NN
agonists ||| S:17759 E:17767 ||| NN
,  ||| S:17767 E:17769 ||| ,
lerisetron  ||| S:17769 E:17780 ||| JJ
binding  ||| S:17780 E:17788 ||| NN
was  ||| S:17788 E:17800 ||| VBD
altered  ||| S:17800 E:17808 ||| VBN
by  ||| S:17808 E:17811 ||| IN
the  ||| S:17811 E:17815 ||| DT
Y142A  ||| S:17815 E:17821 ||| JJ
mutation ||| S:17821 E:17829 ||| NN
.  ||| S:17829 E:17831 ||| .
This  ||| S:17831 E:17836 ||| DT
mutation  ||| S:17836 E:17845 ||| NN
produced  ||| S:17845 E:17854 ||| VBD
an  ||| S:17854 E:17865 ||| DT
increase  ||| S:17865 E:17874 ||| NN
in  ||| S:17874 E:17877 ||| IN
the  ||| S:17877 E:17881 ||| DT
K  ||| S:17881 E:17892 ||| NNP
i  ||| S:17892 E:17894 ||| NN
of  ||| S:17894 E:17897 ||| IN
160  ||| S:17897 E:17901 ||| CD
fold  ||| S:17901 E:17906 ||| NNS
compared  ||| S:17906 E:17915 ||| VBN
to  ||| S:17915 E:17918 ||| TO
wildtype  ||| S:17918 E:17935 ||| VB
receptors ||| S:17935 E:17944 ||| NNS
.  ||| S:17944 E:17946 ||| .
This  ||| S:17946 E:17951 ||| DT
increase  ||| S:17951 E:17960 ||| NN
in  ||| S:17960 E:17963 ||| IN
K  ||| S:17963 E:17974 ||| NNP
i  ||| S:17974 E:17976 ||| FW
indicates  ||| S:17976 E:17986 ||| VBZ
an  ||| S:17986 E:17989 ||| DT
important  ||| S:17989 E:17999 ||| JJ
interaction  ||| S:17999 E:18011 ||| NN
of  ||| S:18011 E:18022 ||| IN
lerisetron  ||| S:18022 E:18033 ||| NN
with  ||| S:18033 E:18038 ||| IN
Y142  ||| S:18038 E:18043 ||| NNP
and  ||| S:18043 E:18047 ||| CC
a  ||| S:18047 E:18049 ||| DT
similarity  ||| S:18049 E:18060 ||| NN
between  ||| S:18060 E:18068 ||| IN
the  ||| S:18068 E:18072 ||| DT
binding  ||| S:18072 E:18088 ||| JJ
location  ||| S:18088 E:18097 ||| NN
of  ||| S:18097 E:18100 ||| IN
lerisetron ||| S:18100 E:18110 ||| NN
,  ||| S:18110 E:18112 ||| ,
5-HT  ||| S:18112 E:18117 ||| NNP
and  ||| S:18117 E:18130 ||| CC
m  ||| S:18130 E:18132 ||| JJ
CPBG ||| S:18132 E:18136 ||| NNP
.  ||| S:18136 E:18138 ||| .
Lerisetron  ||| S:18138 E:18149 ||| NNP
is  ||| S:18149 E:18152 ||| VBZ
the  ||| S:18152 E:18156 ||| DT
only  ||| S:18156 E:18169 ||| JJ
antagonist  ||| S:18169 E:18180 ||| NNS
tested  ||| S:18180 E:18187 ||| VBN
that  ||| S:18187 E:18192 ||| IN
shares  ||| S:18192 E:18199 ||| NNS
a  ||| S:18199 E:18201 ||| DT
binding  ||| S:18201 E:18209 ||| JJ
site  ||| S:18209 E:18214 ||| NN
interaction  ||| S:18214 E:18226 ||| NN
in  ||| S:18226 E:18237 ||| IN
this  ||| S:18237 E:18242 ||| DT
region  ||| S:18242 E:18249 ||| NN
with  ||| S:18249 E:18254 ||| IN
agonists ||| S:18254 E:18262 ||| NN
.  ||| S:18262 E:18264 ||| .
In  ||| S:18264 E:18267 ||| IN
contrast  ||| S:18267 E:18276 ||| NN
to  ||| S:18276 E:18279 ||| TO
5-HT  ||| S:18279 E:18284 ||| CD
and  ||| S:18284 E:18297 ||| CC
m  ||| S:18297 E:18299 ||| JJ
CPBG ||| S:18299 E:18303 ||| NNP
,  ||| S:18303 E:18305 ||| ,
however ||| S:18305 E:18312 ||| RB
,  ||| S:18312 E:18314 ||| ,
lerisetron  ||| S:18314 E:18325 ||| VBD
also  ||| S:18325 E:18338 ||| RB
interacts  ||| S:18338 E:18348 ||| VBN
with  ||| S:18348 E:18353 ||| IN
Y152  ||| S:18353 E:18358 ||| NNP
as  ||| S:18358 E:18361 ||| RB
indicated  ||| S:18361 E:18371 ||| VBN
by  ||| S:18371 E:18374 ||| IN
the  ||| S:18374 E:18378 ||| DT
190  ||| S:18378 E:18382 ||| CD
fold  ||| S:18382 E:18387 ||| JJ
increase  ||| S:18387 E:18404 ||| NN
in  ||| S:18404 E:18407 ||| IN
K  ||| S:18407 E:18418 ||| NNP
i  ||| S:18418 E:18420 ||| FW
on  ||| S:18420 E:18423 ||| FW
Y152A  ||| S:18423 E:18429 ||| FW
mutant  ||| S:18429 E:18436 ||| FW
receptors ||| S:18436 E:18445 ||| FW
.  ||| S:18445 E:18447 ||| .
Since  ||| S:18447 E:18461 ||| IN
neither  ||| S:18461 E:18478 ||| DT
d  ||| S:18478 E:18480 ||| JJ
-tc  ||| S:18480 E:18484 ||| JJ
nor  ||| S:18484 E:18488 ||| CC
[  ||| S:18488 E:18490 ||| -LRB-
3H ||| S:18490 E:18492 ||| NNP
] ||| S:18492 E:18493 ||| -RRB-
granisetron  ||| S:18493 E:18505 ||| JJ
interacts  ||| S:18505 E:18523 ||| NN
with  ||| S:18523 E:18528 ||| IN
Y142  ||| S:18528 E:18533 ||| NNP
or  ||| S:18533 E:18536 ||| CC
Y152 ||| S:18536 E:18540 ||| NNP
,  ||| S:18540 E:18542 ||| ,
there  ||| S:18542 E:18548 ||| EX
appears  ||| S:18548 E:18556 ||| VBZ
to  ||| S:18556 E:18559 ||| TO
be  ||| S:18559 E:18562 ||| VB
a  ||| S:18562 E:18564 ||| DT
difference  ||| S:18564 E:18575 ||| NN
between  ||| S:18575 E:18591 ||| IN
the  ||| S:18591 E:18595 ||| DT
interactions  ||| S:18595 E:18608 ||| NN
formed  ||| S:18608 E:18615 ||| VBN
by  ||| S:18615 E:18618 ||| IN
these  ||| S:18618 E:18624 ||| DT
antagonists  ||| S:18624 E:18636 ||| NN
compared  ||| S:18636 E:18645 ||| VBN
to  ||| S:18645 E:18656 ||| TO
lerisetron ||| S:18656 E:18666 ||| VB
.  ||| S:18666 E:18668 ||| .
The  ||| S:18668 E:18672 ||| DT
binding  ||| S:18672 E:18680 ||| JJ
sites  ||| S:18680 E:18686 ||| NNS
of  ||| S:18686 E:18689 ||| IN
the  ||| S:18689 E:18693 ||| DT
three  ||| S:18693 E:18699 ||| CD
antagonists  ||| S:18699 E:18719 ||| NNS
tested  ||| S:18719 E:18726 ||| VBD
differ  ||| S:18726 E:18733 ||| VBN
with  ||| S:18733 E:18738 ||| IN
respect  ||| S:18738 E:18746 ||| NN
to  ||| S:18746 E:18749 ||| TO
this  ||| S:18749 E:18754 ||| DT
binding  ||| S:18754 E:18762 ||| JJ
loop ||| S:18762 E:18766 ||| NN
.  ||| S:18766 E:18768 ||| .
Since  ||| S:18768 E:18774 ||| IN
the  ||| S:18774 E:18786 ||| DT
role  ||| S:18786 E:18791 ||| NN
of  ||| S:18791 E:18794 ||| IN
a  ||| S:18794 E:18796 ||| DT
competitive  ||| S:18796 E:18808 ||| JJ
antagonist  ||| S:18808 E:18819 ||| NN
is  ||| S:18819 E:18822 ||| VBZ
simply  ||| S:18822 E:18829 ||| RB
to  ||| S:18829 E:18832 ||| TO
block  ||| S:18832 E:18838 ||| VB
the  ||| S:18838 E:18850 ||| DT
binding  ||| S:18850 E:18858 ||| NN
of  ||| S:18858 E:18861 ||| IN
agonists  ||| S:18861 E:18870 ||| NN
and  ||| S:18870 E:18874 ||| CC
prevent  ||| S:18874 E:18882 ||| VB
channel  ||| S:18882 E:18890 ||| NN
opening ||| S:18890 E:18897 ||| NN
,  ||| S:18897 E:18899 ||| ,
the  ||| S:18899 E:18911 ||| DT
specific  ||| S:18911 E:18920 ||| JJ
amino  ||| S:18920 E:18926 ||| JJ
acids  ||| S:18926 E:18932 ||| NNS
that  ||| S:18932 E:18937 ||| IN
interact  ||| S:18937 E:18946 ||| NN
with  ||| S:18946 E:18951 ||| IN
the  ||| S:18951 E:18955 ||| DT
ligand  ||| S:18955 E:18962 ||| NN
can  ||| S:18962 E:18966 ||| MD
vary  ||| S:18966 E:18979 ||| VB
for  ||| S:18979 E:18983 ||| IN
different  ||| S:18983 E:18993 ||| JJ
antagonists ||| S:18993 E:19004 ||| NNS
.  ||| S:19004 E:19006 ||| .
This  ||| S:19006 E:19011 ||| DT
is  ||| S:19011 E:19014 ||| VBZ
less  ||| S:19014 E:19019 ||| RBR
likely  ||| S:19019 E:19026 ||| JJ
to  ||| S:19026 E:19029 ||| TO
be  ||| S:19029 E:19032 ||| VB
the  ||| S:19032 E:19044 ||| DT
case  ||| S:19044 E:19049 ||| NN
with  ||| S:19049 E:19054 ||| IN
agonists  ||| S:19054 E:19063 ||| NN
since  ||| S:19063 E:19069 ||| IN
they  ||| S:19069 E:19074 ||| PRP
must  ||| S:19074 E:19079 ||| MD
produce  ||| S:19079 E:19087 ||| VB
a  ||| S:19087 E:19089 ||| DT
conformational  ||| S:19089 E:19112 ||| JJ
change  ||| S:19112 E:19119 ||| NN
in  ||| S:19119 E:19122 ||| IN
the  ||| S:19122 E:19126 ||| DT
protein  ||| S:19126 E:19134 ||| NN
to  ||| S:19134 E:19137 ||| TO
exert  ||| S:19137 E:19143 ||| VB
their  ||| S:19143 E:19149 ||| PRP$
effects ||| S:19149 E:19156 ||| NNS
.  ||| S:19156 E:19166 ||| .
Only  ||| S:19166 E:19171 ||| RB
two  ||| S:19171 E:19175 ||| CD
mutant  ||| S:19175 E:19182 ||| NNS
receptors  ||| S:19182 E:19192 ||| VBP
failed  ||| S:19192 E:19199 ||| VBN
to  ||| S:19199 E:19202 ||| TO
bind  ||| S:19202 E:19207 ||| VB
[  ||| S:19207 E:19217 ||| -LRB-
3H ||| S:19217 E:19219 ||| NNP
] ||| S:19219 E:19220 ||| -RRB-
granisetron ||| S:19220 E:19231 ||| NN
;  ||| S:19231 E:19233 ||| :
G147A  ||| S:19233 E:19239 ||| CD
and  ||| S:19239 E:19243 ||| CC
V149A ||| S:19243 E:19248 ||| NNP
.  ||| S:19248 E:19250 ||| .
G147  ||| S:19250 E:19255 ||| NNP
is  ||| S:19255 E:19258 ||| VBZ
the  ||| S:19258 E:19262 ||| DT
conserved  ||| S:19262 E:19280 ||| JJ
glycine  ||| S:19280 E:19288 ||| NN
in  ||| S:19288 E:19291 ||| IN
this  ||| S:19291 E:19296 ||| DT
putative  ||| S:19296 E:19305 ||| JJ
binding  ||| S:19305 E:19313 ||| JJ
loop ||| S:19313 E:19317 ||| NN
.  ||| S:19317 E:19319 ||| .
Chirara  ||| S:19319 E:19336 ||| NNP
et.  ||| S:19336 E:19340 ||| NNP
al.  ||| S:19340 E:19344 ||| NNP
have  ||| S:19344 E:19349 ||| VBP
suggested  ||| S:19349 E:19359 ||| VBN
that  ||| S:19359 E:19364 ||| IN
the  ||| S:19364 E:19376 ||| DT
highly  ||| S:19376 E:19383 ||| RB
conserved  ||| S:19383 E:19393 ||| JJ
nature  ||| S:19393 E:19400 ||| NN
of  ||| S:19400 E:19403 ||| IN
the  ||| S:19403 E:19407 ||| DT
glycine  ||| S:19407 E:19415 ||| NN
in  ||| S:19415 E:19418 ||| IN
this  ||| S:19418 E:19423 ||| DT
region  ||| S:19423 E:19430 ||| NN
may  ||| S:19430 E:19442 ||| MD
indicate  ||| S:19442 E:19451 ||| VB
the  ||| S:19451 E:19455 ||| DT
existence  ||| S:19455 E:19465 ||| NN
of  ||| S:19465 E:19468 ||| IN
a  ||| S:19468 E:19470 ||| DT
loop  ||| S:19470 E:19475 ||| JJ
structure  ||| S:19475 E:19485 ||| NN
consisting  ||| S:19485 E:19496 ||| VBG
of  ||| S:19496 E:19507 ||| IN
either  ||| S:19507 E:19514 ||| DT
γ  ||| S:19514 E:19516 ||| NN
or  ||| S:19516 E:19519 ||| CC
a  ||| S:19519 E:19521 ||| DT
loose  ||| S:19521 E:19527 ||| JJ
three  ||| S:19527 E:19533 ||| CD
residue-turn  ||| S:19533 E:19546 ||| NN
in  ||| S:19546 E:19549 ||| IN
the  ||| S:19549 E:19553 ||| DT
nAChR  ||| S:19553 E:19559 ||| JJ
[  ||| S:19559 E:19561 ||| -LRB-
12  ||| S:19561 E:19564 ||| CD
]  ||| S:19564 E:19574 ||| -RRB-
.  ||| S:19574 E:19576 ||| .
Either  ||| S:19576 E:19583 ||| RB
of  ||| S:19583 E:19586 ||| IN
these  ||| S:19586 E:19592 ||| DT
turns  ||| S:19592 E:19598 ||| NNS
would  ||| S:19598 E:19604 ||| MD
bring  ||| S:19604 E:19610 ||| VB
the  ||| S:19610 E:19614 ||| DT
two  ||| S:19614 E:19618 ||| CD
putative  ||| S:19618 E:19635 ||| JJ
β-strands  ||| S:19635 E:19645 ||| NN
together  ||| S:19645 E:19654 ||| RB
such  ||| S:19654 E:19659 ||| JJ
that  ||| S:19659 E:19664 ||| IN
γL109 ||| S:19664 E:19669 ||| NNP
,  ||| S:19669 E:19671 ||| ,
γY111  ||| S:19671 E:19677 ||| NNP
and  ||| S:19677 E:19681 ||| CC
γS115  ||| S:19681 E:19687 ||| NNP
and  ||| S:19687 E:19699 ||| CC
γY117  ||| S:19699 E:19705 ||| NNP
are  ||| S:19705 E:19709 ||| VBP
all  ||| S:19709 E:19713 ||| RB
on  ||| S:19713 E:19716 ||| IN
the  ||| S:19716 E:19720 ||| DT
same  ||| S:19720 E:19725 ||| JJ
side  ||| S:19725 E:19730 ||| NN
of  ||| S:19730 E:19733 ||| IN
an  ||| S:19733 E:19736 ||| DT
antiparallel  ||| S:19736 E:19749 ||| JJ
β-sheet ||| S:19749 E:19756 ||| NN
.  ||| S:19756 E:19766 ||| .
These  ||| S:19766 E:19772 ||| DT
residues  ||| S:19772 E:19781 ||| NNS
have  ||| S:19781 E:19786 ||| VBP
been  ||| S:19786 E:19791 ||| VBN
identified  ||| S:19791 E:19802 ||| VBN
by  ||| S:19802 E:19805 ||| IN
affinity  ||| S:19805 E:19814 ||| JJ
labeling ||| S:19814 E:19822 ||| NN
,  ||| S:19822 E:19832 ||| ,
site-directed  ||| S:19832 E:19846 ||| JJ
mutagenesis  ||| S:19846 E:19858 ||| NN
or  ||| S:19858 E:19861 ||| CC
cysteine  ||| S:19861 E:19870 ||| JJ
substitution  ||| S:19870 E:19883 ||| NN
to  ||| S:19883 E:19886 ||| TO
lie  ||| S:19886 E:19898 ||| VB
on  ||| S:19898 E:19901 ||| IN
the  ||| S:19901 E:19905 ||| DT
same  ||| S:19905 E:19910 ||| JJ
surface ||| S:19910 E:19917 ||| NN
.  ||| S:19917 E:19919 ||| .
A  ||| S:19919 E:19921 ||| DT
classic  ||| S:19921 E:19929 ||| JJ
2-residue  ||| S:19929 E:19939 ||| NNP
β-turn  ||| S:19939 E:19946 ||| NNP
would  ||| S:19946 E:19952 ||| MD
place  ||| S:19952 E:19966 ||| VB
these  ||| S:19966 E:19972 ||| DT
residues  ||| S:19972 E:19981 ||| NN
on  ||| S:19981 E:19984 ||| IN
opposite  ||| S:19984 E:19993 ||| JJ
surfaces  ||| S:19993 E:20002 ||| NNS
[  ||| S:20002 E:20004 ||| -LRB-
12  ||| S:20004 E:20007 ||| CD
]  ||| S:20007 E:20009 ||| -RRB-
.  ||| S:20009 E:20011 ||| .
Substitution  ||| S:20011 E:20032 ||| NNP
of  ||| S:20032 E:20035 ||| IN
the  ||| S:20035 E:20039 ||| DT
conserved  ||| S:20039 E:20049 ||| JJ
glycine  ||| S:20049 E:20057 ||| NN
by  ||| S:20057 E:20060 ||| IN
alanine  ||| S:20060 E:20068 ||| NNS
may  ||| S:20068 E:20072 ||| MD
disrupt  ||| S:20072 E:20080 ||| VB
the  ||| S:20080 E:20092 ||| DT
structure  ||| S:20092 E:20102 ||| NN
of  ||| S:20102 E:20105 ||| IN
this  ||| S:20105 E:20110 ||| DT
region  ||| S:20110 E:20117 ||| NN
and  ||| S:20117 E:20121 ||| CC
prevent  ||| S:20121 E:20129 ||| VB
assembly  ||| S:20129 E:20138 ||| NN
or  ||| S:20138 E:20141 ||| CC
expression  ||| S:20141 E:20160 ||| NN
of  ||| S:20160 E:20163 ||| IN
the  ||| S:20163 E:20167 ||| DT
receptor ||| S:20167 E:20175 ||| NN
.  ||| S:20175 E:20177 ||| .
The  ||| S:20177 E:20181 ||| DT
recent  ||| S:20181 E:20188 ||| JJ
determination  ||| S:20188 E:20202 ||| NN
of  ||| S:20202 E:20205 ||| IN
the  ||| S:20205 E:20209 ||| DT
crystal  ||| S:20209 E:20225 ||| NN
structure  ||| S:20225 E:20235 ||| NN
of  ||| S:20235 E:20238 ||| IN
an  ||| S:20238 E:20241 ||| DT
AChBP  ||| S:20241 E:20247 ||| NN
supports  ||| S:20247 E:20256 ||| VBZ
this  ||| S:20256 E:20261 ||| DT
hypothesis ||| S:20261 E:20271 ||| NN
.  ||| S:20271 E:20273 ||| .
The  ||| S:20273 E:20277 ||| DT
AChBP  ||| S:20277 E:20291 ||| JJ
displays  ||| S:20291 E:20300 ||| NNS
a  ||| S:20300 E:20302 ||| DT
large  ||| S:20302 E:20308 ||| JJ
amount  ||| S:20308 E:20315 ||| NN
of  ||| S:20315 E:20318 ||| IN
homology  ||| S:20318 E:20327 ||| VBG
to  ||| S:20327 E:20330 ||| TO
the  ||| S:20330 E:20334 ||| DT
amino  ||| S:20334 E:20340 ||| JJ
terminal  ||| S:20340 E:20357 ||| NN
of  ||| S:20357 E:20360 ||| IN
LGIC  ||| S:20360 E:20365 ||| NNP
receptors  ||| S:20365 E:20375 ||| NNS
and  ||| S:20375 E:20379 ||| CC
thus  ||| S:20379 E:20384 ||| RB
may  ||| S:20384 E:20388 ||| MD
be  ||| S:20388 E:20391 ||| VB
similar  ||| S:20391 E:20399 ||| JJ
in  ||| S:20399 E:20402 ||| IN
structure  ||| S:20402 E:20412 ||| NN
[  ||| S:20412 E:20414 ||| -LRB-
20  ||| S:20414 E:20425 ||| CD
24  ||| S:20425 E:20428 ||| CD
]  ||| S:20428 E:20430 ||| -RRB-
.  ||| S:20430 E:20432 ||| .
The  ||| S:20432 E:20436 ||| DT
crystal  ||| S:20436 E:20444 ||| NN
structure  ||| S:20444 E:20454 ||| NN
of  ||| S:20454 E:20457 ||| IN
this  ||| S:20457 E:20462 ||| DT
protein  ||| S:20462 E:20470 ||| NN
reveals  ||| S:20470 E:20478 ||| VBZ
a  ||| S:20478 E:20488 ||| DT
loose  ||| S:20488 E:20494 ||| JJ
3  ||| S:20494 E:20496 ||| CD
residue  ||| S:20496 E:20504 ||| NNS
turn  ||| S:20504 E:20509 ||| VBP
incorporating  ||| S:20509 E:20523 ||| VBG
the  ||| S:20523 E:20527 ||| DT
conserved  ||| S:20527 E:20537 ||| FW
glycine  ||| S:20537 E:20553 ||| FW
residue  ||| S:20553 E:20561 ||| FW
[  ||| S:20561 E:20563 ||| -LRB-
24  ||| S:20563 E:20566 ||| CD
]  ||| S:20566 E:20568 ||| -RRB-
.  ||| S:20568 E:20570 ||| .
Homologous  ||| S:20570 E:20581 ||| JJ
residues  ||| S:20581 E:20590 ||| NNS
in  ||| S:20590 E:20593 ||| IN
other  ||| S:20593 E:20599 ||| JJ
LGIC  ||| S:20599 E:20604 ||| NN
subunits  ||| S:20604 E:20621 ||| NNS
have  ||| S:20621 E:20626 ||| VBP
also  ||| S:20626 E:20631 ||| RB
been  ||| S:20631 E:20636 ||| VBN
identified  ||| S:20636 E:20647 ||| VBN
and  ||| S:20647 E:20651 ||| CC
are  ||| S:20651 E:20655 ||| VBP
shown  ||| S:20655 E:20661 ||| VBN
in  ||| S:20661 E:20664 ||| IN
Figure  ||| S:20664 E:20671 ||| NNP
1 ||| S:20671 E:20672 ||| CD
.  ||| S:20672 E:20674 ||| .
The  ||| S:20674 E:20686 ||| DT
residues  ||| S:20686 E:20695 ||| NN
identified  ||| S:20695 E:20706 ||| VBN
in  ||| S:20706 E:20709 ||| IN
this  ||| S:20709 E:20714 ||| DT
study  ||| S:20714 E:20720 ||| NN
as  ||| S:20720 E:20723 ||| IN
altering  ||| S:20723 E:20732 ||| VBG
binding  ||| S:20732 E:20748 ||| JJ
affinity  ||| S:20748 E:20757 ||| NN
of  ||| S:20757 E:20760 ||| IN
5-HT  ||| S:20760 E:20774 ||| CD
3  ||| S:20774 E:20776 ||| CD
R  ||| S:20776 E:20778 ||| NN
ligands  ||| S:20778 E:20786 ||| NNS
would  ||| S:20786 E:20792 ||| MD
also  ||| S:20792 E:20797 ||| RB
be  ||| S:20797 E:20800 ||| VB
present  ||| S:20800 E:20808 ||| JJ
on  ||| S:20808 E:20811 ||| IN
the  ||| S:20811 E:20823 ||| DT
same  ||| S:20823 E:20828 ||| JJ
surface  ||| S:20828 E:20836 ||| NN
if  ||| S:20836 E:20839 ||| IN
this  ||| S:20839 E:20844 ||| DT
structure  ||| S:20844 E:20854 ||| NN
is  ||| S:20854 E:20857 ||| VBZ
present  ||| S:20857 E:20865 ||| JJ
in  ||| S:20865 E:20868 ||| IN
the  ||| S:20868 E:20872 ||| DT
5-HT  ||| S:20872 E:20886 ||| CD
3  ||| S:20886 E:20888 ||| CD
R.  ||| S:20888 E:20891 ||| NNP
While  ||| S:20891 E:20897 ||| IN
Y140  ||| S:20897 E:20902 ||| NNP
lies  ||| S:20902 E:20907 ||| VBZ
somewhat  ||| S:20907 E:20916 ||| RB
outside  ||| S:20916 E:20932 ||| IN
the  ||| S:20932 E:20936 ||| DT
region  ||| S:20936 E:20943 ||| NN
identified  ||| S:20943 E:20954 ||| VBN
by  ||| S:20954 E:20957 ||| IN
Chiara  ||| S:20957 E:20964 ||| NNP
in  ||| S:20964 E:20967 ||| IN
the  ||| S:20967 E:20971 ||| DT
nAChR  ||| S:20971 E:20977 ||| JJ
( ||| S:20977 E:20978 ||| -LRB-
homologous  ||| S:20978 E:20989 ||| RB
to  ||| S:20989 E:21000 ||| TO
γN107 ||| S:21000 E:21005 ||| CD
) ||| S:21005 E:21006 ||| -RRB-
,  ||| S:21006 E:21008 ||| ,
γL109  ||| S:21008 E:21014 ||| NNP
and  ||| S:21014 E:21018 ||| CC
γL119  ||| S:21018 E:21024 ||| NNP
are  ||| S:21024 E:21028 ||| VBP
homologous  ||| S:21028 E:21039 ||| VBN
to  ||| S:21039 E:21042 ||| TO
Y142  ||| S:21042 E:21047 ||| CD
and  ||| S:21047 E:21051 ||| CC
Y152  ||| S:21051 E:21056 ||| CD
of  ||| S:21056 E:21067 ||| IN
the  ||| S:21067 E:21071 ||| DT
5-HT  ||| S:21071 E:21085 ||| NNP
3AS  ||| S:21085 E:21089 ||| NNP
R.  ||| S:21089 E:21092 ||| NNP
The  ||| S:21092 E:21096 ||| DT
ability  ||| S:21096 E:21104 ||| NN
of  ||| S:21104 E:21107 ||| IN
lerisetron  ||| S:21107 E:21118 ||| VBG
to  ||| S:21118 E:21129 ||| TO
interact  ||| S:21129 E:21138 ||| VB
with  ||| S:21138 E:21143 ||| IN
both  ||| S:21143 E:21148 ||| DT
Y142  ||| S:21148 E:21153 ||| NNP
and  ||| S:21153 E:21157 ||| CC
Y152  ||| S:21157 E:21162 ||| NNP
also  ||| S:21162 E:21167 ||| RB
supports  ||| S:21167 E:21176 ||| VBZ
the  ||| S:21176 E:21188 ||| DT
hypothesis  ||| S:21188 E:21199 ||| NN
that  ||| S:21199 E:21204 ||| IN
these  ||| S:21204 E:21210 ||| DT
two  ||| S:21210 E:21214 ||| CD
amino  ||| S:21214 E:21220 ||| CD
acids  ||| S:21220 E:21226 ||| NNS
are  ||| S:21226 E:21230 ||| VBP
present  ||| S:21230 E:21238 ||| JJ
in  ||| S:21238 E:21241 ||| IN
a  ||| S:21241 E:21243 ||| DT
loop  ||| S:21243 E:21256 ||| JJ
structure  ||| S:21256 E:21266 ||| NN
since  ||| S:21266 E:21272 ||| IN
the  ||| S:21272 E:21276 ||| DT
eight  ||| S:21276 E:21282 ||| CD
intervening  ||| S:21282 E:21294 ||| CD
residues  ||| S:21294 E:21303 ||| NNS
would  ||| S:21303 E:21317 ||| MD
position  ||| S:21317 E:21326 ||| VB
Y142  ||| S:21326 E:21331 ||| NNP
and  ||| S:21331 E:21335 ||| CC
Y152  ||| S:21335 E:21340 ||| NNP
too  ||| S:21340 E:21344 ||| RB
far  ||| S:21344 E:21348 ||| RB
apart  ||| S:21348 E:21354 ||| RB
to  ||| S:21354 E:21357 ||| TO
permit  ||| S:21357 E:21364 ||| VB
them  ||| S:21364 E:21369 ||| PRP
both  ||| S:21369 E:21374 ||| VBP
to  ||| S:21374 E:21385 ||| TO
interact  ||| S:21385 E:21394 ||| VB
with  ||| S:21394 E:21399 ||| IN
a  ||| S:21399 E:21401 ||| DT
single  ||| S:21401 E:21408 ||| JJ
ligand  ||| S:21408 E:21415 ||| NNS
even  ||| S:21415 E:21420 ||| RB
if  ||| S:21420 E:21423 ||| IN
they  ||| S:21423 E:21428 ||| PRP
were  ||| S:21428 E:21433 ||| VBD
interacting  ||| S:21433 E:21453 ||| VBN
with  ||| S:21453 E:21458 ||| IN
functional  ||| S:21458 E:21469 ||| JJ
groups  ||| S:21469 E:21476 ||| NNS
on  ||| S:21476 E:21479 ||| IN
opposite  ||| S:21479 E:21488 ||| JJ
ends  ||| S:21488 E:21493 ||| NNS
of  ||| S:21493 E:21496 ||| IN
the  ||| S:21496 E:21500 ||| DT
molecule ||| S:21500 E:21508 ||| NN
.  ||| S:21508 E:21510 ||| .
A  ||| S:21510 E:21520 ||| DT
loop  ||| S:21520 E:21525 ||| JJ
structure  ||| S:21525 E:21535 ||| NN
would  ||| S:21535 E:21541 ||| MD
bring  ||| S:21541 E:21547 ||| VB
them  ||| S:21547 E:21552 ||| PRP
into  ||| S:21552 E:21557 ||| IN
closer  ||| S:21557 E:21564 ||| JJR
proximity  ||| S:21564 E:21574 ||| NNS
and  ||| S:21574 E:21586 ||| CC
permit  ||| S:21586 E:21593 ||| VB
interaction  ||| S:21593 E:21605 ||| VBN
with  ||| S:21605 E:21610 ||| IN
the  ||| S:21610 E:21614 ||| DT
small  ||| S:21614 E:21620 ||| JJ
molecule  ||| S:21620 E:21629 ||| NN
lerisetron ||| S:21629 E:21639 ||| NN
.  ||| S:21639 E:21649 ||| .
All  ||| S:21649 E:21653 ||| DT
three  ||| S:21653 E:21659 ||| CD
tyrosine  ||| S:21659 E:21668 ||| CD
mutations  ||| S:21668 E:21678 ||| NNS
were  ||| S:21678 E:21683 ||| VBD
investigated  ||| S:21683 E:21696 ||| VBN
using  ||| S:21696 E:21702 ||| VBG
a  ||| S:21702 E:21712 ||| DT
whole  ||| S:21712 E:21718 ||| JJ
cell  ||| S:21718 E:21723 ||| NN
patch  ||| S:21723 E:21729 ||| NN
clamp  ||| S:21729 E:21735 ||| VBZ
assay  ||| S:21735 E:21741 ||| VBN
to  ||| S:21741 E:21744 ||| TO
determine  ||| S:21744 E:21754 ||| VB
if  ||| S:21754 E:21757 ||| IN
functional  ||| S:21757 E:21776 ||| JJ
changes  ||| S:21776 E:21784 ||| NNS
could  ||| S:21784 E:21790 ||| MD
be  ||| S:21790 E:21793 ||| VB
observed ||| S:21793 E:21801 ||| VBN
.  ||| S:21801 E:21803 ||| .
Whole  ||| S:21803 E:21809 ||| JJ
cell  ||| S:21809 E:21814 ||| NN
responses  ||| S:21814 E:21824 ||| NNS
could  ||| S:21824 E:21830 ||| MD
not  ||| S:21830 E:21842 ||| RB
be  ||| S:21842 E:21845 ||| VB
obtained  ||| S:21845 E:21854 ||| VBN
for  ||| S:21854 E:21858 ||| IN
Y140A  ||| S:21858 E:21864 ||| NNP
or  ||| S:21864 E:21867 ||| CC
Y142A ||| S:21867 E:21872 ||| NNP
,  ||| S:21872 E:21874 ||| ,
although  ||| S:21874 E:21883 ||| IN
specific  ||| S:21883 E:21892 ||| JJ
binding  ||| S:21892 E:21908 ||| NN
of  ||| S:21908 E:21911 ||| IN
[  ||| S:21911 E:21913 ||| -LRB-
3H ||| S:21913 E:21915 ||| NNP
] ||| S:21915 E:21916 ||| -RRB-
granisetron  ||| S:21916 E:21928 ||| NN
was  ||| S:21928 E:21932 ||| VBD
observed ||| S:21932 E:21940 ||| VBN
.  ||| S:21940 E:21942 ||| .
These  ||| S:21942 E:21948 ||| DT
data  ||| S:21948 E:21953 ||| NNS
suggest  ||| S:21953 E:21961 ||| VBP
that ||| S:21961 E:21965 ||| RB
,  ||| S:21965 E:21975 ||| ,
while  ||| S:21975 E:21981 ||| IN
the  ||| S:21981 E:21985 ||| DT
receptors  ||| S:21985 E:21995 ||| NNS
do  ||| S:21995 E:21998 ||| VBP
assemble  ||| S:21998 E:22007 ||| VBN
and  ||| S:22007 E:22011 ||| CC
are  ||| S:22011 E:22015 ||| VBP
capable  ||| S:22015 E:22023 ||| JJ
of  ||| S:22023 E:22026 ||| IN
binding  ||| S:22026 E:22042 ||| JJ
[  ||| S:22042 E:22044 ||| -LRB-
3H ||| S:22044 E:22046 ||| NNP
] ||| S:22046 E:22047 ||| -RRB-
granisetron ||| S:22047 E:22058 ||| NN
,  ||| S:22058 E:22060 ||| ,
they  ||| S:22060 E:22065 ||| PRP
are  ||| S:22065 E:22069 ||| VBP
either  ||| S:22069 E:22076 ||| RB
not  ||| S:22076 E:22080 ||| RB
transported  ||| S:22080 E:22092 ||| VBN
to  ||| S:22092 E:22095 ||| TO
the  ||| S:22095 E:22107 ||| DT
cell  ||| S:22107 E:22112 ||| NN
surface  ||| S:22112 E:22120 ||| NN
or  ||| S:22120 E:22123 ||| CC
are  ||| S:22123 E:22127 ||| VBP
non-responsive  ||| S:22127 E:22142 ||| JJ
to  ||| S:22142 E:22145 ||| TO
5-HT  ||| S:22145 E:22150 ||| CD
at  ||| S:22150 E:22161 ||| IN
concentrations  ||| S:22161 E:22176 ||| NNS
of  ||| S:22176 E:22179 ||| IN
1  ||| S:22179 E:22181 ||| CD
mM  ||| S:22181 E:22184 ||| JJ
or  ||| S:22184 E:22187 ||| CC
less ||| S:22187 E:22191 ||| JJR
.  ||| S:22191 E:22201 ||| .
Y152A  ||| S:22201 E:22207 ||| NNP
does  ||| S:22207 E:22212 ||| VBZ
produce  ||| S:22212 E:22220 ||| VB
functional  ||| S:22220 E:22231 ||| JJ
channels  ||| S:22231 E:22240 ||| NNS
however  ||| S:22240 E:22248 ||| RB
they  ||| S:22248 E:22261 ||| PRP
display  ||| S:22261 E:22269 ||| VBP
distinctly  ||| S:22269 E:22280 ||| RB
altered  ||| S:22280 E:22288 ||| VBN
response  ||| S:22288 E:22297 ||| NN
kinetics  ||| S:22297 E:22306 ||| NN
when  ||| S:22306 E:22311 ||| WRB
compared  ||| S:22311 E:22328 ||| VBN
to  ||| S:22328 E:22331 ||| TO
wildtype  ||| S:22331 E:22340 ||| VB
receptors ||| S:22340 E:22349 ||| NNS
.  ||| S:22349 E:22351 ||| .
Y152A  ||| S:22351 E:22357 ||| NNP
responses  ||| S:22357 E:22367 ||| NNS
do  ||| S:22367 E:22370 ||| VBP
not  ||| S:22370 E:22374 ||| RB
show  ||| S:22374 E:22379 ||| VB
the  ||| S:22379 E:22391 ||| DT
rapid  ||| S:22391 E:22397 ||| JJ
rise  ||| S:22397 E:22402 ||| NN
times  ||| S:22402 E:22408 ||| NNS
observed  ||| S:22408 E:22417 ||| VBD
in  ||| S:22417 E:22420 ||| IN
wt  ||| S:22420 E:22423 ||| JJ
receptors ||| S:22423 E:22432 ||| NNS
.  ||| S:22432 E:22434 ||| .
The  ||| S:22434 E:22438 ||| DT
extremely  ||| S:22438 E:22456 ||| RB
slow  ||| S:22456 E:22461 ||| JJ
rise  ||| S:22461 E:22466 ||| NN
times  ||| S:22466 E:22472 ||| NNS
observed  ||| S:22472 E:22481 ||| VBD
for  ||| S:22481 E:22485 ||| IN
Y152A  ||| S:22485 E:22491 ||| CD
receptors  ||| S:22491 E:22501 ||| NNS
may  ||| S:22501 E:22505 ||| MD
indicate  ||| S:22505 E:22514 ||| VB
a  ||| S:22514 E:22524 ||| DT
change  ||| S:22524 E:22531 ||| NN
in  ||| S:22531 E:22534 ||| IN
rate  ||| S:22534 E:22539 ||| NN
constants  ||| S:22539 E:22549 ||| VBZ
preceding  ||| S:22549 E:22559 ||| VBG
channel  ||| S:22559 E:22567 ||| NN
opening ||| S:22567 E:22574 ||| NN
.  ||| S:22574 E:22576 ||| .
These  ||| S:22576 E:22590 ||| DT
changes  ||| S:22590 E:22598 ||| NNS
in  ||| S:22598 E:22601 ||| IN
the  ||| S:22601 E:22605 ||| DT
rate  ||| S:22605 E:22610 ||| NN
constants  ||| S:22610 E:22620 ||| NN
for  ||| S:22620 E:22624 ||| IN
either  ||| S:22624 E:22631 ||| DT
agonist  ||| S:22631 E:22639 ||| JJ
binding  ||| S:22639 E:22647 ||| NN
or  ||| S:22647 E:22658 ||| CC
channel  ||| S:22658 E:22666 ||| VB
opening  ||| S:22666 E:22674 ||| VBG
also  ||| S:22674 E:22679 ||| RB
produce  ||| S:22679 E:22687 ||| VB
a  ||| S:22687 E:22689 ||| DT
140  ||| S:22689 E:22693 ||| CD
fold  ||| S:22693 E:22698 ||| JJ
decrease  ||| S:22698 E:22707 ||| NN
in  ||| S:22707 E:22710 ||| IN
the  ||| S:22710 E:22722 ||| DT
observed  ||| S:22722 E:22731 ||| JJ
EC  ||| S:22731 E:22743 ||| NNP
50  ||| S:22743 E:22746 ||| CD
for  ||| S:22746 E:22750 ||| IN
5-HT  ||| S:22750 E:22755 ||| CD
activation ||| S:22755 E:22765 ||| NNS
.  ||| S:22765 E:22767 ||| .
The  ||| S:22767 E:22771 ||| DT
slow  ||| S:22771 E:22776 ||| JJ
rise  ||| S:22776 E:22781 ||| NN
is  ||| S:22781 E:22792 ||| VBZ
followed  ||| S:22792 E:22801 ||| VBN
by  ||| S:22801 E:22804 ||| IN
a  ||| S:22804 E:22806 ||| DT
non-desensitizing  ||| S:22806 E:22824 ||| JJ
phase  ||| S:22824 E:22830 ||| NN
of  ||| S:22830 E:22833 ||| IN
the  ||| S:22833 E:22837 ||| DT
response  ||| S:22837 E:22846 ||| NN
that  ||| S:22846 E:22859 ||| WDT
is  ||| S:22859 E:22862 ||| VBZ
dramatically  ||| S:22862 E:22875 ||| RB
different  ||| S:22875 E:22885 ||| JJ
from  ||| S:22885 E:22890 ||| IN
the  ||| S:22890 E:22894 ||| DT
fast  ||| S:22894 E:22899 ||| JJ
desensitization  ||| S:22899 E:22923 ||| NN
observed  ||| S:22923 E:22932 ||| VBD
for  ||| S:22932 E:22936 ||| IN
wt  ||| S:22936 E:22939 ||| JJ
5-HT  ||| S:22939 E:22953 ||| NNP
3AS  ||| S:22953 E:22957 ||| NNP
Rs ||| S:22957 E:22959 ||| NNP
.  ||| S:22959 E:22961 ||| .
Lack  ||| S:22961 E:22966 ||| NN
of  ||| S:22966 E:22969 ||| IN
desensitization  ||| S:22969 E:22985 ||| NNS
could  ||| S:22985 E:22999 ||| MD
result  ||| S:22999 E:23006 ||| VB
from  ||| S:23006 E:23011 ||| IN
either  ||| S:23011 E:23018 ||| RB
a  ||| S:23018 E:23020 ||| DT
stabilization  ||| S:23020 E:23034 ||| NN
of  ||| S:23034 E:23037 ||| IN
the  ||| S:23037 E:23041 ||| DT
open  ||| S:23041 E:23046 ||| JJ
state  ||| S:23046 E:23052 ||| NN
of  ||| S:23052 E:23055 ||| IN
the  ||| S:23055 E:23067 ||| DT
channel  ||| S:23067 E:23075 ||| NN
or  ||| S:23075 E:23078 ||| CC
a  ||| S:23078 E:23080 ||| DT
destabilization  ||| S:23080 E:23096 ||| NN
of  ||| S:23096 E:23099 ||| IN
the  ||| S:23099 E:23103 ||| DT
desensitized  ||| S:23103 E:23116 ||| JJ
state ||| S:23116 E:23121 ||| NN
.  ||| S:23121 E:23131 ||| .
Mutations  ||| S:23131 E:23141 ||| NNS
of  ||| S:23141 E:23144 ||| IN
homologous  ||| S:23144 E:23155 ||| NN
or  ||| S:23155 E:23158 ||| CC
nearby  ||| S:23158 E:23165 ||| JJ
residues  ||| S:23165 E:23174 ||| NNS
in  ||| S:23174 E:23177 ||| IN
both  ||| S:23177 E:23182 ||| PDT
the  ||| S:23182 E:23194 ||| DT
nAChR  ||| S:23194 E:23200 ||| JJ
and  ||| S:23200 E:23204 ||| CC
GABA  ||| S:23204 E:23218 ||| NNP
A  ||| S:23218 E:23220 ||| NNP
receptors  ||| S:23220 E:23230 ||| NNS
have  ||| S:23230 E:23235 ||| VBP
also  ||| S:23235 E:23240 ||| RB
been  ||| S:23240 E:23245 ||| VBN
demonstrated  ||| S:23245 E:23266 ||| VBN
to  ||| S:23266 E:23269 ||| TO
alter  ||| S:23269 E:23275 ||| VB
the  ||| S:23275 E:23279 ||| DT
agonist  ||| S:23279 E:23287 ||| JJ
response ||| S:23287 E:23295 ||| NN
.  ||| S:23295 E:23297 ||| .
Mutation  ||| S:23297 E:23306 ||| NN
of  ||| S:23306 E:23309 ||| IN
the  ||| S:23309 E:23313 ||| DT
homologous  ||| S:23313 E:23332 ||| JJ
residue  ||| S:23332 E:23340 ||| NN
in  ||| S:23340 E:23343 ||| IN
the  ||| S:23343 E:23347 ||| DT
GABA  ||| S:23347 E:23361 ||| NNP
A  ||| S:23361 E:23363 ||| DT
receptor  ||| S:23363 E:23372 ||| NN
γ-subunit  ||| S:23372 E:23382 ||| NNS
( ||| S:23382 E:23383 ||| -LRB-
T142 ||| S:23383 E:23387 ||| NNP
)  ||| S:23387 E:23389 ||| -RRB-
to  ||| S:23389 E:23392 ||| TO
serine  ||| S:23392 E:23407 ||| VB
altered  ||| S:23407 E:23415 ||| VBN
the  ||| S:23415 E:23419 ||| DT
efficacy  ||| S:23419 E:23428 ||| NN
of  ||| S:23428 E:23431 ||| IN
the  ||| S:23431 E:23435 ||| DT
agonist  ||| S:23435 E:23443 ||| JJ
Flumazenil ||| S:23443 E:23453 ||| NNP
,  ||| S:23453 E:23455 ||| ,
converting  ||| S:23455 E:23474 ||| VBG
it  ||| S:23474 E:23477 ||| PRP
to  ||| S:23477 E:23480 ||| TO
a  ||| S:23480 E:23482 ||| DT
partial  ||| S:23482 E:23490 ||| JJ
agonist  ||| S:23490 E:23498 ||| NNS
[  ||| S:23498 E:23500 ||| -LRB-
29  ||| S:23500 E:23503 ||| CD
]  ||| S:23503 E:23505 ||| -RRB-
.  ||| S:23505 E:23507 ||| .
In  ||| S:23507 E:23510 ||| IN
the  ||| S:23510 E:23514 ||| DT
nAChR ||| S:23514 E:23519 ||| JJ
,  ||| S:23519 E:23521 ||| ,
mutation  ||| S:23521 E:23530 ||| NN
of  ||| S:23530 E:23541 ||| IN
mouse  ||| S:23541 E:23547 ||| NN
and  ||| S:23547 E:23551 ||| CC
rat  ||| S:23551 E:23555 ||| CD
εP121  ||| S:23555 E:23561 ||| CD
to  ||| S:23561 E:23564 ||| TO
leucine  ||| S:23564 E:23572 ||| VB
altered  ||| S:23572 E:23580 ||| VBN
both  ||| S:23580 E:23585 ||| PDT
the  ||| S:23585 E:23589 ||| DT
binding  ||| S:23589 E:23597 ||| NN
of  ||| S:23597 E:23608 ||| IN
acetylcholine  ||| S:23608 E:23622 ||| NN
and  ||| S:23622 E:23626 ||| CC
the  ||| S:23626 E:23630 ||| DT
stability  ||| S:23630 E:23640 ||| NN
of  ||| S:23640 E:23643 ||| IN
the  ||| S:23643 E:23647 ||| DT
open  ||| S:23647 E:23652 ||| JJ
state  ||| S:23652 E:23658 ||| NN
of  ||| S:23658 E:23661 ||| IN
the  ||| S:23661 E:23673 ||| DT
channel.  ||| S:23673 E:23682 ||| NNP
εP121  ||| S:23682 E:23688 ||| NNP
is  ||| S:23688 E:23691 ||| VBZ
homologous  ||| S:23691 E:23702 ||| VBN
to  ||| S:23702 E:23705 ||| TO
P154  ||| S:23705 E:23710 ||| CD
in  ||| S:23710 E:23713 ||| IN
the  ||| S:23713 E:23717 ||| DT
5-HT  ||| S:23717 E:23731 ||| CD
3  ||| S:23731 E:23733 ||| CD
R  ||| S:23733 E:23735 ||| NN
and  ||| S:23735 E:23739 ||| CC
is  ||| S:23739 E:23742 ||| VBZ
only  ||| S:23742 E:23747 ||| RB
two  ||| S:23747 E:23751 ||| CD
residues  ||| S:23751 E:23760 ||| NNS
away  ||| S:23760 E:23765 ||| RB
from  ||| S:23765 E:23778 ||| IN
Y152 ||| S:23778 E:23782 ||| CD
.  ||| S:23782 E:23784 ||| .
The  ||| S:23784 E:23788 ||| DT
authors  ||| S:23788 E:23796 ||| NNS
of  ||| S:23796 E:23799 ||| IN
this  ||| S:23799 E:23804 ||| DT
study  ||| S:23804 E:23810 ||| NN
concluded  ||| S:23810 E:23820 ||| VBD
that  ||| S:23820 E:23825 ||| IN
this  ||| S:23825 E:23830 ||| DT
portion  ||| S:23830 E:23846 ||| NN
of  ||| S:23846 E:23849 ||| IN
the  ||| S:23849 E:23853 ||| DT
acetylcholine  ||| S:23853 E:23867 ||| JJ
binding  ||| S:23867 E:23875 ||| JJ
site  ||| S:23875 E:23880 ||| NN
was  ||| S:23880 E:23884 ||| VBD
closely  ||| S:23884 E:23892 ||| RB
linked  ||| S:23892 E:23899 ||| VBN
to  ||| S:23899 E:23902 ||| TO
the  ||| S:23902 E:23914 ||| DT
channel  ||| S:23914 E:23922 ||| NN
opening  ||| S:23922 E:23930 ||| NN
region  ||| S:23930 E:23937 ||| NN
of  ||| S:23937 E:23940 ||| IN
the  ||| S:23940 E:23944 ||| DT
receptor  ||| S:23944 E:23953 ||| NN
[  ||| S:23953 E:23955 ||| -LRB-
30  ||| S:23955 E:23958 ||| CD
]  ||| S:23958 E:23960 ||| -RRB-
.  ||| S:23960 E:23962 ||| .
It  ||| S:23962 E:23965 ||| PRP
is  ||| S:23965 E:23976 ||| VBZ
reasonable  ||| S:23976 E:23987 ||| JJ
to  ||| S:23987 E:23990 ||| TO
conclude  ||| S:23990 E:23999 ||| VB
that  ||| S:23999 E:24004 ||| IN
the  ||| S:24004 E:24008 ||| DT
homologous  ||| S:24008 E:24019 ||| JJ
region  ||| S:24019 E:24026 ||| NN
in  ||| S:24026 E:24029 ||| IN
the  ||| S:24029 E:24041 ||| DT
5-HT  ||| S:24041 E:24055 ||| CD
3  ||| S:24055 E:24057 ||| CD
R  ||| S:24057 E:24059 ||| NN
may  ||| S:24059 E:24063 ||| MD
perform  ||| S:24063 E:24071 ||| VB
a  ||| S:24071 E:24073 ||| DT
similar  ||| S:24073 E:24081 ||| JJ
function ||| S:24081 E:24089 ||| NN
.  ||| S:24089 E:24091 ||| .
The  ||| S:24091 E:24103 ||| DT
link  ||| S:24103 E:24108 ||| NN
between  ||| S:24108 E:24116 ||| IN
an  ||| S:24116 E:24119 ||| DT
agonist  ||| S:24119 E:24127 ||| JJ
binding  ||| S:24127 E:24135 ||| JJ
domain  ||| S:24135 E:24142 ||| NN
and  ||| S:24142 E:24146 ||| CC
a  ||| S:24146 E:24148 ||| DT
conformational  ||| S:24148 E:24171 ||| JJ
change  ||| S:24171 E:24178 ||| NN
leading  ||| S:24178 E:24186 ||| VBG
to  ||| S:24186 E:24189 ||| TO
channel  ||| S:24189 E:24197 ||| VB
opening  ||| S:24197 E:24205 ||| NN
is  ||| S:24205 E:24208 ||| VBZ
not  ||| S:24208 E:24212 ||| RB
unexpected  ||| S:24212 E:24223 ||| JJ
since  ||| S:24223 E:24237 ||| IN
the  ||| S:24237 E:24241 ||| DT
two  ||| S:24241 E:24245 ||| CD
must  ||| S:24245 E:24250 ||| MD
obviously  ||| S:24250 E:24260 ||| RB
be  ||| S:24260 E:24263 ||| VB
linked ||| S:24263 E:24269 ||| VBN
.  ||| S:24269 E:24271 ||| .
If  ||| S:24271 E:24274 ||| IN
binding  ||| S:24274 E:24282 ||| VBG
to  ||| S:24282 E:24285 ||| TO
this  ||| S:24285 E:24290 ||| DT
region  ||| S:24290 E:24305 ||| NN
of  ||| S:24305 E:24308 ||| IN
the  ||| S:24308 E:24312 ||| DT
receptor  ||| S:24312 E:24321 ||| NN
is  ||| S:24321 E:24324 ||| VBZ
shown  ||| S:24324 E:24330 ||| VBN
to  ||| S:24330 E:24333 ||| TO
be  ||| S:24333 E:24336 ||| VB
a  ||| S:24336 E:24338 ||| DT
critical  ||| S:24338 E:24347 ||| JJ
step  ||| S:24347 E:24352 ||| NN
between  ||| S:24352 E:24360 ||| IN
the  ||| S:24360 E:24372 ||| DT
binding  ||| S:24372 E:24380 ||| NN
of  ||| S:24380 E:24383 ||| IN
agonists  ||| S:24383 E:24392 ||| NN
and  ||| S:24392 E:24396 ||| CC
the  ||| S:24396 E:24400 ||| DT
opening  ||| S:24400 E:24408 ||| NN
of  ||| S:24408 E:24411 ||| IN
the  ||| S:24411 E:24415 ||| DT
channel ||| S:24415 E:24422 ||| NN
,  ||| S:24422 E:24424 ||| ,
further  ||| S:24424 E:24440 ||| JJ
investigation  ||| S:24440 E:24454 ||| NN
of  ||| S:24454 E:24457 ||| IN
the  ||| S:24457 E:24461 ||| DT
amino  ||| S:24461 E:24467 ||| JJ
acids  ||| S:24467 E:24473 ||| NNS
in  ||| S:24473 E:24476 ||| IN
this  ||| S:24476 E:24481 ||| DT
loop  ||| S:24481 E:24486 ||| NN
may  ||| S:24486 E:24490 ||| MD
provide  ||| S:24490 E:24506 ||| VB
valuable  ||| S:24506 E:24515 ||| JJ
clues  ||| S:24515 E:24521 ||| NNS
to  ||| S:24521 E:24524 ||| TO
molecular  ||| S:24524 E:24534 ||| JJ
basis  ||| S:24534 E:24540 ||| NN
of  ||| S:24540 E:24543 ||| IN
this  ||| S:24543 E:24548 ||| DT
process ||| S:24548 E:24555 ||| NN
.  ||| S:24555 E:24579 ||| .
Conclusions  ||| S:24579 E:24599 ||| VBG
Our  ||| S:24599 E:24603 ||| PRP$
data  ||| S:24603 E:24608 ||| NNS
indicate  ||| S:24608 E:24617 ||| VBP
an  ||| S:24617 E:24620 ||| DT
important  ||| S:24620 E:24630 ||| JJ
role  ||| S:24630 E:24635 ||| NN
for  ||| S:24635 E:24639 ||| IN
this  ||| S:24639 E:24644 ||| DT
putative  ||| S:24644 E:24661 ||| JJ
binding  ||| S:24661 E:24669 ||| JJ
site  ||| S:24669 E:24674 ||| NN
loop  ||| S:24674 E:24679 ||| NN
in  ||| S:24679 E:24682 ||| IN
the  ||| S:24682 E:24686 ||| DT
interaction  ||| S:24686 E:24698 ||| NN
of  ||| S:24698 E:24701 ||| IN
the  ||| S:24701 E:24705 ||| DT
5-HT  ||| S:24705 E:24719 ||| CD
3  ||| S:24719 E:24721 ||| CD
R  ||| S:24721 E:24723 ||| NN
with  ||| S:24723 E:24728 ||| IN
different  ||| S:24728 E:24738 ||| JJ
ligands  ||| S:24738 E:24746 ||| NN
and  ||| S:24746 E:24758 ||| CC
illustrate  ||| S:24758 E:24769 ||| VB
the  ||| S:24769 E:24773 ||| DT
difference  ||| S:24773 E:24784 ||| NN
in  ||| S:24784 E:24787 ||| IN
binding  ||| S:24787 E:24795 ||| VBG
of  ||| S:24795 E:24798 ||| IN
different  ||| S:24798 E:24816 ||| JJ
structural  ||| S:24816 E:24827 ||| JJ
classes  ||| S:24827 E:24835 ||| NNS
of  ||| S:24835 E:24838 ||| IN
ligands ||| S:24838 E:24845 ||| NN
.  ||| S:24845 E:24847 ||| .
Each  ||| S:24847 E:24852 ||| DT
structural  ||| S:24852 E:24863 ||| JJ
class  ||| S:24863 E:24869 ||| NN
shows  ||| S:24869 E:24883 ||| VBZ
different  ||| S:24883 E:24893 ||| JJ
patterns  ||| S:24893 E:24902 ||| NNS
of  ||| S:24902 E:24905 ||| IN
interaction  ||| S:24905 E:24917 ||| NN
with  ||| S:24917 E:24922 ||| IN
amino  ||| S:24922 E:24928 ||| JJ
acids  ||| S:24928 E:24934 ||| NNS
in  ||| S:24934 E:24937 ||| IN
this  ||| S:24937 E:24950 ||| DT
region  ||| S:24950 E:24957 ||| NN
of  ||| S:24957 E:24960 ||| IN
the  ||| S:24960 E:24964 ||| DT
receptor.  ||| S:24964 E:24974 ||| NNP
[  ||| S:24974 E:24976 ||| -LRB-
3H ||| S:24976 E:24978 ||| NNP
] ||| S:24978 E:24979 ||| -RRB-
granisetron  ||| S:24979 E:24991 ||| NN
does  ||| S:24991 E:24996 ||| VBZ
not  ||| S:24996 E:25000 ||| RB
appear  ||| S:25000 E:25007 ||| VB
to  ||| S:25007 E:25018 ||| TO
interact  ||| S:25018 E:25027 ||| VB
with  ||| S:25027 E:25032 ||| IN
any  ||| S:25032 E:25036 ||| DT
of  ||| S:25036 E:25039 ||| IN
the  ||| S:25039 E:25043 ||| DT
amino  ||| S:25043 E:25049 ||| JJ
acids  ||| S:25049 E:25055 ||| NNS
tested  ||| S:25055 E:25062 ||| VBN
while  ||| S:25062 E:25077 ||| IN
d  ||| S:25077 E:25079 ||| JJ
-tc  ||| S:25079 E:25083 ||| JJ
interacts  ||| S:25083 E:25093 ||| NN
with  ||| S:25093 E:25098 ||| IN
only  ||| S:25098 E:25103 ||| RB
Y140 ||| S:25103 E:25107 ||| CD
,  ||| S:25107 E:25118 ||| ,
m  ||| S:25118 E:25120 ||| VBG
CPBG  ||| S:25120 E:25125 ||| NNP
and  ||| S:25125 E:25129 ||| CC
5-HT  ||| S:25129 E:25134 ||| CD
with  ||| S:25134 E:25139 ||| IN
Y142  ||| S:25139 E:25144 ||| NNP
and  ||| S:25144 E:25156 ||| CC
lerisetron  ||| S:25156 E:25167 ||| NN
with  ||| S:25167 E:25172 ||| IN
both  ||| S:25172 E:25177 ||| DT
Y142  ||| S:25177 E:25182 ||| NNP
and  ||| S:25182 E:25186 ||| CC
Y152 ||| S:25186 E:25190 ||| NNP
.  ||| S:25190 E:25192 ||| .
Similar  ||| S:25192 E:25200 ||| JJ
selective  ||| S:25200 E:25218 ||| JJ
effects  ||| S:25218 E:25226 ||| NNS
have  ||| S:25226 E:25231 ||| VBP
been  ||| S:25231 E:25236 ||| VBN
observed  ||| S:25236 E:25245 ||| VBN
on  ||| S:25245 E:25248 ||| IN
other  ||| S:25248 E:25254 ||| JJ
residues  ||| S:25254 E:25263 ||| NNS
including  ||| S:25263 E:25281 ||| VBG
W183 ||| S:25281 E:25285 ||| NNP
,  ||| S:25285 E:25287 ||| ,
W89 ||| S:25287 E:25290 ||| NNP
,  ||| S:25290 E:25292 ||| ,
F107  ||| S:25292 E:25297 ||| NNP
and  ||| S:25297 E:25301 ||| CC
E106  ||| S:25301 E:25306 ||| CD
among  ||| S:25306 E:25312 ||| IN
others  ||| S:25312 E:25319 ||| NNS
[  ||| S:25319 E:25321 ||| -LRB-
20  ||| S:25321 E:25324 ||| CD
21  ||| S:25324 E:25327 ||| CD
25  ||| S:25327 E:25330 ||| CD
26  ||| S:25330 E:25333 ||| CD
]  ||| S:25333 E:25335 ||| -RRB-
.  ||| S:25335 E:25337 ||| .
Our  ||| S:25337 E:25349 ||| PRP$
data  ||| S:25349 E:25354 ||| NNS
in  ||| S:25354 E:25357 ||| IN
conjunction  ||| S:25357 E:25369 ||| NN
with  ||| S:25369 E:25374 ||| IN
those  ||| S:25374 E:25380 ||| DT
of  ||| S:25380 E:25383 ||| IN
other  ||| S:25383 E:25389 ||| JJ
laboratories  ||| S:25389 E:25410 ||| NNS
indicates  ||| S:25410 E:25420 ||| VBZ
the  ||| S:25420 E:25424 ||| DT
differences  ||| S:25424 E:25436 ||| NNS
in  ||| S:25436 E:25439 ||| IN
orientation  ||| S:25439 E:25451 ||| NN
of  ||| S:25451 E:25454 ||| IN
different  ||| S:25454 E:25472 ||| JJ
ligands  ||| S:25472 E:25480 ||| NN
within  ||| S:25480 E:25487 ||| IN
the  ||| S:25487 E:25491 ||| DT
same  ||| S:25491 E:25496 ||| JJ
binding  ||| S:25496 E:25504 ||| JJ
cleft ||| S:25504 E:25509 ||| NN
.  ||| S:25509 E:25511 ||| .
These  ||| S:25511 E:25517 ||| DT
differences  ||| S:25517 E:25529 ||| NNS
in  ||| S:25529 E:25540 ||| IN
orientation  ||| S:25540 E:25552 ||| JJ
result  ||| S:25552 E:25559 ||| NN
in  ||| S:25559 E:25562 ||| IN
different  ||| S:25562 E:25572 ||| JJ
amino  ||| S:25572 E:25578 ||| JJ
acid ||| S:25578 E:25582 ||| NN
/ ||| S:25582 E:25583 ||| CD
functional  ||| S:25583 E:25594 ||| JJ
group  ||| S:25594 E:25608 ||| NN
interactions ||| S:25608 E:25620 ||| NNS
.  ||| S:25620 E:25622 ||| .
As  ||| S:25622 E:25625 ||| IN
the  ||| S:25625 E:25629 ||| DT
structural  ||| S:25629 E:25640 ||| JJ
detail  ||| S:25640 E:25647 ||| NN
of  ||| S:25647 E:25650 ||| IN
these  ||| S:25650 E:25664 ||| DT
interactions  ||| S:25664 E:25677 ||| NN
emerges ||| S:25677 E:25684 ||| VBZ
,  ||| S:25684 E:25686 ||| ,
these  ||| S:25686 E:25692 ||| DT
differences  ||| S:25692 E:25704 ||| NNS
could  ||| S:25704 E:25710 ||| MD
potentially  ||| S:25710 E:25730 ||| RB
be  ||| S:25730 E:25733 ||| VB
exploited  ||| S:25733 E:25743 ||| VBN
to  ||| S:25743 E:25746 ||| TO
produce  ||| S:25746 E:25754 ||| VB
more  ||| S:25754 E:25759 ||| RBR
potent  ||| S:25759 E:25766 ||| JJ
and  ||| S:25766 E:25770 ||| CC
specific  ||| S:25770 E:25779 ||| JJ
ligands ||| S:25779 E:25786 ||| NN
.  ||| S:25786 E:25796 ||| .
For  ||| S:25796 E:25800 ||| IN
example  ||| S:25800 E:25808 ||| NN
construction  ||| S:25808 E:25821 ||| NN
of  ||| S:25821 E:25824 ||| IN
a  ||| S:25824 E:25826 ||| DT
"hybrid ||| S:25826 E:25833 ||| NN
"  ||| S:25833 E:25835 ||| ''
ligand  ||| S:25835 E:25842 ||| NNS
that  ||| S:25842 E:25847 ||| WDT
combines  ||| S:25847 E:25864 ||| VBZ
the  ||| S:25864 E:25868 ||| DT
interactions  ||| S:25868 E:25881 ||| NN
of  ||| S:25881 E:25884 ||| IN
[  ||| S:25884 E:25886 ||| -LRB-
3H ||| S:25886 E:25888 ||| NNP
] ||| S:25888 E:25889 ||| -RRB-
granisetron  ||| S:25889 E:25901 ||| NN
with  ||| S:25901 E:25906 ||| IN
those  ||| S:25906 E:25912 ||| DT
of  ||| S:25912 E:25924 ||| IN
d  ||| S:25924 E:25926 ||| JJ
-tc ||| S:25926 E:25929 ||| NN
,  ||| S:25929 E:25931 ||| ,
5-HT  ||| S:25931 E:25936 ||| NNP
or  ||| S:25936 E:25948 ||| CC
m  ||| S:25948 E:25950 ||| JJ
CPBG  ||| S:25950 E:25955 ||| NNP
could  ||| S:25955 E:25961 ||| MD
produce  ||| S:25961 E:25969 ||| VB
an  ||| S:25969 E:25972 ||| DT
antagonist  ||| S:25972 E:25991 ||| NN
with  ||| S:25991 E:25996 ||| IN
increased  ||| S:25996 E:26006 ||| JJ
affinity  ||| S:26006 E:26015 ||| JJ
due  ||| S:26015 E:26019 ||| JJ
to  ||| S:26019 E:26022 ||| TO
the  ||| S:26022 E:26026 ||| DT
additional  ||| S:26026 E:26037 ||| JJ
binding  ||| S:26037 E:26053 ||| JJ
energy  ||| S:26053 E:26060 ||| NN
of  ||| S:26060 E:26063 ||| IN
these  ||| S:26063 E:26069 ||| DT
interactions  ||| S:26069 E:26082 ||| NN
and  ||| S:26082 E:26086 ||| CC
a  ||| S:26086 E:26088 ||| DT
greater  ||| S:26088 E:26096 ||| JJR
specificity  ||| S:26096 E:26116 ||| NN
since  ||| S:26116 E:26122 ||| IN
it  ||| S:26122 E:26125 ||| PRP
would  ||| S:26125 E:26131 ||| MD
utilize  ||| S:26131 E:26139 ||| VB
more  ||| S:26139 E:26144 ||| RBR
structural  ||| S:26144 E:26155 ||| JJ
features  ||| S:26155 E:26164 ||| NNS
of  ||| S:26164 E:26167 ||| IN
the  ||| S:26167 E:26179 ||| DT
binding  ||| S:26179 E:26187 ||| JJ
site ||| S:26187 E:26191 ||| NN
.  ||| S:26191 E:26201 ||| .
The  ||| S:26201 E:26205 ||| DT
requirement  ||| S:26205 E:26217 ||| NN
of  ||| S:26217 E:26220 ||| IN
a  ||| S:26220 E:26222 ||| DT
glycine  ||| S:26222 E:26230 ||| NN
at  ||| S:26230 E:26233 ||| IN
position  ||| S:26233 E:26242 ||| NN
147  ||| S:26242 E:26246 ||| CD
and  ||| S:26246 E:26250 ||| CC
the  ||| S:26250 E:26262 ||| DT
ability  ||| S:26262 E:26270 ||| NN
of  ||| S:26270 E:26273 ||| IN
lerisetron  ||| S:26273 E:26284 ||| VBG
to  ||| S:26284 E:26287 ||| TO
interact  ||| S:26287 E:26296 ||| VB
with  ||| S:26296 E:26301 ||| IN
both  ||| S:26301 E:26306 ||| DT
Y142  ||| S:26306 E:26311 ||| NNP
and  ||| S:26311 E:26315 ||| CC
Y152  ||| S:26315 E:26328 ||| NNP
also  ||| S:26328 E:26333 ||| RB
support  ||| S:26333 E:26341 ||| VB
the  ||| S:26341 E:26345 ||| DT
hypothesis  ||| S:26345 E:26356 ||| NN
that  ||| S:26356 E:26361 ||| IN
the  ||| S:26361 E:26365 ||| DT
secondary  ||| S:26365 E:26375 ||| JJ
structure  ||| S:26375 E:26385 ||| NN
in  ||| S:26385 E:26396 ||| IN
this  ||| S:26396 E:26401 ||| DT
region  ||| S:26401 E:26408 ||| NN
of  ||| S:26408 E:26411 ||| IN
the  ||| S:26411 E:26415 ||| DT
receptor  ||| S:26415 E:26424 ||| NN
is  ||| S:26424 E:26427 ||| VBZ
formed  ||| S:26427 E:26434 ||| VBN
by  ||| S:26434 E:26437 ||| IN
a  ||| S:26437 E:26439 ||| DT
loop  ||| S:26439 E:26444 ||| JJ
structure ||| S:26444 E:26453 ||| NN
.  ||| S:26453 E:26463 ||| .
If  ||| S:26463 E:26466 ||| IN
the  ||| S:26466 E:26470 ||| DT
loose  ||| S:26470 E:26476 ||| JJ
3  ||| S:26476 E:26478 ||| CD
residue  ||| S:26478 E:26486 ||| NNS
turn  ||| S:26486 E:26491 ||| VBP
proposed  ||| S:26491 E:26500 ||| VBN
by  ||| S:26500 E:26503 ||| IN
Chiara  ||| S:26503 E:26519 ||| NNP
et.  ||| S:26519 E:26523 ||| NNP
al.  ||| S:26523 E:26527 ||| NNP
and  ||| S:26527 E:26531 ||| CC
shown  ||| S:26531 E:26537 ||| VBN
for  ||| S:26537 E:26541 ||| IN
the  ||| S:26541 E:26545 ||| DT
AChBP  ||| S:26545 E:26551 ||| NN
is  ||| S:26551 E:26562 ||| VBZ
present  ||| S:26562 E:26570 ||| JJ
in  ||| S:26570 E:26573 ||| IN
the  ||| S:26573 E:26577 ||| DT
5-HT  ||| S:26577 E:26591 ||| CD
3  ||| S:26591 E:26593 ||| CD
R ||| S:26593 E:26594 ||| NN
,  ||| S:26594 E:26596 ||| ,
then  ||| S:26596 E:26601 ||| RB
Y140 ||| S:26601 E:26605 ||| CD
,  ||| S:26605 E:26607 ||| ,
Y142  ||| S:26607 E:26612 ||| NNP
and  ||| S:26612 E:26616 ||| CC
Y152  ||| S:26616 E:26621 ||| NNP
would  ||| S:26621 E:26627 ||| MD
be  ||| S:26627 E:26638 ||| VB
present  ||| S:26638 E:26646 ||| JJ
on  ||| S:26646 E:26649 ||| IN
the  ||| S:26649 E:26653 ||| DT
same  ||| S:26653 E:26658 ||| JJ
side  ||| S:26658 E:26663 ||| NN
of  ||| S:26663 E:26666 ||| IN
the  ||| S:26666 E:26670 ||| DT
sheet  ||| S:26670 E:26676 ||| NN
and  ||| S:26676 E:26680 ||| CC
all  ||| S:26680 E:26684 ||| DT
three  ||| S:26684 E:26690 ||| CD
would  ||| S:26690 E:26704 ||| MD
be  ||| S:26704 E:26707 ||| VB
capable  ||| S:26707 E:26715 ||| JJ
of  ||| S:26715 E:26718 ||| IN
extending  ||| S:26718 E:26728 ||| VBG
into  ||| S:26728 E:26733 ||| IN
the  ||| S:26733 E:26737 ||| DT
binding  ||| S:26737 E:26745 ||| JJ
site ||| S:26745 E:26749 ||| NN
.  ||| S:26749 E:26751 ||| .
A  ||| S:26751 E:26753 ||| DT
similar  ||| S:26753 E:26769 ||| JJ
observation  ||| S:26769 E:26781 ||| NN
has  ||| S:26781 E:26785 ||| VBZ
been  ||| S:26785 E:26790 ||| VBN
made  ||| S:26790 E:26795 ||| VBN
for  ||| S:26795 E:26799 ||| IN
the  ||| S:26799 E:26803 ||| DT
nAChR  ||| S:26803 E:26809 ||| JJ
where  ||| S:26809 E:26815 ||| WRB
γS111 ||| S:26815 E:26820 ||| NNP
,  ||| S:26820 E:26822 ||| ,
γY117 ||| S:26822 E:26827 ||| NNP
,  ||| S:26827 E:26837 ||| ,
γL119 ||| S:26837 E:26842 ||| NNP
,  ||| S:26842 E:26844 ||| ,
δR113  ||| S:26844 E:26850 ||| NNP
and  ||| S:26850 E:26854 ||| CC
δT119  ||| S:26854 E:26860 ||| CD
of  ||| S:26860 E:26863 ||| IN
the  ||| S:26863 E:26867 ||| DT
mouse  ||| S:26867 E:26873 ||| JJ
nAChR  ||| S:26873 E:26879 ||| JJ
receptor  ||| S:26879 E:26888 ||| NN
and  ||| S:26888 E:26900 ||| CC
γL109  ||| S:26900 E:26906 ||| NNP
and  ||| S:26906 E:26910 ||| CC
γY111  ||| S:26910 E:26916 ||| CD
of  ||| S:26916 E:26919 ||| IN
the  ||| S:26919 E:26923 ||| DT
torpedo  ||| S:26923 E:26931 ||| JJ
nAChR  ||| S:26931 E:26937 ||| NNS
are  ||| S:26937 E:26941 ||| VBP
all  ||| S:26941 E:26945 ||| RB
thought  ||| S:26945 E:26953 ||| VBN
to  ||| S:26953 E:26956 ||| TO
be  ||| S:26956 E:26967 ||| VB
present  ||| S:26967 E:26975 ||| JJ
in  ||| S:26975 E:26978 ||| IN
the  ||| S:26978 E:26982 ||| DT
binding  ||| S:26982 E:26990 ||| JJ
site  ||| S:26990 E:26995 ||| NN
[  ||| S:26995 E:26997 ||| -LRB-
12  ||| S:26997 E:27000 ||| CD
13  ||| S:27000 E:27003 ||| CD
14  ||| S:27003 E:27006 ||| CD
15  ||| S:27006 E:27009 ||| CD
16  ||| S:27009 E:27012 ||| CD
17  ||| S:27012 E:27015 ||| CD
18  ||| S:27015 E:27018 ||| CD
]  ||| S:27018 E:27020 ||| -RRB-
.  ||| S:27020 E:27044 ||| .
Materials  ||| S:27044 E:27054 ||| NNS
and  ||| S:27054 E:27058 ||| CC
Methods  ||| S:27058 E:27085 ||| NNP
Materials  ||| S:27085 E:27105 ||| NNPS
[  ||| S:27105 E:27107 ||| -LRB-
3H ||| S:27107 E:27109 ||| NNP
] ||| S:27109 E:27110 ||| -RRB-
granisetron  ||| S:27110 E:27122 ||| NN
was  ||| S:27122 E:27126 ||| VBD
purchased  ||| S:27126 E:27136 ||| VBN
from  ||| S:27136 E:27141 ||| IN
New  ||| S:27141 E:27145 ||| NNP
England  ||| S:27145 E:27163 ||| NNP
Nuclear ||| S:27163 E:27170 ||| NNP
,  ||| S:27170 E:27172 ||| ,
5-HT  ||| S:27172 E:27177 ||| NNP
from  ||| S:27177 E:27182 ||| IN
Spectrum ||| S:27182 E:27190 ||| NNP
,  ||| S:27190 E:27192 ||| ,
and  ||| S:27192 E:27207 ||| CC
m  ||| S:27207 E:27209 ||| JJ
CPBG  ||| S:27209 E:27214 ||| NNP
and  ||| S:27214 E:27229 ||| CC
d  ||| S:27229 E:27231 ||| JJ
-tc  ||| S:27231 E:27235 ||| NN
from  ||| S:27235 E:27240 ||| IN
Research  ||| S:27240 E:27249 ||| NNP
Biochemical  ||| S:27249 E:27271 ||| NNP
International ||| S:27271 E:27284 ||| NNP
.  ||| S:27284 E:27286 ||| .
Lerisetron  ||| S:27286 E:27297 ||| NNP
was  ||| S:27297 E:27301 ||| VBD
provided  ||| S:27301 E:27310 ||| VBN
by  ||| S:27310 E:27313 ||| IN
Dr.  ||| S:27313 E:27317 ||| NNP
Karen  ||| S:27317 E:27333 ||| NNP
Kirschbaum  ||| S:27333 E:27344 ||| NNP
at  ||| S:27344 E:27347 ||| IN
The  ||| S:27347 E:27351 ||| DT
University  ||| S:27351 E:27362 ||| NNP
of  ||| S:27362 E:27365 ||| IN
Louisiana  ||| S:27365 E:27375 ||| NNP
at  ||| S:27375 E:27378 ||| IN
Monroe ||| S:27378 E:27384 ||| NNP
,  ||| S:27384 E:27396 ||| ,
Monroe ||| S:27396 E:27402 ||| NNP
,  ||| S:27402 E:27404 ||| ,
LA ||| S:27404 E:27406 ||| NNP
.  ||| S:27406 E:27408 ||| .
All  ||| S:27408 E:27412 ||| DT
other  ||| S:27412 E:27418 ||| JJ
reagents  ||| S:27418 E:27427 ||| NN
were  ||| S:27427 E:27432 ||| VBD
obtained  ||| S:27432 E:27441 ||| VBN
from  ||| S:27441 E:27456 ||| IN
commercial  ||| S:27456 E:27467 ||| JJ
sources ||| S:27467 E:27474 ||| NNS
.  ||| S:27474 E:27504 ||| .
Site  ||| S:27504 E:27509 ||| FW
directed  ||| S:27509 E:27518 ||| FW
mutagenesis  ||| S:27518 E:27540 ||| FW
Wild  ||| S:27540 E:27545 ||| FW
type  ||| S:27545 E:27550 ||| FW
5-HT  ||| S:27550 E:27566 ||| FW
3AS  ||| S:27566 E:27570 ||| FW
mouse  ||| S:27570 E:27576 ||| FW
receptor  ||| S:27576 E:27585 ||| FW
cDNA  ||| S:27585 E:27590 ||| NNP
was  ||| S:27590 E:27594 ||| VBD
obtained  ||| S:27594 E:27613 ||| VBN
from  ||| S:27613 E:27618 ||| IN
Dr.  ||| S:27618 E:27622 ||| NNP
Michael  ||| S:27622 E:27630 ||| NNP
White  ||| S:27630 E:27636 ||| NNP
[  ||| S:27636 E:27638 ||| -LRB-
20  ||| S:27638 E:27641 ||| CD
]  ||| S:27641 E:27643 ||| -RRB-
.  ||| S:27643 E:27645 ||| .
Mutant  ||| S:27645 E:27652 ||| JJ
receptors  ||| S:27652 E:27662 ||| NNS
were  ||| S:27662 E:27677 ||| VBD
constructed  ||| S:27677 E:27689 ||| VBN
using  ||| S:27689 E:27695 ||| VBG
either  ||| S:27695 E:27702 ||| RB
the  ||| S:27702 E:27706 ||| DT
Quick  ||| S:27706 E:27712 ||| NNP
Change  ||| S:27712 E:27719 ||| NNP
Mutagenesis  ||| S:27719 E:27731 ||| NNP
kit  ||| S:27731 E:27745 ||| NN
( ||| S:27745 E:27746 ||| -LRB-
Stratagene ||| S:27746 E:27756 ||| NNP
)  ||| S:27756 E:27758 ||| -RRB-
or  ||| S:27758 E:27761 ||| CC
the  ||| S:27761 E:27765 ||| DT
Altered  ||| S:27765 E:27773 ||| NNP
Sites  ||| S:27773 E:27779 ||| NNP
Mutagenesis  ||| S:27779 E:27791 ||| NNP
kit  ||| S:27791 E:27805 ||| NN
( ||| S:27805 E:27806 ||| -LRB-
Promega ||| S:27806 E:27813 ||| NNP
) ||| S:27813 E:27814 ||| -RRB-
.  ||| S:27814 E:27816 ||| .
All  ||| S:27816 E:27820 ||| DT
mutations  ||| S:27820 E:27830 ||| NN
were  ||| S:27830 E:27835 ||| VBD
confirmed  ||| S:27835 E:27845 ||| VBN
by  ||| S:27845 E:27848 ||| IN
commercial  ||| S:27848 E:27859 ||| JJ
DNA  ||| S:27859 E:27873 ||| NN
sequencing ||| S:27873 E:27883 ||| NN
.  ||| S:27883 E:27913 ||| .
Cell  ||| S:27913 E:27918 ||| NN
culture  ||| S:27918 E:27926 ||| NN
and  ||| S:27926 E:27930 ||| CC
transfection  ||| S:27930 E:27953 ||| CD
tsA201  ||| S:27953 E:27960 ||| CD
cells ||| S:27960 E:27965 ||| NNS
,  ||| S:27965 E:27967 ||| ,
a  ||| S:27967 E:27969 ||| DT
derivative  ||| S:27969 E:27980 ||| JJ
of  ||| S:27980 E:27983 ||| IN
HEK293  ||| S:27983 E:27990 ||| CD
cells ||| S:27990 E:27995 ||| NNS
,  ||| S:27995 E:27997 ||| ,
were  ||| S:27997 E:28012 ||| VBD
seeded  ||| S:28012 E:28019 ||| VBN
at  ||| S:28019 E:28022 ||| IN
a  ||| S:28022 E:28024 ||| DT
density  ||| S:28024 E:28032 ||| NN
of  ||| S:28032 E:28035 ||| IN
5  ||| S:28035 E:28037 ||| CD
×  ||| S:28037 E:28039 ||| CD
10  ||| S:28039 E:28042 ||| CD
6cells ||| S:28042 E:28048 ||| CD
/ ||| S:28048 E:28049 ||| CD
100  ||| S:28049 E:28053 ||| CD
mm  ||| S:28053 E:28056 ||| JJ
dish ||| S:28056 E:28060 ||| NN
.  ||| S:28060 E:28062 ||| .
Cells  ||| S:28062 E:28078 ||| NNS
were  ||| S:28078 E:28083 ||| VBD
grown  ||| S:28083 E:28089 ||| VBN
in  ||| S:28089 E:28092 ||| IN
DMEM  ||| S:28092 E:28097 ||| NNP
medium  ||| S:28097 E:28104 ||| NN
containing  ||| S:28104 E:28115 ||| VBG
10 ||| S:28115 E:28117 ||| CD
%  ||| S:28117 E:28119 ||| NN
FBS ||| S:28119 E:28122 ||| NNP
,  ||| S:28122 E:28124 ||| ,
100  ||| S:28124 E:28138 ||| CD
units ||| S:28138 E:28143 ||| NNS
/ ||| S:28143 E:28144 ||| SYM
ml  ||| S:28144 E:28147 ||| FW
penicillin ||| S:28147 E:28157 ||| FW
/ ||| S:28157 E:28158 ||| FW
streptomycin  ||| S:28158 E:28171 ||| FW
for  ||| S:28171 E:28175 ||| IN
nine  ||| S:28175 E:28180 ||| CD
hours  ||| S:28180 E:28186 ||| NNS
in  ||| S:28186 E:28189 ||| IN
5 ||| S:28189 E:28190 ||| CD
%  ||| S:28190 E:28192 ||| NN
CO  ||| S:28192 E:28206 ||| NNP
2  ||| S:28206 E:28208 ||| CD
and  ||| S:28208 E:28212 ||| CC
transfected  ||| S:28212 E:28224 ||| NN
with  ||| S:28224 E:28229 ||| IN
10  ||| S:28229 E:28232 ||| CD
μg  ||| S:28232 E:28235 ||| CD
mouse  ||| S:28235 E:28251 ||| CD
5-HT  ||| S:28251 E:28267 ||| CD
3AS  ||| S:28267 E:28271 ||| CD
R  ||| S:28271 E:28273 ||| NN
cDNA  ||| S:28273 E:28278 ||| NN
per  ||| S:28278 E:28282 ||| IN
100  ||| S:28282 E:28286 ||| CD
mm  ||| S:28286 E:28289 ||| NNS
dish  ||| S:28289 E:28294 ||| VBP
using  ||| S:28294 E:28300 ||| VBG
the  ||| S:28300 E:28314 ||| DT
calcium  ||| S:28314 E:28322 ||| JJ
phosphate  ||| S:28322 E:28332 ||| JJ
technique  ||| S:28332 E:28342 ||| NN
( ||| S:28342 E:28343 ||| -LRB-
New  ||| S:28343 E:28347 ||| NNP
Life  ||| S:28347 E:28352 ||| NNP
Technologies ||| S:28352 E:28364 ||| NNPS
,  ||| S:28364 E:28366 ||| ,
NY ||| S:28366 E:28368 ||| NNP
) ||| S:28368 E:28369 ||| -RRB-
.  ||| S:28369 E:28381 ||| .
Media  ||| S:28381 E:28387 ||| NNS
was  ||| S:28387 E:28391 ||| VBD
changed  ||| S:28391 E:28399 ||| VBN
12-14  ||| S:28399 E:28405 ||| CD
hrs  ||| S:28405 E:28409 ||| NN
after  ||| S:28409 E:28415 ||| IN
transfection ||| S:28415 E:28427 ||| NN
.  ||| S:28427 E:28429 ||| .
The  ||| S:28429 E:28433 ||| DT
cells  ||| S:28433 E:28449 ||| NNS
were  ||| S:28449 E:28454 ||| VBD
allowed  ||| S:28454 E:28462 ||| VBN
to  ||| S:28462 E:28465 ||| TO
grow  ||| S:28465 E:28470 ||| VB
for  ||| S:28470 E:28474 ||| IN
another  ||| S:28474 E:28482 ||| DT
24  ||| S:28482 E:28485 ||| CD
hours  ||| S:28485 E:28491 ||| NNS
and  ||| S:28491 E:28495 ||| CC
then  ||| S:28495 E:28510 ||| RB
harvested ||| S:28510 E:28519 ||| VBN
.  ||| S:28519 E:28531 ||| .
For  ||| S:28531 E:28535 ||| IN
whole  ||| S:28535 E:28541 ||| JJ
cell  ||| S:28541 E:28546 ||| NN
patch  ||| S:28546 E:28552 ||| NN
clamp  ||| S:28552 E:28558 ||| NN
experiments ||| S:28558 E:28569 ||| NNS
,  ||| S:28569 E:28571 ||| ,
tsA201  ||| S:28571 E:28578 ||| CD
cells  ||| S:28578 E:28594 ||| NNS
were  ||| S:28594 E:28599 ||| VBD
seeded  ||| S:28599 E:28606 ||| VBN
to  ||| S:28606 E:28609 ||| TO
a  ||| S:28609 E:28611 ||| DT
density  ||| S:28611 E:28619 ||| NN
of  ||| S:28619 E:28622 ||| IN
0.25  ||| S:28622 E:28627 ||| CD
×  ||| S:28627 E:28629 ||| CD
10  ||| S:28629 E:28632 ||| CD
6cells ||| S:28632 E:28638 ||| CD
/ ||| S:28638 E:28639 ||| CD
60  ||| S:28639 E:28642 ||| CD
mm  ||| S:28642 E:28645 ||| JJ
dish ||| S:28645 E:28649 ||| NN
.  ||| S:28649 E:28661 ||| .
Cells  ||| S:28661 E:28667 ||| NNS
were  ||| S:28667 E:28672 ||| VBD
grown  ||| S:28672 E:28678 ||| VBN
in  ||| S:28678 E:28681 ||| IN
DMEM  ||| S:28681 E:28686 ||| NNP
culture  ||| S:28686 E:28694 ||| NN
medium  ||| S:28694 E:28701 ||| NN
containing  ||| S:28701 E:28712 ||| VBG
10 ||| S:28712 E:28714 ||| CD
%  ||| S:28714 E:28726 ||| NN
FBS  ||| S:28726 E:28730 ||| NNP
and  ||| S:28730 E:28734 ||| CC
100  ||| S:28734 E:28738 ||| CD
units ||| S:28738 E:28743 ||| NNS
/ ||| S:28743 E:28744 ||| SYM
ml  ||| S:28744 E:28747 ||| FW
penicillin ||| S:28747 E:28757 ||| FW
/ ||| S:28757 E:28758 ||| FW
streptomycin  ||| S:28758 E:28771 ||| FW
for  ||| S:28771 E:28775 ||| IN
12  ||| S:28775 E:28778 ||| CD
hours  ||| S:28778 E:28794 ||| NNS
prior  ||| S:28794 E:28800 ||| RB
to  ||| S:28800 E:28803 ||| TO
transfection ||| S:28803 E:28815 ||| VB
.  ||| S:28815 E:28817 ||| .
Transfections  ||| S:28817 E:28831 ||| NNP
were  ||| S:28831 E:28836 ||| VBD
performed  ||| S:28836 E:28846 ||| VBN
using  ||| S:28846 E:28862 ||| VBG
Superfect  ||| S:28862 E:28872 ||| NNP
Transfection  ||| S:28872 E:28885 ||| NNP
Reagent  ||| S:28885 E:28893 ||| NNP
( ||| S:28893 E:28894 ||| -LRB-
Qiagen ||| S:28894 E:28900 ||| NNP
,  ||| S:28900 E:28902 ||| ,
CA ||| S:28902 E:28904 ||| NNP
) ||| S:28904 E:28905 ||| -RRB-
.  ||| S:28905 E:28907 ||| .
Ten  ||| S:28907 E:28911 ||| CD
μg  ||| S:28911 E:28914 ||| NN
of  ||| S:28914 E:28927 ||| IN
cDNA  ||| S:28927 E:28932 ||| NNP
were  ||| S:28932 E:28937 ||| VBD
mixed  ||| S:28937 E:28943 ||| VBN
with  ||| S:28943 E:28948 ||| IN
DMEM  ||| S:28948 E:28953 ||| NNP
medium  ||| S:28953 E:28960 ||| NN
containing  ||| S:28960 E:28971 ||| VBG
no  ||| S:28971 E:28974 ||| DT
serum  ||| S:28974 E:28980 ||| NN
or  ||| S:28980 E:28993 ||| CC
antibiotics  ||| S:28993 E:29005 ||| NN
in  ||| S:29005 E:29008 ||| IN
a  ||| S:29008 E:29010 ||| DT
volume  ||| S:29010 E:29017 ||| NN
of  ||| S:29017 E:29020 ||| IN
150  ||| S:29020 E:29024 ||| CD
μl ||| S:29024 E:29026 ||| NNS
.  ||| S:29026 E:29028 ||| .
Twenty  ||| S:29028 E:29035 ||| CD
μl  ||| S:29035 E:29038 ||| NN
of  ||| S:29038 E:29041 ||| IN
Superfect  ||| S:29041 E:29061 ||| NNP
reagent  ||| S:29061 E:29069 ||| NN
were  ||| S:29069 E:29074 ||| VBD
then  ||| S:29074 E:29079 ||| RB
added  ||| S:29079 E:29085 ||| VBN
and  ||| S:29085 E:29089 ||| CC
the  ||| S:29089 E:29093 ||| DT
mixture  ||| S:29093 E:29101 ||| NN
incubated  ||| S:29101 E:29111 ||| NN
at  ||| S:29111 E:29114 ||| IN
room  ||| S:29114 E:29129 ||| NN
temperature  ||| S:29129 E:29141 ||| NN
for  ||| S:29141 E:29145 ||| IN
15  ||| S:29145 E:29148 ||| CD
min ||| S:29148 E:29151 ||| NNS
.  ||| S:29151 E:29153 ||| .
The  ||| S:29153 E:29157 ||| DT
reaction  ||| S:29157 E:29166 ||| NN
was  ||| S:29166 E:29170 ||| VBD
terminated  ||| S:29170 E:29181 ||| VBN
by  ||| S:29181 E:29194 ||| IN
adding  ||| S:29194 E:29201 ||| VBG
1  ||| S:29201 E:29203 ||| CD
ml  ||| S:29203 E:29206 ||| NN
of  ||| S:29206 E:29209 ||| IN
DMEM  ||| S:29209 E:29214 ||| NNP
medium  ||| S:29214 E:29221 ||| NN
containing  ||| S:29221 E:29232 ||| VBG
10 ||| S:29232 E:29234 ||| CD
%  ||| S:29234 E:29236 ||| NN
FBS  ||| S:29236 E:29240 ||| NNP
and  ||| S:29240 E:29244 ||| CC
100  ||| S:29244 E:29258 ||| CD
units ||| S:29258 E:29263 ||| NNS
/ ||| S:29263 E:29264 ||| SYM
ml  ||| S:29264 E:29267 ||| FW
penicillin ||| S:29267 E:29277 ||| FW
/ ||| S:29277 E:29278 ||| FW
streptomycin  ||| S:29278 E:29291 ||| FW
and  ||| S:29291 E:29295 ||| CC
the  ||| S:29295 E:29299 ||| DT
entire  ||| S:29299 E:29306 ||| JJ
mixture  ||| S:29306 E:29324 ||| NN
added  ||| S:29324 E:29330 ||| VBD
to  ||| S:29330 E:29333 ||| TO
cells  ||| S:29333 E:29339 ||| NNS
in  ||| S:29339 E:29342 ||| IN
the  ||| S:29342 E:29346 ||| DT
60  ||| S:29346 E:29349 ||| CD
mm  ||| S:29349 E:29352 ||| JJ
dish ||| S:29352 E:29356 ||| NN
.  ||| S:29356 E:29358 ||| .
Cells  ||| S:29358 E:29364 ||| NNS
were  ||| S:29364 E:29369 ||| VBD
exposed  ||| S:29369 E:29377 ||| VBN
to  ||| S:29377 E:29390 ||| TO
Superfect  ||| S:29390 E:29400 ||| NNP
Reagent  ||| S:29400 E:29408 ||| NNP
for  ||| S:29408 E:29412 ||| IN
3  ||| S:29412 E:29414 ||| CD
hours ||| S:29414 E:29419 ||| NNS
.  ||| S:29419 E:29421 ||| .
At  ||| S:29421 E:29424 ||| IN
that  ||| S:29424 E:29429 ||| DT
time ||| S:29429 E:29433 ||| NN
,  ||| S:29433 E:29435 ||| ,
the  ||| S:29435 E:29439 ||| DT
reagent  ||| S:29439 E:29457 ||| NN
was  ||| S:29457 E:29461 ||| VBD
replaced  ||| S:29461 E:29470 ||| VBN
with  ||| S:29470 E:29475 ||| IN
DMEM  ||| S:29475 E:29480 ||| NNP
medium  ||| S:29480 E:29487 ||| NN
containing  ||| S:29487 E:29498 ||| VBG
10 ||| S:29498 E:29500 ||| CD
%  ||| S:29500 E:29502 ||| NN
FBS  ||| S:29502 E:29506 ||| NNP
and  ||| S:29506 E:29510 ||| CC
100  ||| S:29510 E:29524 ||| CD
units ||| S:29524 E:29529 ||| NNS
/ ||| S:29529 E:29530 ||| SYM
ml  ||| S:29530 E:29533 ||| FW
penicillin ||| S:29533 E:29543 ||| FW
/ ||| S:29543 E:29544 ||| FW
streptomycin  ||| S:29544 E:29557 ||| FW
and  ||| S:29557 E:29561 ||| CC
incubated  ||| S:29561 E:29571 ||| NN
for  ||| S:29571 E:29575 ||| IN
an  ||| S:29575 E:29588 ||| DT
additional  ||| S:29588 E:29599 ||| JJ
24  ||| S:29599 E:29602 ||| CD
hours  ||| S:29602 E:29608 ||| NNS
prior  ||| S:29608 E:29614 ||| RB
to  ||| S:29614 E:29617 ||| TO
use ||| S:29617 E:29620 ||| VB
.  ||| S:29620 E:29650 ||| .
Binding  ||| S:29650 E:29658 ||| JJ
assays  ||| S:29658 E:29675 ||| JJ
Transfected  ||| S:29675 E:29687 ||| JJ
cells  ||| S:29687 E:29693 ||| NNS
were  ||| S:29693 E:29698 ||| VBD
scraped  ||| S:29698 E:29706 ||| VBN
from  ||| S:29706 E:29711 ||| IN
the  ||| S:29711 E:29715 ||| DT
dishes ||| S:29715 E:29721 ||| NNS
,  ||| S:29721 E:29723 ||| ,
washed  ||| S:29723 E:29740 ||| VBD
twice  ||| S:29740 E:29746 ||| RB
with  ||| S:29746 E:29751 ||| IN
Dulbecco ||| S:29751 E:29759 ||| NNP
's  ||| S:29759 E:29762 ||| POS
PBS  ||| S:29762 E:29766 ||| NNP
( ||| S:29766 E:29767 ||| -LRB-
New  ||| S:29767 E:29771 ||| NNP
Life  ||| S:29771 E:29776 ||| NNP
Technologies ||| S:29776 E:29788 ||| NNPS
,  ||| S:29788 E:29790 ||| ,
NY ||| S:29790 E:29792 ||| NNP
) ||| S:29792 E:29793 ||| -RRB-
,  ||| S:29793 E:29805 ||| ,
then  ||| S:29805 E:29810 ||| RB
resuspended  ||| S:29810 E:29822 ||| VBN
in  ||| S:29822 E:29825 ||| IN
1.0  ||| S:29825 E:29829 ||| CD
ml  ||| S:29829 E:29832 ||| JJ
ice  ||| S:29832 E:29836 ||| NN
cold  ||| S:29836 E:29841 ||| JJ
PBS ||| S:29841 E:29844 ||| NNP
/ ||| S:29844 E:29845 ||| CD
100  ||| S:29845 E:29849 ||| CD
mm  ||| S:29849 E:29852 ||| JJ
dish ||| S:29852 E:29856 ||| NN
.  ||| S:29856 E:29868 ||| .
Cells  ||| S:29868 E:29874 ||| NNS
were  ||| S:29874 E:29879 ||| VBD
either  ||| S:29879 E:29886 ||| RB
used  ||| S:29886 E:29891 ||| VBN
fresh  ||| S:29891 E:29897 ||| JJ
or  ||| S:29897 E:29900 ||| CC
frozen  ||| S:29900 E:29907 ||| VBN
at  ||| S:29907 E:29910 ||| IN
this  ||| S:29910 E:29915 ||| DT
step  ||| S:29915 E:29920 ||| NN
until  ||| S:29920 E:29936 ||| IN
needed ||| S:29936 E:29942 ||| VBN
.  ||| S:29942 E:29944 ||| .
Immediately  ||| S:29944 E:29956 ||| RB
prior  ||| S:29956 E:29962 ||| RB
to  ||| S:29962 E:29965 ||| TO
use ||| S:29965 E:29968 ||| VB
,  ||| S:29968 E:29970 ||| ,
cells  ||| S:29970 E:29976 ||| NNS
were  ||| S:29976 E:29981 ||| VBD
homogenized  ||| S:29981 E:30003 ||| VBN
on  ||| S:30003 E:30006 ||| IN
ice  ||| S:30006 E:30010 ||| NN
in  ||| S:30010 E:30013 ||| IN
PBS  ||| S:30013 E:30017 ||| NNP
using  ||| S:30017 E:30023 ||| VBG
a  ||| S:30023 E:30025 ||| DT
glass  ||| S:30025 E:30031 ||| NN
tissue  ||| S:30031 E:30038 ||| NN
homogenizer  ||| S:30038 E:30050 ||| VBZ
then  ||| S:30050 E:30065 ||| RB
centrifuged  ||| S:30065 E:30077 ||| VBN
at  ||| S:30077 E:30080 ||| IN
35  ||| S:30080 E:30083 ||| CD
000  ||| S:30083 E:30087 ||| CD
×  ||| S:30087 E:30089 ||| CD
g  ||| S:30089 E:30091 ||| NN
for  ||| S:30091 E:30095 ||| IN
30  ||| S:30095 E:30098 ||| CD
minutes  ||| S:30098 E:30106 ||| NNS
in  ||| S:30106 E:30109 ||| IN
a  ||| S:30109 E:30111 ||| DT
Beckman  ||| S:30111 E:30129 ||| NNP
JA20  ||| S:30129 E:30134 ||| FW
rotor  ||| S:30134 E:30140 ||| FW
( ||| S:30140 E:30141 ||| -LRB-
4°C ||| S:30141 E:30144 ||| NNP
) ||| S:30144 E:30145 ||| -RRB-
.  ||| S:30145 E:30147 ||| .
Membranes  ||| S:30147 E:30157 ||| NNP
were  ||| S:30157 E:30162 ||| VBD
washed  ||| S:30162 E:30169 ||| VBN
once  ||| S:30169 E:30174 ||| RB
more  ||| S:30174 E:30179 ||| JJR
with  ||| S:30179 E:30194 ||| IN
PBS  ||| S:30194 E:30198 ||| NNP
at  ||| S:30198 E:30201 ||| IN
4°C  ||| S:30201 E:30205 ||| NNP
then  ||| S:30205 E:30210 ||| RB
resuspended  ||| S:30210 E:30222 ||| VBN
in  ||| S:30222 E:30225 ||| IN
1  ||| S:30225 E:30227 ||| CD
ml  ||| S:30227 E:30230 ||| JJ
PBS ||| S:30230 E:30233 ||| NNP
/ ||| S:30233 E:30234 ||| CD
100  ||| S:30234 E:30238 ||| CD
mm  ||| S:30238 E:30241 ||| JJ
dish ||| S:30241 E:30245 ||| NN
.  ||| S:30245 E:30257 ||| .
Protein  ||| S:30257 E:30265 ||| NN
content  ||| S:30265 E:30273 ||| NN
was  ||| S:30273 E:30277 ||| VBD
determined  ||| S:30277 E:30288 ||| VBN
using  ||| S:30288 E:30294 ||| VBG
a  ||| S:30294 E:30296 ||| DT
Lowry  ||| S:30296 E:30302 ||| JJ
assay  ||| S:30302 E:30318 ||| NNS
( ||| S:30318 E:30319 ||| -LRB-
Sigma ||| S:30319 E:30324 ||| NNP
.  ||| S:30324 E:30326 ||| .
Diagnostics ||| S:30326 E:30337 ||| NNP
,  ||| S:30337 E:30339 ||| ,
St.  ||| S:30339 E:30343 ||| NNP
Louis ||| S:30343 E:30348 ||| NNP
,  ||| S:30348 E:30350 ||| ,
MO ||| S:30350 E:30352 ||| NNP
) ||| S:30352 E:30353 ||| -RRB-
.  ||| S:30353 E:30355 ||| .
Membranes  ||| S:30355 E:30365 ||| NNP
were  ||| S:30365 E:30380 ||| VBD
initially  ||| S:30380 E:30390 ||| RB
prepared  ||| S:30390 E:30399 ||| VBN
and  ||| S:30399 E:30403 ||| CC
B  ||| S:30403 E:30416 ||| NNP
max  ||| S:30416 E:30420 ||| NN
and  ||| S:30420 E:30424 ||| CC
K  ||| S:30424 E:30437 ||| NNP
d  ||| S:30437 E:30439 ||| SYM
values  ||| S:30439 E:30446 ||| VBZ
determined  ||| S:30446 E:30457 ||| VBN
in  ||| S:30457 E:30460 ||| IN
the  ||| S:30460 E:30464 ||| DT
presence  ||| S:30464 E:30483 ||| NN
and  ||| S:30483 E:30487 ||| CC
absence  ||| S:30487 E:30495 ||| NN
of  ||| S:30495 E:30498 ||| IN
a  ||| S:30498 E:30500 ||| DT
cocktail  ||| S:30500 E:30509 ||| NN
of  ||| S:30509 E:30512 ||| IN
protease  ||| S:30512 E:30521 ||| JJ
inhibitors  ||| S:30521 E:30542 ||| NNS
( ||| S:30542 E:30543 ||| -LRB-
Complete  ||| S:30543 E:30552 ||| NNP
Protease  ||| S:30552 E:30561 ||| NNP
Inhibitor  ||| S:30561 E:30571 ||| NNP
Cocktail ||| S:30571 E:30579 ||| NNP
,  ||| S:30579 E:30581 ||| ,
Roche  ||| S:30581 E:30587 ||| NNP
Diagnostics ||| S:30587 E:30598 ||| NNPS
,  ||| S:30598 E:30610 ||| ,
Mannheim  ||| S:30610 E:30619 ||| NNP
Germany ||| S:30619 E:30626 ||| NNP
) ||| S:30626 E:30627 ||| -RRB-
.  ||| S:30627 E:30629 ||| .
No  ||| S:30629 E:30632 ||| DT
change  ||| S:30632 E:30639 ||| NN
in  ||| S:30639 E:30642 ||| IN
B  ||| S:30642 E:30655 ||| NNP
max  ||| S:30655 E:30659 ||| NN
was  ||| S:30659 E:30663 ||| VBD
observed  ||| S:30663 E:30672 ||| VBN
as  ||| S:30672 E:30675 ||| IN
a  ||| S:30675 E:30677 ||| DT
result  ||| S:30677 E:30684 ||| NN
of  ||| S:30684 E:30697 ||| IN
omitting  ||| S:30697 E:30706 ||| VBG
the  ||| S:30706 E:30710 ||| DT
protease  ||| S:30710 E:30719 ||| JJ
inhibitor  ||| S:30719 E:30729 ||| NNS
( ||| S:30729 E:30730 ||| -LRB-
B  ||| S:30730 E:30743 ||| NNP
max  ||| S:30743 E:30747 ||| NNS
( ||| S:30747 E:30748 ||| -LRB-
+  ||| S:30748 E:30750 ||| FW
protease  ||| S:30750 E:30759 ||| FW
inhibitor ||| S:30759 E:30768 ||| FW
) ||| S:30768 E:30769 ||| -RRB-
=  ||| S:30769 E:30771 ||| SYM
3.1  ||| S:30771 E:30775 ||| FW
±  ||| S:30775 E:30777 ||| FW
0.11  ||| S:30777 E:30792 ||| FW
pmoles ||| S:30792 E:30798 ||| FW
/ ||| S:30798 E:30799 ||| FW
mg  ||| S:30799 E:30802 ||| FW
protein  ||| S:30802 E:30810 ||| FW
vs  ||| S:30810 E:30813 ||| FW
B  ||| S:30813 E:30826 ||| NNP
max  ||| S:30826 E:30830 ||| NNS
( ||| S:30830 E:30831 ||| -LRB-
-  ||| S:30831 E:30833 ||| FW
protease  ||| S:30833 E:30842 ||| FW
inhibitor ||| S:30842 E:30851 ||| FW
)  ||| S:30851 E:30853 ||| -RRB-
=  ||| S:30853 E:30855 ||| SYM
3.2  ||| S:30855 E:30859 ||| CD
±  ||| S:30859 E:30871 ||| CD
0.13  ||| S:30871 E:30876 ||| CD
pmoles ||| S:30876 E:30882 ||| CD
/ ||| S:30882 E:30883 ||| CD
mg  ||| S:30883 E:30886 ||| CD
protein. ||| S:30886 E:30894 ||| CD
)  ||| S:30894 E:30896 ||| -RRB-
hence  ||| S:30896 E:30902 ||| RB
all  ||| S:30902 E:30906 ||| DT
assays  ||| S:30906 E:30913 ||| NN
were  ||| S:30913 E:30918 ||| VBD
performed  ||| S:30918 E:30938 ||| VBN
in  ||| S:30938 E:30941 ||| IN
the  ||| S:30941 E:30945 ||| DT
absence  ||| S:30945 E:30953 ||| NN
of  ||| S:30953 E:30956 ||| IN
the  ||| S:30956 E:30960 ||| DT
cocktail ||| S:30960 E:30968 ||| NN
.  ||| S:30968 E:30970 ||| .
Binding  ||| S:30970 E:30978 ||| JJ
assays  ||| S:30978 E:30985 ||| NN
were  ||| S:30985 E:31000 ||| VBD
performed  ||| S:31000 E:31010 ||| VBN
in  ||| S:31010 E:31013 ||| IN
PBS ||| S:31013 E:31016 ||| NNP
.  ||| S:31016 E:31028 ||| .
For  ||| S:31028 E:31032 ||| IN
K  ||| S:31032 E:31045 ||| NNP
d  ||| S:31045 E:31047 ||| SYM
determinations ||| S:31047 E:31061 ||| FW
,  ||| S:31061 E:31063 ||| ,
100  ||| S:31063 E:31067 ||| CD
μl  ||| S:31067 E:31070 ||| NN
of  ||| S:31070 E:31073 ||| IN
homogenate  ||| S:31073 E:31094 ||| NN
was  ||| S:31094 E:31098 ||| VBD
incubated  ||| S:31098 E:31108 ||| VBN
at  ||| S:31108 E:31111 ||| IN
37°C  ||| S:31111 E:31116 ||| CD
for  ||| S:31116 E:31120 ||| IN
1  ||| S:31120 E:31122 ||| CD
hour  ||| S:31122 E:31127 ||| NN
with  ||| S:31127 E:31132 ||| IN
varying  ||| S:31132 E:31150 ||| VBG
concentrations  ||| S:31150 E:31165 ||| NNS
of  ||| S:31165 E:31168 ||| IN
[  ||| S:31168 E:31170 ||| -LRB-
3H ||| S:31170 E:31172 ||| NNP
] ||| S:31172 E:31173 ||| -RRB-
granisetron  ||| S:31173 E:31185 ||| NNS
( ||| S:31185 E:31186 ||| -LRB-
NEN ||| S:31186 E:31189 ||| NNP
,  ||| S:31189 E:31191 ||| ,
MA ||| S:31191 E:31193 ||| NNP
) ||| S:31193 E:31194 ||| -RRB-
.  ||| S:31194 E:31196 ||| .
Specific  ||| S:31196 E:31215 ||| JJ
binding  ||| S:31215 E:31223 ||| NN
of  ||| S:31223 E:31226 ||| IN
[  ||| S:31226 E:31228 ||| -LRB-
3H ||| S:31228 E:31230 ||| NNP
] ||| S:31230 E:31231 ||| -RRB-
granisetron  ||| S:31231 E:31243 ||| NN
was  ||| S:31243 E:31247 ||| VBD
determined  ||| S:31247 E:31258 ||| VBN
as  ||| S:31258 E:31261 ||| IN
the  ||| S:31261 E:31265 ||| DT
bound  ||| S:31265 E:31271 ||| NN
[  ||| S:31271 E:31283 ||| -LRB-
3H ||| S:31283 E:31285 ||| NNP
] ||| S:31285 E:31286 ||| -RRB-
granisetron  ||| S:31286 E:31298 ||| VBZ
not  ||| S:31298 E:31302 ||| RB
displaced  ||| S:31302 E:31312 ||| VBN
by  ||| S:31312 E:31315 ||| IN
a  ||| S:31315 E:31317 ||| DT
saturating  ||| S:31317 E:31338 ||| JJ
concentration  ||| S:31338 E:31352 ||| NN
of  ||| S:31352 E:31355 ||| IN
a  ||| S:31355 E:31357 ||| DT
competing  ||| S:31357 E:31367 ||| JJ
ligand ||| S:31367 E:31373 ||| NN
.  ||| S:31373 E:31375 ||| .
K  ||| S:31375 E:31388 ||| NNP
d  ||| S:31388 E:31390 ||| NN
values  ||| S:31390 E:31397 ||| NNS
were  ||| S:31397 E:31402 ||| VBD
determined  ||| S:31402 E:31413 ||| VBN
by  ||| S:31413 E:31416 ||| IN
fitting  ||| S:31416 E:31434 ||| VBG
the  ||| S:31434 E:31438 ||| DT
binding  ||| S:31438 E:31446 ||| JJ
data  ||| S:31446 E:31451 ||| NNS
to  ||| S:31451 E:31454 ||| TO
the  ||| S:31454 E:31458 ||| DT
following  ||| S:31458 E:31468 ||| JJ
equation  ||| S:31468 E:31477 ||| NN
using  ||| S:31477 E:31483 ||| VBG
Graphpad  ||| S:31483 E:31502 ||| NNP
PRISM  ||| S:31502 E:31508 ||| NNP
( ||| S:31508 E:31509 ||| -LRB-
San  ||| S:31509 E:31513 ||| NNP
Diego  ||| S:31513 E:31519 ||| NNP
CA ||| S:31519 E:31521 ||| NNP
) ||| S:31521 E:31522 ||| -RRB-
:  ||| S:31522 E:31524 ||| :
B  ||| S:31524 E:31526 ||| NNP
=  ||| S:31526 E:31528 ||| NNP
B  ||| S:31528 E:31541 ||| NNP
max  ||| S:31541 E:31545 ||| NNS
[ ||| S:31545 E:31546 ||| -LRB-
L ||| S:31546 E:31547 ||| NNP
]  ||| S:31547 E:31549 ||| -RRB-
n ||| S:31549 E:31550 ||| FW
/  ||| S:31550 E:31552 ||| FW
( ||| S:31552 E:31553 ||| -LRB-
[ ||| S:31553 E:31554 ||| -LRB-
L ||| S:31554 E:31555 ||| NNP
]  ||| S:31555 E:31557 ||| -RRB-
n+  ||| S:31557 E:31560 ||| NNP
K  ||| S:31560 E:31562 ||| NNP
n ||| S:31562 E:31563 ||| CD
) ||| S:31563 E:31564 ||| -RRB-
,  ||| S:31564 E:31566 ||| ,
where  ||| S:31566 E:31572 ||| WRB
B  ||| S:31572 E:31574 ||| NNP
is  ||| S:31574 E:31587 ||| VBZ
bound  ||| S:31587 E:31593 ||| VBN
ligand ||| S:31593 E:31599 ||| NN
,  ||| S:31599 E:31601 ||| ,
B  ||| S:31601 E:31614 ||| NNP
max  ||| S:31614 E:31618 ||| NN
is  ||| S:31618 E:31621 ||| VBZ
the  ||| S:31621 E:31625 ||| DT
maximum  ||| S:31625 E:31633 ||| JJ
binding  ||| S:31633 E:31641 ||| NN
at  ||| S:31641 E:31654 ||| IN
equilibrium  ||| S:31654 E:31666 ||| JJ
L  ||| S:31666 E:31668 ||| NNP
is  ||| S:31668 E:31671 ||| VBZ
the  ||| S:31671 E:31675 ||| DT
free  ||| S:31675 E:31680 ||| JJ
ligand  ||| S:31680 E:31687 ||| JJ
concentration  ||| S:31687 E:31701 ||| NN
and  ||| S:31701 E:31705 ||| CC
n  ||| S:31705 E:31707 ||| NN
is  ||| S:31707 E:31720 ||| VBZ
the  ||| S:31720 E:31724 ||| DT
Hill  ||| S:31724 E:31729 ||| NNP
coefficient ||| S:31729 E:31740 ||| NN
.  ||| S:31740 E:31752 ||| .
K  ||| S:31752 E:31765 ||| NNP
i  ||| S:31765 E:31767 ||| FW
determinations ||| S:31767 E:31781 ||| FW
,  ||| S:31781 E:31783 ||| ,
100  ||| S:31783 E:31787 ||| CD
μl  ||| S:31787 E:31790 ||| NN
of  ||| S:31790 E:31793 ||| IN
homogenate  ||| S:31793 E:31814 ||| NN
was  ||| S:31814 E:31818 ||| VBD
incubated  ||| S:31818 E:31828 ||| VBN
at  ||| S:31828 E:31831 ||| IN
37°C  ||| S:31831 E:31836 ||| CD
for  ||| S:31836 E:31840 ||| IN
2  ||| S:31840 E:31842 ||| CD
hours  ||| S:31842 E:31848 ||| NNS
with  ||| S:31848 E:31853 ||| IN
varying  ||| S:31853 E:31871 ||| VBG
concentrations  ||| S:31871 E:31886 ||| NNS
of  ||| S:31886 E:31889 ||| IN
inhibitor  ||| S:31889 E:31899 ||| NN
and  ||| S:31899 E:31903 ||| CC
[  ||| S:31903 E:31905 ||| -LRB-
3H ||| S:31905 E:31907 ||| NNP
] ||| S:31907 E:31908 ||| -RRB-
granisetron  ||| S:31908 E:31920 ||| NNS
( ||| S:31920 E:31921 ||| -LRB-
NEN ||| S:31921 E:31924 ||| NNP
,  ||| S:31924 E:31936 ||| ,
MA ||| S:31936 E:31938 ||| NNP
) ||| S:31938 E:31939 ||| -RRB-
.  ||| S:31939 E:31941 ||| .
Binding  ||| S:31941 E:31949 ||| NNP
was  ||| S:31949 E:31953 ||| VBD
terminated  ||| S:31953 E:31964 ||| VBN
by  ||| S:31964 E:31967 ||| IN
rapid  ||| S:31967 E:31973 ||| JJ
filtration  ||| S:31973 E:31984 ||| NN
onto  ||| S:31984 E:31989 ||| IN
a  ||| S:31989 E:32001 ||| DT
GF ||| S:32001 E:32003 ||| NNP
/ ||| S:32003 E:32004 ||| NNP
B  ||| S:32004 E:32006 ||| NNP
filters ||| S:32006 E:32013 ||| NNS
.  ||| S:32013 E:32015 ||| .
The  ||| S:32015 E:32019 ||| DT
IC  ||| S:32019 E:32033 ||| NNP
50  ||| S:32033 E:32036 ||| CD
values  ||| S:32036 E:32043 ||| NNS
were  ||| S:32043 E:32048 ||| VBD
calculated  ||| S:32048 E:32059 ||| VBN
by  ||| S:32059 E:32062 ||| IN
fitting  ||| S:32062 E:32080 ||| VBG
the  ||| S:32080 E:32084 ||| DT
data  ||| S:32084 E:32089 ||| NNS
to  ||| S:32089 E:32092 ||| TO
the  ||| S:32092 E:32096 ||| DT
following  ||| S:32096 E:32106 ||| JJ
equation  ||| S:32106 E:32115 ||| NN
using  ||| S:32115 E:32121 ||| VBG
Graphpad  ||| S:32121 E:32130 ||| NNP
PRISM  ||| S:32130 E:32146 ||| NNP
( ||| S:32146 E:32147 ||| -LRB-
San  ||| S:32147 E:32151 ||| NNP
Diego  ||| S:32151 E:32157 ||| NNP
CA ||| S:32157 E:32159 ||| NNP
) ||| S:32159 E:32160 ||| -RRB-
:  ||| S:32160 E:32162 ||| :
θ  ||| S:32162 E:32164 ||| CD
=  ||| S:32164 E:32166 ||| SYM
1 ||| S:32166 E:32167 ||| CD
/  ||| S:32167 E:32169 ||| CD
( ||| S:32169 E:32170 ||| -LRB-
1+ ||| S:32170 E:32172 ||| NNP
( ||| S:32172 E:32173 ||| -LRB-
L ||| S:32173 E:32174 ||| NNP
/ ||| S:32174 E:32175 ||| NNP
IC  ||| S:32175 E:32189 ||| NNP
50  ||| S:32189 E:32192 ||| CD
) ||| S:32192 E:32193 ||| -RRB-
) ||| S:32193 E:32194 ||| -RRB-
,  ||| S:32194 E:32196 ||| ,
where  ||| S:32196 E:32202 ||| WRB
θ  ||| S:32202 E:32204 ||| NN
is  ||| S:32204 E:32207 ||| VBZ
the  ||| S:32207 E:32211 ||| DT
fractional  ||| S:32211 E:32232 ||| JJ
amount  ||| S:32232 E:32239 ||| NN
of  ||| S:32239 E:32242 ||| IN
[  ||| S:32242 E:32244 ||| -LRB-
3H ||| S:32244 E:32246 ||| NNP
] ||| S:32246 E:32247 ||| -RRB-
granisetron  ||| S:32247 E:32259 ||| VBZ
bound  ||| S:32259 E:32265 ||| VBN
in  ||| S:32265 E:32268 ||| IN
the  ||| S:32268 E:32272 ||| DT
presence  ||| S:32272 E:32281 ||| NN
of  ||| S:32281 E:32294 ||| IN
inhibitor  ||| S:32294 E:32304 ||| NN
at  ||| S:32304 E:32307 ||| IN
concentration  ||| S:32307 E:32321 ||| NN
L  ||| S:32321 E:32323 ||| NNP
as  ||| S:32323 E:32326 ||| RB
compared  ||| S:32326 E:32335 ||| VBN
to  ||| S:32335 E:32338 ||| TO
the  ||| S:32338 E:32342 ||| DT
amount  ||| S:32342 E:32349 ||| NN
of  ||| S:32349 E:32362 ||| IN
[  ||| S:32362 E:32364 ||| -LRB-
3H ||| S:32364 E:32366 ||| NNP
] ||| S:32366 E:32367 ||| -RRB-
granisetron  ||| S:32367 E:32379 ||| VBZ
bound  ||| S:32379 E:32385 ||| VBN
in  ||| S:32385 E:32388 ||| IN
the  ||| S:32388 E:32392 ||| DT
absence  ||| S:32392 E:32400 ||| NN
of  ||| S:32400 E:32403 ||| IN
inhibitor ||| S:32403 E:32412 ||| NN
.  ||| S:32412 E:32414 ||| .
IC  ||| S:32414 E:32428 ||| NNP
50  ||| S:32428 E:32431 ||| CD
is  ||| S:32431 E:32434 ||| VBZ
the  ||| S:32434 E:32438 ||| DT
concentration  ||| S:32438 E:32452 ||| NN
at  ||| S:32452 E:32455 ||| IN
which  ||| S:32455 E:32461 ||| WDT
θ  ||| S:32461 E:32463 ||| VBD
=  ||| S:32463 E:32475 ||| CD
0.5 ||| S:32475 E:32478 ||| CD
.  ||| S:32478 E:32480 ||| .
The  ||| S:32480 E:32484 ||| DT
K  ||| S:32484 E:32497 ||| NNP
i  ||| S:32497 E:32499 ||| FW
is  ||| S:32499 E:32502 ||| VBZ
calculated  ||| S:32502 E:32513 ||| VBN
from  ||| S:32513 E:32518 ||| IN
the  ||| S:32518 E:32522 ||| DT
IC  ||| S:32522 E:32536 ||| NNP
50  ||| S:32536 E:32539 ||| CD
value  ||| S:32539 E:32545 ||| NN
using  ||| S:32545 E:32551 ||| VBG
the  ||| S:32551 E:32555 ||| DT
Cheng-Prusoff  ||| S:32555 E:32579 ||| JJ
equation ||| S:32579 E:32587 ||| NN
.  ||| S:32587 E:32617 ||| .
Electrophysiological  ||| S:32617 E:32638 ||| NNP
Recordings  ||| S:32638 E:32659 ||| NNP
Transfected  ||| S:32659 E:32671 ||| NNP
cells  ||| S:32671 E:32677 ||| NNS
were  ||| S:32677 E:32682 ||| VBD
transferred  ||| S:32682 E:32694 ||| VBN
to  ||| S:32694 E:32697 ||| TO
a  ||| S:32697 E:32699 ||| DT
recording  ||| S:32699 E:32719 ||| NN
chamber  ||| S:32719 E:32727 ||| NN
containing  ||| S:32727 E:32738 ||| VBG
extracellular  ||| S:32738 E:32752 ||| JJ
solution  ||| S:32752 E:32761 ||| NN
( ||| S:32761 E:32762 ||| -LRB-
140  ||| S:32762 E:32766 ||| CD
mM  ||| S:32766 E:32769 ||| JJ
NaCl ||| S:32769 E:32773 ||| NN
,  ||| S:32773 E:32785 ||| ,
1.7  ||| S:32785 E:32789 ||| CD
mM  ||| S:32789 E:32792 ||| JJ
MgCl  ||| S:32792 E:32808 ||| JJ
2  ||| S:32808 E:32810 ||| CD
,  ||| S:32810 E:32812 ||| ,
5  ||| S:32812 E:32814 ||| CD
mM  ||| S:32814 E:32817 ||| JJ
KCl ||| S:32817 E:32820 ||| NN
,  ||| S:32820 E:32822 ||| ,
1.8  ||| S:32822 E:32826 ||| CD
mM  ||| S:32826 E:32829 ||| JJ
CaCl  ||| S:32829 E:32845 ||| JJ
2  ||| S:32845 E:32847 ||| CD
,  ||| S:32847 E:32849 ||| ,
25  ||| S:32849 E:32852 ||| CD
mM  ||| S:32852 E:32855 ||| JJ
HEPES  ||| S:32855 E:32861 ||| NNP
pH  ||| S:32861 E:32864 ||| NNP
7.4 ||| S:32864 E:32867 ||| CD
) ||| S:32867 E:32868 ||| -RRB-
.  ||| S:32868 E:32870 ||| .
Patch  ||| S:32870 E:32886 ||| JJ
electrodes  ||| S:32886 E:32897 ||| NNS
of  ||| S:32897 E:32900 ||| IN
resistance  ||| S:32900 E:32911 ||| NN
2.5-3.0  ||| S:32911 E:32919 ||| NNP
MΩ  ||| S:32919 E:32922 ||| NNP
were  ||| S:32922 E:32927 ||| VBD
filled  ||| S:32927 E:32934 ||| VBN
with  ||| S:32934 E:32949 ||| IN
filtered  ||| S:32949 E:32958 ||| JJ
intracellular  ||| S:32958 E:32972 ||| JJ
solution  ||| S:32972 E:32981 ||| NN
containing  ||| S:32981 E:32992 ||| VBG
145  ||| S:32992 E:32996 ||| CD
mM  ||| S:32996 E:32999 ||| JJ
KCl ||| S:32999 E:33002 ||| NN
,  ||| S:33002 E:33004 ||| ,
2  ||| S:33004 E:33016 ||| CD
mM  ||| S:33016 E:33019 ||| JJ
MgCl  ||| S:33019 E:33035 ||| JJ
2  ||| S:33035 E:33037 ||| CD
,  ||| S:33037 E:33039 ||| ,
1  ||| S:33039 E:33041 ||| CD
mM  ||| S:33041 E:33044 ||| JJ
EGTA ||| S:33044 E:33048 ||| NNP
,  ||| S:33048 E:33050 ||| ,
25  ||| S:33050 E:33053 ||| CD
mM  ||| S:33053 E:33056 ||| JJ
HEPES  ||| S:33056 E:33062 ||| NNP
( ||| S:33062 E:33063 ||| -LRB-
pH  ||| S:33063 E:33066 ||| NNP
7.4 ||| S:33066 E:33069 ||| CD
) ||| S:33069 E:33070 ||| -RRB-
.  ||| S:33070 E:33082 ||| .
Cells  ||| S:33082 E:33088 ||| NNS
were  ||| S:33088 E:33093 ||| VBD
clamped  ||| S:33093 E:33101 ||| VBN
in  ||| S:33101 E:33104 ||| IN
whole  ||| S:33104 E:33110 ||| JJ
cell  ||| S:33110 E:33115 ||| NN
configuration  ||| S:33115 E:33129 ||| NN
at  ||| S:33129 E:33132 ||| IN
a  ||| S:33132 E:33144 ||| DT
holding  ||| S:33144 E:33152 ||| NN
potential  ||| S:33152 E:33162 ||| NN
of  ||| S:33162 E:33165 ||| IN
-60  ||| S:33165 E:33169 ||| NNP
mV ||| S:33169 E:33171 ||| NNP
.  ||| S:33171 E:33173 ||| .
A  ||| S:33173 E:33175 ||| DT
continuous  ||| S:33175 E:33186 ||| JJ
extracellular  ||| S:33186 E:33210 ||| JJ
solution  ||| S:33210 E:33219 ||| NN
flow  ||| S:33219 E:33224 ||| NN
( ||| S:33224 E:33225 ||| -LRB-
0.8  ||| S:33225 E:33229 ||| FW
ml ||| S:33229 E:33231 ||| FW
/ ||| S:33231 E:33232 ||| FW
min ||| S:33232 E:33235 ||| FW
)  ||| S:33235 E:33237 ||| -RRB-
was  ||| S:33237 E:33241 ||| VBD
maintained  ||| S:33241 E:33252 ||| VBN
throughout  ||| S:33252 E:33263 ||| IN
the  ||| S:33263 E:33277 ||| DT
recording  ||| S:33277 E:33287 ||| NN
procedure.  ||| S:33287 E:33298 ||| NNP
5-HT  ||| S:33298 E:33303 ||| NNP
was  ||| S:33303 E:33307 ||| VBD
dissolved  ||| S:33307 E:33317 ||| VBN
in  ||| S:33317 E:33320 ||| IN
extracellular  ||| S:33320 E:33344 ||| JJ
solution  ||| S:33344 E:33353 ||| NN
and  ||| S:33353 E:33357 ||| CC
delivered  ||| S:33357 E:33367 ||| VBN
to  ||| S:33367 E:33370 ||| TO
cells  ||| S:33370 E:33376 ||| NNS
using  ||| S:33376 E:33382 ||| VBG
a  ||| S:33382 E:33384 ||| DT
rapid  ||| S:33384 E:33390 ||| JJ
perfusion  ||| S:33390 E:33410 ||| JJ
system  ||| S:33410 E:33417 ||| NN
( ||| S:33417 E:33418 ||| -LRB-
Warner  ||| S:33418 E:33425 ||| NNP
Instruments ||| S:33425 E:33436 ||| NNP
,  ||| S:33436 E:33438 ||| ,
Hamden ||| S:33438 E:33444 ||| NNP
,  ||| S:33444 E:33446 ||| ,
CT ||| S:33446 E:33448 ||| NNP
)  ||| S:33448 E:33450 ||| -RRB-
at  ||| S:33450 E:33453 ||| IN
a  ||| S:33453 E:33455 ||| DT
rate  ||| S:33455 E:33470 ||| NN
matching  ||| S:33470 E:33479 ||| VBG
the  ||| S:33479 E:33483 ||| DT
extracellular  ||| S:33483 E:33497 ||| JJ
solution  ||| S:33497 E:33506 ||| NN
flow  ||| S:33506 E:33511 ||| NN
rate ||| S:33511 E:33515 ||| NN
.  ||| S:33515 E:33517 ||| .
The  ||| S:33517 E:33521 ||| DT
drug  ||| S:33521 E:33536 ||| NN
perfusions  ||| S:33536 E:33547 ||| VBZ
lasted  ||| S:33547 E:33554 ||| VBN
for  ||| S:33554 E:33558 ||| IN
a  ||| S:33558 E:33560 ||| DT
period  ||| S:33560 E:33567 ||| NN
varying  ||| S:33567 E:33575 ||| VBG
from  ||| S:33575 E:33580 ||| IN
4  ||| S:33580 E:33582 ||| CD
to  ||| S:33582 E:33585 ||| TO
8  ||| S:33585 E:33597 ||| CD
seconds ||| S:33597 E:33604 ||| NNS
.  ||| S:33604 E:33606 ||| .
Currents  ||| S:33606 E:33615 ||| JJ
elicited  ||| S:33615 E:33624 ||| NN
by  ||| S:33624 E:33627 ||| IN
agonist  ||| S:33627 E:33635 ||| JJ
application  ||| S:33635 E:33647 ||| NN
were  ||| S:33647 E:33662 ||| VBD
measured  ||| S:33662 E:33671 ||| VBN
using  ||| S:33671 E:33677 ||| VBG
an  ||| S:33677 E:33680 ||| DT
Axopatch  ||| S:33680 E:33689 ||| NNP
200  ||| S:33689 E:33693 ||| CD
B  ||| S:33693 E:33695 ||| NN
amplifier  ||| S:33695 E:33705 ||| NNS
( ||| S:33705 E:33706 ||| -LRB-
Foster  ||| S:33706 E:33713 ||| NNP
City ||| S:33713 E:33717 ||| NNP
,  ||| S:33717 E:33729 ||| ,
CA ||| S:33729 E:33731 ||| NNP
) ||| S:33731 E:33732 ||| -RRB-
.  ||| S:33732 E:33734 ||| .
The  ||| S:33734 E:33738 ||| DT
data  ||| S:33738 E:33743 ||| NNS
were  ||| S:33743 E:33748 ||| VBD
plotted  ||| S:33748 E:33756 ||| JJ
and  ||| S:33756 E:33760 ||| CC
analyzed  ||| S:33760 E:33769 ||| VBD
by  ||| S:33769 E:33772 ||| IN
non-linear  ||| S:33772 E:33793 ||| JJ
curve  ||| S:33793 E:33799 ||| NN
fitting  ||| S:33799 E:33807 ||| NNS
( ||| S:33807 E:33808 ||| -LRB-
Graphpad  ||| S:33808 E:33817 ||| NNP
PRISM ||| S:33817 E:33822 ||| NNP
,  ||| S:33822 E:33824 ||| ,
San  ||| S:33824 E:33828 ||| NNP
Diego  ||| S:33828 E:33834 ||| NNP
CA ||| S:33834 E:33836 ||| NNP
)  ||| S:33836 E:33838 ||| -RRB-
according  ||| S:33838 E:33848 ||| VBG
to  ||| S:33848 E:33861 ||| TO
the  ||| S:33861 E:33865 ||| DT
following  ||| S:33865 E:33875 ||| JJ
equation ||| S:33875 E:33883 ||| NN
:  ||| S:33883 E:33885 ||| :
I  ||| S:33885 E:33887 ||| PRP
=  ||| S:33887 E:33889 ||| SYM
1 ||| S:33889 E:33890 ||| CD
/ ||| S:33890 E:33891 ||| CD
( ||| S:33891 E:33892 ||| -LRB-
1  ||| S:33892 E:33894 ||| CD
+ ||| S:33894 E:33895 ||| CD
( ||| S:33895 E:33896 ||| -LRB-
EC  ||| S:33896 E:33910 ||| NNP
50  ||| S:33910 E:33913 ||| CD
/  ||| S:33913 E:33915 ||| CD
[ ||| S:33915 E:33916 ||| -LRB-
C ||| S:33916 E:33917 ||| $
] ||| S:33917 E:33918 ||| CD
)  ||| S:33918 E:33920 ||| -RRB-
n ||| S:33920 E:33921 ||| NN
) ||| S:33921 E:33922 ||| -RRB-
,  ||| S:33922 E:33924 ||| ,
where  ||| S:33924 E:33930 ||| WRB
is  ||| S:33930 E:33933 ||| VBZ
the  ||| S:33933 E:33937 ||| DT
normalized  ||| S:33937 E:33958 ||| JJ
current  ||| S:33958 E:33966 ||| JJ
at  ||| S:33966 E:33969 ||| IN
5-HT  ||| S:33969 E:33974 ||| CD
concentration  ||| S:33974 E:33988 ||| NN
[ ||| S:33988 E:33989 ||| -LRB-
C ||| S:33989 E:33990 ||| NNP
] ||| S:33990 E:33991 ||| -RRB-
,  ||| S:33991 E:33993 ||| ,
EC  ||| S:33993 E:34007 ||| NNP
50  ||| S:34007 E:34010 ||| CD
is  ||| S:34010 E:34013 ||| VBZ
the  ||| S:34013 E:34017 ||| DT
concentration  ||| S:34017 E:34031 ||| NN
of  ||| S:34031 E:34034 ||| IN
5-HT  ||| S:34034 E:34039 ||| NNP
needed  ||| S:34039 E:34056 ||| VBD
to  ||| S:34056 E:34059 ||| TO
obtain  ||| S:34059 E:34066 ||| VB
half  ||| S:34066 E:34071 ||| DT
maximal  ||| S:34071 E:34079 ||| JJ
activation  ||| S:34079 E:34090 ||| NN
and  ||| S:34090 E:34094 ||| CC
n  ||| S:34094 E:34096 ||| NN
is  ||| S:34096 E:34099 ||| VBZ
the  ||| S:34099 E:34103 ||| DT
apparent  ||| S:34103 E:34122 ||| JJ
Hill  ||| S:34122 E:34127 ||| NNP
coefficient ||| S:34127 E:34138 ||| NN
.  ||| S:34138 E:34164 ||| .
